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ABSTRACT
Neurofibromatosis type 2 is an autosomal dominant disease characterized by the formation of
schwannomas and other peripheral neuropathies. The nf2 gene encodes the protein
Schwannomin, or merlin. Schwannomin (Sch) is a membrane-cytoskeletal linking protein that
suppresses cell proliferation at high cell density and modulates cell shape. Sch’s tumor
suppressive activity is regulated by its localization, conformation, and phosphorylation at serine
518 (S518). Sch’s localization is dependent on binding the scaffold protein, paxillin.
Phosphorylation of Sch at S518 regulates its conformation and tumor suppressor function. In a
negative feedback loop, unphosphorylated Sch restricts cell proliferation downstream of Rac and
p21-activated kinase (Pak), whereas Pak-induced phosphorylation inactivates Sch’s ability to
inhibit Pak and cell proliferation. Little is known about the function of the phosphorylated form
of Sch, or the molecular mechanisms leading to its phosphorylation. Here we demonstrate that
Sch-S518 phosphorylation is dependent on paxillin-binding and plasma membrane localization
in SCs. Phosphorylation of Sch at the plasma membrane is mediated by Cdc42-Pak and results
in altered SC morphology and polarity. Moreover, we have identified two extracellular stimuli
that trigger Sch-S518 phosphorylation; these are neuregulin (NRG) and laminin, two potent
activators of SC proliferation and myelination. NRG promotes Sch-S518 phosphorylation
downstream of ErbB2/ErbB3 through PKA, whereas laminin-1 stimulation of β1 integrin
promotes Pak- dependent phosphorylation of Sch-S518. Additionally, we find that Sch promotes
process formation and elongation in primary and myelinating SCs, independent of Sch S518
phosphorylation. However, Sch phosphorylation was found to influence SC differentiation, as
expression of an unphosphorylatable variant, Sch-S518A, facilitated SC myelination, whereas
iii

expression of a phospho-mimicking variant, Sch-S518D, reduced the SC’s ability to myelinate.
Together, these findings have identified receptor-mediated and paxillin-dependent pathways that
regulate phosphorylation and inactivation of Sch’s tumor suppressor function. Additionally,
these results have elucidated novel normal functions for Sch during peripheral nerve
development and myelination, and identify novel therapeutic targets for treatment of NF2 and
other peripheral neuropathies.

iv

ACKNOWLEDGMENTS
I would like to thank Dr. Fernandez-Valle, Jorge Lopera, and Marga Bott for all your guidance,
help and support. I would also like to thank my committee members for all of your insightful
comments and suggestions. And last, but not least, I would like to thank my parents and family
for always supporting me in every endeavor, and for allowing me to follow my dreams.

v

TABLE OF CONTENTS
LIST OF FIGURES ...................................................................................................................... xii
CHAPTER 1 GENERAL INTRODUCTION ................................................................................ 1
1.1 Neurofibromatosis Type 2 .................................................................................................... 1
1.2 Schwannomin, A Novel Membrane-Cytoskeletal Protein Regulating Cell Proliferation. ... 3
1.2.1 Structure And Function Of Schwannomin..................................................................... 3
1.2.2 Conformational Regulation Of Schwannomin Activity ................................................ 4
1.2.3 Phosphorylation Of Schwannomin S518 Is Mediated By p21-Activated Kinase And
Protein Kinase A ..................................................................................................................... 5
1.2.4 Schwannomin’s Regulation of Actin Polymerization Dynamics .................................. 7
1.2.5 Protein Interactions Regulating Schwannomin Function .............................................. 9
1.3 Schwann Cells: The Myelinating Glia Of The Peripheral Nervous System....................... 13
1.3.1 Signals Determining SC Differentiation And Myelination ......................................... 14
1.3.2 Extracellular Matrix Mediated SC Development: Signaling from Laminins and β1
integrin .................................................................................................................................. 16
1.3.3 Axonal Cues Regulating SC Development: The Roles Of Neuregulin And ErbB2 In
SC Myelination ..................................................................................................................... 18
2.1 Introduction......................................................................................................................... 21
2.2 Materials and Methods........................................................................................................ 24
2.2.1 Materials ...................................................................................................................... 24
2.2.2 Cell Culture.................................................................................................................. 24
2.2.3 Transfections................................................................................................................ 25
vi

2.2.4 Immunoprecipitation And Western Blotting ............................................................... 25
2.2.5 Immunostaining ........................................................................................................... 25
2.2.6 Pak-CRIB Pull Down Assay........................................................................................ 26
2.3 Results................................................................................................................................. 28
2.3.1 Deletion Of Paxillin Binding Domain 1 Prevents Sch Phosphorylation ..................... 28
2.3.2 Deletion Of PBD2 Is Not Associated With Increased P-Pak Levels........................... 29
2.3.3 Expression Of Active Forms Of Cdc42 And Rac Indiscriminately Increases P-Pak
Levels In SCs ........................................................................................................................ 30
2.3.4 Expression Of Active Cdc42 And Rac Does Not Promote Unrestricted
Phosphorylation Of Endogenous Sch But Does Increase Phosphorylation Of Sch-GFP..... 31
2.3.5 Inhibition Of Rac-GTP Does Not Reduce Phosphorylation Of Sch S518 Or Pak ...... 32
2.3.6 PS518-Sch And Paxillin Co-Localize With Cdc42 And P-Pak In Membrane
Protrusions ............................................................................................................................ 33
2.3.7 Sch Serine 518 Phosphorylation Modulates Morphology In SCs ............................... 33
2.4 Discussion ........................................................................................................................... 35
2.4.1 Interactions With Paxillin Regulate Sch S518 Phosphorylation.................................. 35
2.4.2 Evidence For Cdc42-Pak Dependent S518 Phosphorylation....................................... 36
2.4.3 Activation Of Cdc42-Pak Dependent Sch S518 Phosphorylation............................... 37
2.4.4 Sch Regulates The Organization Of The Actin Cytoskeleton ..................................... 38
2.4.5 Two Pools Of Sch With Distinct Functions................................................................. 39

vii

CHAPTER 3 NEUREGULIN AND LAMININ STIMULATE PHOSPHORYLATION OF THE
NF2 TUMOR SUPPRESSOR IN SCHWANN CELLS BY DISTINCT PROTEIN KINASE A
AND P21-ACTIVATED KINASE DEPENDENT PATHWAYS ............................................... 60
3.1 Introduction......................................................................................................................... 60
3.2 Materials and Methods........................................................................................................ 62
3.2.1 Materials ...................................................................................................................... 62
3.2.2 Cell Culture.................................................................................................................. 62
3.2.3 Immunostaining ........................................................................................................... 63
3.2.4 Western Blotting .......................................................................................................... 63
3.2.5 Immunoprecipitation.................................................................................................... 64
3.2.6 Transfections................................................................................................................ 64
3.3 Results................................................................................................................................. 65
3.3.1 NRG1β and Laminin-1 Induce Phosphorylation of Sch at SC Distal Tips and Radial
Membrane Protrusions .......................................................................................................... 65
3.3.2 NRG1β Promotes Sch Phosphorylation Through PKA............................................... 66
3.3.3 Laminin-1 Promotes Phosphorylation Of Sch-S518 By Pak....................................... 67
3.3.4 β1 Integrin And ErbB2 Exist As A Functional Co-Receptor Complex On The SC
Surface .................................................................................................................................. 68
3.3.5 Dual Stimulation With NRG1β And Laminin-1 Does Not Synergistically Increase Sch
Phosphorylation .................................................................................................................... 70
3.4 Discussion ........................................................................................................................... 72
3.4.1 Two Distinct Receptor Mediated Pathways Promote Sch Phosphorylation................ 72
viii

3.4.2 ErbB2 Modulates β1 Integrin Signaling ...................................................................... 74
3.4.3 Implications For Schwannoma Development.............................................................. 74
CHAPTER 4 EXPRESSION OF THE NF2 TUMOR SUPRESSOR IN SCHWANN CELLS
PROMOTES PROCESS EXTENSION AND MYELINATION................................................. 97
4.1 Introduction......................................................................................................................... 97
4.2 Materials and Methods...................................................................................................... 100
4.2.1 Materials .................................................................................................................... 100
4.2.2 Cell Culture................................................................................................................ 100
4.2.3 Transfection Of Schwann Cell And Dorsal Root Ganglion Neuron Co-Cultures ..... 101
4.2.4 Immunostaining ......................................................................................................... 101
4.3 Results............................................................................................................................... 102
4.3.1 Sch Expression Promotes Process Extension In SCs................................................. 102
4.3.2 Sch Expression Increases Myelin Internodal Length................................................. 103
4.3.3 Myelin Formation But Not Internodal Length Is Dependent On Sch-S518
Phosphorylation .................................................................................................................. 104
4.3.4 Sch-S518 Phosphorylation Decreases With The Onset Of Myelination ................... 105
4.3.5 GFP-Positive Myelin Segments Express CASPR and P-ERM at the Paranode and
Node of Ranvier.................................................................................................................. 106
4.4 Discussion ......................................................................................................................... 108
4.4.1 Control of Process Formation and Extension By Sch................................................ 109
4.4.2 SC Myelination is Regulated by Sch-S518 Phosphorylation .................................... 109
4.4.3 Implications for the Development of Myelin Abnormalities and Neuropathies........ 110
ix

CHAPTER 5 GENRAL DISCUSSION...................................................................................... 121
5.1 Schwannomin-S518 Phosphorylation Is Dependent On Paxillin Binding and Plasma
Membrane Localization ...................................................................................................... 121
5.2 Schwannomin-S518 Phosphorylation Is Stimulated By NRG And Laminin-1 Through
Distinct PKA And Pak Mediated Pathways........................................................................ 122
5.3 Schwannomin Promotes Process Elongation In Primary And Myelinating SCs And
Controls Myelination In A Phosphorylation Dependent Manner ....................................... 124
5.4 Implications for Schwannomin Phosphorylation During SC Development: Control Of
SC Process Formation and Extension, Migration, Proliferation, And Myelination ........... 125
5.5 Implications for the Development of Schwannomas and Neurofibromatosis Type 2 .. 130
APPENDIX: EXPERIMENTAL PROCEDURES .................................................................... 133
A.1 Molecular Cloning Procedures......................................................................................... 134
A.1.1 Bacterial Transformation of Plasmid DNA .............................................................. 134
A.1.2 Mini Prep of Plasmid DNA (Qiagen QIAprep Miniprep Protocol/Method) ............ 136
A.2 Biochemical Procedures................................................................................................... 137
A.2.1 Transfection of Primary Rat Schwann Cells (Lipofectamine 2000)......................... 137
A.2.2 Transfection of Dissociated Schwann Cell/ Dorsal Root Ganglion Neuron Co-cultures
(Lipofectamine 2000).......................................................................................................... 139
A.2.3 Extraction of Primary Rat Schwann Cells (transfected and non-transfected) .......... 141
A.2.4 Lowry Method For The Determination Of Cell Lysate Protein Concentration........ 143
A.2.5 Immunoprecipitation using Total Schwann Cell Extract.......................................... 144
A.2.6 Magnetic Bead Immunoprecipitation of β1 integrin................................................. 146
x

A.2.7 Preparation Of SDS-PAGE Gel And Electrophoretic Separation Of Proteins ......... 147
A2.8 Electrophoretic Transfer Of SDS-PAGE To A PVDF Membrane. ........................... 149
A.2.9 Immunoblotting......................................................................................................... 150
A.2.10 Immunostaining of Primary Rat Schwann Cells..................................................... 151
A.2.11 Immunostaining of Dissociated Schwann Cell/ Dorsal Root Ganglion Neuron Cocultures................................................................................................................................ 152
A.3 Cell Culture Procedures ................................................................................................... 154
A.3.1 Rat Sciatic Nerve Dissection..................................................................................... 154
A.3.2 THY 1.1 Treatment ................................................................................................... 158
A.3.3 Rat Dorsal Root Ganglion Dissection....................................................................... 160
A.3.4 Laminin Coating ....................................................................................................... 166
LIST OF REFERENCES............................................................................................................ 170

xi

LIST OF FIGURES
Figure 2.1 PBD1 Is Required For Serine 518 Phosphorylation Of Sch........................................ 41
Figure 2.2 Sch-GFP Is Phosphorylated At Restricted Plasma Membrane Domains. ................... 43
Figure 2.3 Deletion Of PBD2 Is Not Associated With Increased Pak Activity In SCs................ 45
Figure 2.4 Expression Of Active Cdc42 And Rac Increases Endogenous P-Pak Levels. ............ 47
Figure 2.5 Expression Of Active Cdc42 and Rac Does Not Increase Phosphorylation of
Endogenous Sch............................................................................................................................ 49
Figure 2.6 Expression Of Active Cdc42 And Rac Increases S518 Phosphorylation Of Exogenous
Sch-GFP........................................................................................................................................ 51
Figure 2.7 Inhibition of Rac GTPase Does Not Reduce Sch S518 and Pak Phosphorylation...... 53
Figure 2.8 Sch-PS518, Paxillin, Cdc42, P-Pak, But not Rac Colocalize In Membrane Protrusions.
....................................................................................................................................................... 56
Figure 2.9 Sch Phosphorylation Status Alters SC Morphology. .................................................. 58
Figure 3.1 Phosphorylated Forms Of ErbB2, Sch, And Pak Co-localize With Paxillin And Cdc42
In Processes, Their Distal Tips And Radial Protrusions Following Acute Stimulation With
NRG1β.......................................................................................................................................... 78
Figure 3.2 NRG1β And Laminin-1 Induce Sch Phosphorylation In SC Processes...................... 80
Figure 3.3 NRG1β Stimulates Phosphorylation Of Sch By PKA ................................................ 83
Figure 3.4 Laminin-1 Stimulates Phosphorylation Of Sch........................................................... 85
Figure 3.5 Catalytically Inactive Pak Inhibits Sch Phosphorylation In SCs Adhering To Laminin1..................................................................................................................................................... 87

xii

Figure 3.6 β1 integrin And ErbB2 Exist As A Complex On The Plasma Membrane. ................. 89
Figure 3.7 AG825 Increases Sch Phosphorylation In Response To Laminin-1 And NRG1β...... 93
Figure 3.8 Model Of ErbB And β1 Integrin Induced Phosphorylation Of Sch And Inactivation Of
Its Tumor Suppressor Function In Subconfluent SCs................................................................... 95
Figure 4.1 Expression Of Sch Increases SC Process Length...................................................... 113
Figure 4.2 Sch Increases The Myelin Internodal Length And The Frequency Of Myelination Is
Dependent On S518 Phosphorylation......................................................................................... 115
Figure 4.3 Sch-S518 Phosphorylation Decreases In SC At The Onset Of Myelination............. 117
Figure 4.4 Expression Of Sch Phospho-variants Does Not Alter CASPR Or P-ERM Localization
In Myelinating SC/DRGN Co-Cultures...................................................................................... 119

xiii

CHAPTER 1
GENERAL INTRODUCTION
1.1 Neurofibromatosis Type 2
Neurofibromatosis type 2 (NF2) is an autosomal dominant inherited disease affecting
approximately 1 in 25,000 individuals (reviewed in Ferner, 2007). NF2 is characterized by the
formation of multiple benign nervous system tumors, including schwannomas, meningiomas,
and ependymomas, as well as ocular abnormalities (Gutmann et al., 1997; Ferner 2007). The
hallmark of NF2 is the formation of bilateral vestibular schwannomas on the 8th cranial nerve,
resulting in loss of hearing and tinnitus, and loss of balance and dizziness (reviewed in
Houshmandi and Gutmann, 2007). Individuals with NF2 can also develop cutaneous
schwannomas, focal amyotrophy resulting in foot drop, facial mononeuropathy, cataracts, orbital
meningiomas, and retinal hamartomas. Most of these symptoms present themselves in children
with inherited NF2, as opposed to adults with non-inherited NF2 (reviewed in MacCollin and
Mautner, 1998). Although NF2 has been found in children under the age of 15, and as young as
2, the average age of onset is between 18-24 years (Evans et al, 1992). The later onset of NF2
can be partially explained by the fact that 50% of individuals with NF2 have a non-inherited,
sporadic form that arises after an individual acquires spontaneous mutations in the NF2 gene,
and therefore the appearance of symptoms can take years to manifest. Another factor
contributing to the delayed onset of NF2 symptoms is the slow growth of the schwannomas.
Moreover, the growth rate of the tumors appears to decrease with increasing age (Patronas et al.,
2001). The major factor accounting for the highest rate of morbidity and mortality in NF2 is the
formation of cranial meningiomas that occur in approximately 45% of NF2 patients (Evans et al.,
1

2005). Other factors contributing to the mortality of individuals with NF2 are the severity of the
disease, the location and amount of tumors, the age at diagnosis, and the treatment regimen.

NF2 is caused by mutations within the nf2 gene located on chromosome 22q12.2. NF2
comprises 17 exons, and naturally occurring mutations can be found throughout all exons. These
mutations include missense, non-sense, frameshift, splice site and somatic mosaicism (Baser et
al., 2005). The severity of NF2 depends on the type of mutation, non-sense and frameshift being
the most severe, and the exon in which the mutation occurs. Splice site mutations found in exons
1-5, and particularly those in exons 2-3, indicate a more severe phenotype than those arising
from exons 11-15 (Baser et al., 2005). The criteria for diagnosis of NF2 has evolved, as initially
family history was a prerequisite for disease development, but as mentioned above, non-inherited
NF2 comprises 50% of all cases. The current clinical criteria for diagnosis include the
appearance of tumors other than bilateral vestibular schwannomas that develop in both familial
and non-familial cases (reviewed in Hanemann and Evans, 2006). Treatment for individuals
with NF2 is limited, and consists of surgery to remove tumors, tumor-focused radiological
surgery, and auditory brainstem implants, but all of these treatments involve high risks. Surgery
to remove the tumors often results in facial nerve damage, corneal ulceration, disfigurement, and
permanent hearing loss, and is only recommended in severe cases involving large tumor growth,
and brainstem compression (Evans et al., 2005). Stereotatic radiosurgery, where radiation is
applied directly to the tumor growth, can delay hearing loss, but it can also lead to the
development of other brain malignancies (Rowe et al., 2002). The auditory brainstem implant
has been shown to alleviate the loss of hearing and improve cochlear nerve function, but unless
2

NF2 is diagnosed early, this treatment might not benefit the patient (Lustig et al., 2006). Any
advancement in the detection and treatment would not only benefit those individuals afflicted
with NF2, but individuals with other neuropathies such as Schwannomatosis.

1.2 Schwannomin, A Novel Membrane-Cytoskeletal Protein Regulating Cell
Proliferation.
1.2.1 Structure And Function Of Schwannomin
The nf2 gene encodes a 595 amino acid protein termed Schwannomin, or Merlin, that is
approximately 68kD (Rouleau et al., 1993; Trofatter et al., 1993). Schwannomin is ubiquitously
expressed, and found in all tissues, but the highest levels of expression are found in Schwann
cells, peripheral neurons, meningial cells and the lens (Claudio et al., 1997; den Bakker et al.,
1999). Schwannomin was found to be mutated or absent in individuals with NF2, and was
therefore classified as a tumor suppressor. Unlike classical tumor suppressors, such as p53 and
Rb that inhibit proliferation by acting directly on the cell cycle, Schwannomin’s growth
suppression is indirect, and occurs through its association with plasma membrane components
and the actin cytoskeleton.

Schwannomin is related to the ERM (ezrin, radixin, and moesin) family of membranecytoskeletal linking proteins (Troffater et al., 1993). Because the related ERMs lack the ability
to suppress cell growth, Schwannomin is a unique family member (Rouleau et al., 1993;
Troffater et al., 1993). Schwannomin and ERM share the highest homology within the N3

terminus, referred to as the FERM domain. The FERM domain is a globular structure comprised
of three subdomains, F1-F3, that structurally resembles a cloverleaf (reviewed in Ramesh, 2004).
This structure is responsible for the interaction and localization of ERMs and Schwannomin to
the plasma membrane (reviewed in Tsukita and Yonemura, 1999; Brault et al., 2001). The Cterminus of ERM and Schwannomin are less homologous, and therefore suggests that
Schwannomin’s inhibitory function might be encoded within this domain. Unlike ERMs,
Schwannomin’s C-terminus does not contain an actin binding region. However, Schwannomin
can bind actin through a region localized within the N-terminus (Xu et al., 1998; Brault et al.,
2001; James et al., 2001).

1.2.2 Conformational Regulation Of Schwannomin Activity
Key to the activity of ERMs and Schwannomin is their ability to form intramolecular and
intermolecular associations (Sherman et al., 1997; Hamada et al., 2000; Pearson et al., 2000).
Additional functions important to the activity of Schwannomin and ERMs include the
phosphorylation and localization of each within the cell. ERMs and Schwannomin can bind to
one another, creating dimers and/ or oligomers. They can also self-associate in a “head-to-tail”
fashion, where the N-terminal FERM domain binds and masks the charged C-terminus. For
ERMs, self association renders the proteins inactive, as they can no longer associate with actin.
However, for Schwannomin, the closed, self-associated conformation is considered to be the
active tumor suppressor form (Surace et al., 2004; reviewed in Okada et al., 2006). Both
intramolecular and intermolecular associations are relieved by interactions with phospholipids
like phosphoinositol-4, 5-bisphosphate, and phosphorylation (Hamada et al., 2000).
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Phosphorylation occurs at a conserved C-terminal threonine in ERMS, and at serine 518 in
Schwannomin (Hirao et al., 1996; Matsui et al., 1998; Gonzalez-Agosti et al., 1999; Rong et al.,
2004). In the open, phosphorylated conformation, ERMs can actively associate with membrane
components and bind actin, allowing for extracellular stimulus induced restructuring of the actin
cytoskeleton (reviewed in Tsukita and Yonemura, 1999). For Schwannomin, the role S518
phosphorylation plays on regulating its function remains elusive. Studies have shown that S518
phosphorylation negatively regulates Schwannomin’s ability to suppress growth, but it does not
concomitantly increase cell proliferation (Shaw et al., 2001; Surace et al., 2004). Furthermore,
the morphological and physiological changes that phosphorylation of Schwannomin at S518
imparts on the cell are poorly understood.

1.2.3 Phosphorylation Of Schwannomin S518 Is Mediated By p21-Activated Kinase And
Protein Kinase A
Until recently, the only characterized phosphorylation site on Schwannomin was the C-terminal
serine 518 residue. Schwannomin S518 can be phosphorylated by two kinases, p21-activaed
kinase (Pak) and protein kinase A (PKA; Kissil et al., 2002; Xiao et al., 2002). Little is known
about the upstream mechanisms leading to either Pak- or PKA-mediated phosphorylation of
Schwannomin in any cell type. Moreover, only 2 papers out of 24 have examined Schwannomin
phosphorylation in Schwann cells, the afflicted cell in NF2 (Rangwala et al., 2005; Muranen et
al., 2007). What is known, is that phosphorylation of Schwannomin S518 by Pak is dependent
on the activity of Rac and/or Cdc42, members of the Rho GTPase family of actin cytoskeleton
regulators (Shaw et al., 2001; reviewed in Hall, 2005). Studies performed in schwannoma cells
5

indicated that Schwannomin and Pak might co-regulate the activities of one another, as these
cells expressed high levels of active Pak and Rac in the absence of Schwannomin expression
(Kaempchen et al., 2003). Indeed, Schwannomin and Pak participate in a negative feedback
loop, whereby Pak phosphorylation of S518 inactivates Schwannomin’s growth suppression.
Conversely, Schwannomin in an unphosphorylated state can bind and inhibit Pak activity (Kissil
et al., 2003; Hirokawa et al., 2004). There is, however, a debate pertaining to the residues within
Schwannomin that bind and inhibit Pak activity. One study suggests that Schwannomin binds
Pak at its CRIB domain (Cdc42/Rac interactive binding domain), through the C-terminal
residues 447-524 (Hirokawa et al., 2004). The binding of Rac/Cdc42-GTP to Pak’s CRIB
domain results in a conformational change that releases the autoinhibitory domain of Pak from
it’s kinase domain, allowing Pak to autophosphorylate (at T423; Thompson et al., 1998; Zenke et
al., 1999). Another study suggests that Schwannomin binds Pak through an N-terminal region,
and that this interaction prevents Pak from targeting to the plasma membrane and to focal
adhesions (Kissil et al., 2002). Although these studies provide insight into Schwannomin’s
ability to inhibit growth, it is important to note that both studies were performed in vitro, and not
in cells. Similarly, PKA was shown through in vitro binding and kinase assays, to associate with
and phosphorylate Schwannomin, at S518, in a Pak independent manner. Aside from these
results, little else is known about the mechanisms contributing to PKA-dependent
phosphorylation of Schwannomin in any cell type (Alfthan et al., 2004). Interestingly, there is
now evidence that Akt/protein kinase B can phosphorylate an alternative serine (S315), as well
as a threonine (T280) within the N-terminus of Schwannomin, targeting Schwannomin for
ubiquitin-mediated degradation (Tang et al., 2007).
6

Many factors regulate the overall phosphorylation state of Schwannomin at S518, such as cell
density, cell attachment, and growth factors (Shaw et al., 1998; Morrison et al., 2001; Lallemand
et al., 2003). With increasing cell density, Schwannomin phosphorylation is reduced, allowing
contact-dependent inhibition of growth. The suppression of growth observed may be mediated
by the interaction of Schwannomin with the plasma membrane receptors N-cadherin and CD44
(Morrison et al., 2001; Lallemand et al., 2003). Studies performed in NIH-3T3 cells
demonstrated that loss of adhesion resulted in decreased Schwannomin phosphorylation.
Accordingly, attachment of the cells to fibronectin, a component of the extracellular matrix,
resulted in phosphorylation of Schwannomin (Shaw et al., 1998). Stimulation of a rat
schwannoma cell line (RT4) expressing exogenous Schwannomin with hyaluronic acid resulted
in the reduction of Schwannomin phosphorylation levels (Morrison et al., 2001).

1.2.4 Schwannomin’s Regulation of Actin Polymerization Dynamics
Aside from tumor suppression, Schwannomin also has the ability to rearrange the cortical actin
cytoskeleton and induce morphological changes in cell structure, but the mechanism(s) that
allow Schwannomin to regulate morphology are unclear. Over-expression of Schwannomin
results in the formation of processes and microspikes in cells of fibroblast origin and
schwannoma cells (Gutmann et al., 1999; Stokowski and Cox, 1999; Kissil et al., 2002; Surace et
al., 2004). In these cells, Schwannomin is localized at the plasma membrane, along microspikes
and in membrane ruffles, similar to the localization of ERMs (Scherer and Gutmann, 1996; Shaw
et al., 1998; Brault et al., 2001; Kissil et al., 2002). Schwannoma cells lacking functional
7

Schwannomin expression, assume a more rounded shape, with elaborated stress fibers (Pelton et
al., 1998; Kaempchen et al., 2003; Nakai et al., 2006). Upon reintroduction of Schwannomin, the
schwannoma cells begin to assume a spindle, bipolar morphology, reminiscent of normal
Schwann cells. In similar studies using RT4 rat schwannoma cells, the reintroduction of
exogenous wild-type Schwannomin caused the tumorigenic cells to assume a typical SC
morphology (Surace et al., 2004).

One possible mechanism that might contribute to Schwannomin’s ability to direct actin
polymerization dynamics involves S518 phosphorylation. Studies utilizing RT4 schwannoma
and LLC-PKI epithelial cells, examined the expression patterns and localizations of
Schwannomin S518 phospho-variants (Surace 2004, Kissil 2002). A phospho-mimicking form
of Schwannomin, where S518 was mutated to an aspartate (S518D), localized within vesicular
structures in LLC-PKI cells, whereas both the wild type and an unphosphorylatable form of
Schwannomin, where S518 was mutated to an alanine (S518A) localized in a typical fashion to
the plasma membrane (Kissil et al., 2002). RT4 schwannoma cells expressing Schwannomin
S518D formed elongated processes, while the wild-type and Schwannomin S518A assumed a
normal plasma membrane distribution (Surace et al., 2004). These findings emphasize the fact
that Schwannomin not only functions as a growth regulator but also as an active regulator of
actin dynamics, a process that may be regulated by phosphorylation. Therefore any discoveries
regarding the effect(s) of S518 phosphorylation on Schwannomin’s function would lead to
increased understanding of Schwannomin’s role during the development of peripheral
neuropathies, like NF2.
8

1.2.5 Protein Interactions Regulating Schwannomin Function
Schwannomin interacts with several proteins associated with focal adhesion formation, cell-cell
adhesion, proliferation and survival. These proteins include paxillin, β1 integrin, ErbB2, as well
as, cadherins, CD44, Akt and HEI10(Morrison et al., 2001; Fernandez-Valle et al., 2002;
Lallemand et al., 2003; Rangwala et al., 2005; Gronholm et al., 2006; tang et al., 2007). An
interaction of significant physiological relevance is Schwannomin’s association with paxillin.
Schwannomin contains two paxillin binding domains (PBD; Fernandez-Valle et al., 2002).
PBD1, located between amino acids 50-70 in the N-terminus of Schwannomin, is responsible for
Schwannomin’s localization to the plasma membrane. PBD1 is encoded by exon 2 of
Schwannomin, a region that when conditionally deleted in mice results in a characteristic NF2
phenotype consisting of Schwann cell hyperplasia, schwannoma formation, and dysmyelination
(Giovannini et al., 2000; Fernandez-Valle et al., 2002). Patients with mutations within this exon
present the more severe forms of NF2, indicating that paxillin-mediated plasma membrane
localization is critical for Schwannomin’s tumor suppressor function. PBD2, located between
amino acids 425-450, has no known function and is encoded by exons 11 and 12 of the NF2
gene. Mutations within this region have been identified, but are not usually linked to an
increased severity of NF2.

Paxillin is an adaptor protein that serves as a molecular scaffold for several interacting proteins
involved in focal adhesion formation, such as focal adhesion kinase (FAK), in receptor mediated
signal transduction, such as β1 integrin and ErbB2, and in actin rearrangement, such as talin and
9

vinculin (reviewed in Turner, 2000). Paxillin contains four double Zn2+ finger LIM domains and
five leucine aspartate (LD) rich regions. LIM domains 2-3 are responsible for paxillin’s
membrane localization, whereas the LD domains are responsible for binding the majority of
paxillin’s numerous interacting signaling proteins. FAK binds paxillin at LD2, facilitating the
indirect interaction of paxillin with receptor tyrosine kinases, like ErbB2, through the SH2/SH3
binding domains of FAK (Brown et al., 1996). Another LD-mediated association that could
have great significance to NF2 is the indirect interaction of Pak with paxillin. The association of
Pak with paxillin is mediated through its interaction with the Pak-interacting exchange factor
(Pix) and the paxillin kinase linker (PKL; Turner et al., 1999). PKL binds paxillin at LD4, and is
an ARF -associated guanine nucleotide activating protein (GAP). GAPs regulate the activity of
small G-proteins, like ARF and the Rho GTPases by inactivating them through the hydrolysis of
GTP to GDP. Pix binds both Pak and PKL, and is a guanine nucleotide exchange factor (GEF)
that activates the Rho GTPases by exchanging GDP for GTP. Pix facilitates the activation of
Pak due its ability to activate both Rac and/or Cdc42. Interestingly, Schwannomin can bind
paxillin at both LD2 and LD3 (unpublished observations, CFV and SEG). Whereas LD2 has
other binding partners like FAK and vinculin, no other protein is known to associate with the
LD3 domain of paxillin. Although Schwannomin and Pak, if bound to paxillin, would be in a
close molecular proximity that could allow for the phosphorylation of Sch-S518, it is not known
whether paxillin binding is required for this event. Due to the significance of paxillin binding to
Schwannomin function, the molecular consequence of this interaction would be critical in
determining both Schwannomin’s and paxillin’s role during the development of NF2.
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Integrins are a group of transmembrane cell adhesion molecules that are heterodimeric in nature
and are composed of an α and a β subunit. These receptors are activated in response to binding
extracellular matrix (ECM) components such as fibronectin, laminin, vitronectin, and collagen
(reviewed in Lee and Juliano, 2004). Through interactions of their cytoplasmic tails with focal
adhesion molecules, integrins associate with the actin cytoskeleton, linking the extracellular
environment with the inner cytoarchitecture of cells. Aside from adhesion, integrins are also
important regulators of proliferation, differentiation, survival, apoptosis, migration and cell
morphology in many cell types (reviewed in Hynes, 2002). Integrins can engage in bidirectional signaling whereby extracellular signals can trigger intracellular events (outside-in
signaling), or intracellular events can induce integrins to adhere to the ECM (inside-out
signaling). The intracellular transduction of signals induced by integrins can also occur in two
ways: either (1) directly downstream of the integrin subunits alone (in-cis), or (2) through the coactivation of other membrane receptors such as growth factor stimulated receptor tyrosine
kinases (in-trans). Downstream signaling molecules activated in response to integrin adherence
to the ECM include, FAK, MAP kinases (MAPKs), extracellular signal regulated kinase (Erk), cJun kinase (JNK) and the Rho GTPases, Rac, Cdc42, and Rho, and Pak; all important regulators
of cell proliferation, cell spreading and cell morphology (reviewed in Lee and Juliano, 2004).
Another important molecule found to interact with integrins is paxillin, which was shown to
directly associate with peptides mimicking the common region of the intracellular domain of β1
integrin, and to directly bind the intracellular tail of α4 integrin (Schaller et al., 1995; Tanaka et
al, 1996; Han et al., 2001). Interestingly, Schwannomin can also associate with β1 integrin, and
more specifically it can bind to the intracellular cytoplasmic domain of β1 integrin directly
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(Obremski et al., 1998; unpublished observation, CFV). Although Schwannomin can interact
with integrins, the physiological consequences of this interaction are unknown. Because β1
integrin can associate with paxillin and lead to the activation of Rac, Cdc42, and Pak, it is
possible that stimulation of β1 integrin through adherence to the ECM could regulate
Schwannomin function.

The ErbB receptors are members of the EGF superfamily of receptor tyrosine kinases that are
stimulated in response to growth factors. There are four family members, ErbB1 (EGFR),
ErbB2, ErbB3, and ErbB4. Upon binding to growth factors, ErbB1, ErbB3, and ErbB4 initiate
the formation of hetero- and homo-dimeric signaling complexes (reviewed in Citri et al., 2003).
Schwann cells express significant amounts of ErbB2 and ErbB3, and very low levels of ErbB4.
The ErbB2/ErbB3 heterodimer is the most prevalent and widely studied signaling complex
activated in Schwann cells (reviewed in Nave and Salzer, 2006). Interestingly, ErbB3 can bind
ligand but it is deficient in kinase activity, whereas ErbB2 cannot bind ligand but has an active
catalytic domain; therefore the signaling from either ErbB2 or ErbB3 can only be achieved when
the receptors dimerize (Guy et al., 1994; Klapper et al., 1999). The growth factor family present
within the nervous system that activates ErbB2/ErbB3 is known as the neuregulins (NRG), and
they are needed for every stage of Schwann cell development. Upon binding NRG, ErbB3 and
ErbB2 dimerize, allowing the activation of downstream signaling pathways leading to
proliferation, such as Ras-MEK (from ErbB2), and survival, such PI3K and Akt (from ErbB3).
ErbB2 is considered a potent oncogene and its overexpression or constitutive activation is found
in multiple cancer types, such as breast, lung, prostate, and ovarian cancers (reviewed in Hsieh
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and Moasser, 2007). Schwannoma cells deficient in Schwannomin expression have also been
shown to have upregulated ErbB2 signaling (Hansen and Linthicum, 2004). Additionally, the
RT4 schwannoma cell line contains a point mutation within the catalytic domain of ErbB2 that
causes constitutive activation of ErbB2, and hyperproliferation of these cells (Nikitin et al.,
1991). This evidence suggests that Schwannomin signaling might regulate ErbB2 function.
Indeed, Schwannomin was shown to participate in receptor internalization dynamics of EGFR
and regulate its activity in mouse embryonic fibroblasts (Curto et al., 2007). Moreover,
Schwannomin was shown to indirectly associate with ErbB2 through paxillin (Fernandez-Valle
et al., 2002). Although Schwannomin and ErbB2 interact in a cooperative signaling pathway, the
consequences of this association on Schwannomin function have not been explored. ErbB2 has
been shown to stimulate the activities of Pak and the Rho GTPases, Rac and Cdc42 (reviewed in
Lee and Juliano, 2004). It therefore is possible that activation of ErbB2 may alter
Schwannomin’s ability to suppress growth by promoting its Pak-dependent phosphorylation.

1.3 Schwann Cells: The Myelinating Glia Of The Peripheral Nervous System
Schwann cells (SC) are specialized glia of the peripheral nervous system that are responsible for
myelinating axons to allow for the proper and fast conduction of the action potential. SCs arise
from neural crest cells (NCC), and through stages of regulated development these cells can
mature into SC precursors, then immature SCs, and finally either non-myelinating or myelinating
SCs. Unlike oligodendroglia in the central nervous system, SC myelination and development is
reversible, that is, upon axonal injury myelinating SCs can de-differentiate and revert back to an
immature SC stage. As the axon re-innervates the muscle, the SCs will re-contact and
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remyelinate axons (reviewed in Jessen and Mirsky, 2005). Each stage of SC development is
intimately coordinated and dependent on axonal cues and the extracellular environment, most
notably the axonal mitogen NRG1 type 3, and laminin, a component of a specialized form of
ECM formed by SCs. Both NRG1 type 3 and laminin are required for all stages of SC
development including maturation, proliferation, migration, and differentiation. Whereas NRG1
type 3 is expressed by NCCs and in all stages of axonal and SC development, the basal lamina is
present only after NCCs mature into SCs. Aside from NRG and laminin, several additional
proteins have been identified as specific markers for the different stages of SC development,
such as activator protein 2α (AP2α) that is present in NCCs and SC precursors, Cadherin 19 that
is expressed in SC precursors only, and glial fibrillary acidic protein (GFAP), S100 calcium
binding protein (S100), Oct6, and O4 that are only expressed in immature and mature SCs.
Although several proteins are known to be present at certain stages of development, the
molecular mechanisms controlling SC differentiation and myelination have been only partially
elucidated.

1.3.1 Signals Determining SC Differentiation And Myelination
Myelination is a process that requires the formation of a one-to-one relationship of a SC with a
large diameter axon. Ensheathment involves the extension of multiple processes from one SC
around multiple small diameter axons. Several morphological steps are involved in the initiation
of myelination. First, in a process termed radial sorting, axon bundles are separated by the
extension of multiple SC processes around and through axons. This process is coordinated with
proliferation, as the segregation of axons enables SCs to sense the numbers and diameters of
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axons that will need to be myelinated. After radial sorting and the identification of large
diameter axons, the SCs destined to myelinate must retract some processes and instead extend
processes bi-directionally along the axon to form the internode, the region between two Nodes of
Ranvier. Once the internode is established, a SC will then extend an expansive membrane
laterally and envelop and wrap an axon, creating a multi-lamellar layer. Like the other stages of
SC development, myelinating SCs can be identified by the expression of proteins like myelin
basic protein (MBP), P0, and β4 integrin (reviewed in Jessen and Mirsky 2005). MBP and P0
are proteins involved in the compaction of the myelin layer, while β4 integrin is thought to be
responsible for anchoring the external SC membrane to the basal lamina. β4 integrin is able to
stabilize the SC cytostructure more effectively because it has a longer cytoplasmic domain that
interacts directly with intermediate filaments rather than actin filaments. Other proteins
regulated during SC myelination are the transcription factors Krox-20 and octamer-binding
transcription factor 6 (Oct-6). These transcription factors are inversely regulated upon SC
differentiation. Oct-6 expression is downregulated in myelinating SCs, whereas Krox-20
expression and function is upregulated, as its expression is known to precede and be required for
transcription of the myelin genes, P0 and MBP. Peripheral neuropathies such as Charcot-MarieTooth (CMT) disease and congenital hypomyelinating neuropathy (CGN) are caused by
mutations in Krox-20, resulting in demyelination and myelin abnormalities (Yoshihara et al.,
2000; Decker et al., 2006). While it is known that proteins like MBP, P0 and β4 integrin are
upregulated, and the expression of transcription factors like Krox20 and Oct-6 are controlled
during myelination, the mechanisms inducing differentiation of an immature SC into a
myelinating SC are still elusive.
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1.3.2 Extracellular Matrix Mediated SC Development: Signaling from Laminins and β1
integrin
Basement membrane(s), or basal lamina, is a specialized form of extracellular matrix (ECM) that
surrounds individual cells and is mostly comprised of laminin (reviewed in Colognato and
Yurchenco, 2000). Laminins are a family of glycoproteins that form heterotrimers containing an
α, β, and γ subunit. Laminins can self-associate, as well as interact with other ECM components
such as collagen and fibronectin. Laminins are responsible for providing the structural integrity
of the basal lamina, and are key regulators of cellular events in Schwann cell development, like
proliferation, migration, and differentiation. The deposition of basal lamina by SCs is important
to their maturation into a myelinating phenotype. Several peripheral neuropathies, such as CMT,
and muscular dystrophies, such as merosin-deficient muscular dystrophy, are caused by
mutations in laminin isoforms (reviewed in Feltri and Wrabetz, 2005). Seven laminin genes are
present in the mammalian neuromuscular system including, α1, α2, α4, α5, β1, β2 and γ1
(reviewed in Patton, 2000). From the seven laminin genes expressed the neuromuscular system,
seven laminin isoforms are produced, laminins 1, 2, 4, 8, 9, 10, and 11. Present in all the laminin
isoforms is the laminin γ1 subunit (reviewed in Patton, 2000). Conditional ablation of laminin γ1
in mouse Schwann cells leads to dysmyelination, as SCs are unable to radial sort and initiate
myelination. Furthermore, depending on the stage of development when the laminin genes are
knocked out, it can also lead to reduced SC proliferation and apoptosis (Chen and Strickland,
2003; Yu et al., 2005).
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The receptors on SCs responsible for binding laminins are the integrins, β1 and β4, and
dystroglycan. Similar to the conditional deletion of the laminin γ1 gene, conditional knockout of
β1 integrin in mice results in the failure of SCs to radially sort axons within bundles, leading to
impaired myelination. A recent attempt to characterize the downstream signaling events
deregulated in β1 integrin null mice showed that conditional deletion of Rac, a member of the
Rho GTPase family of cytoskeletal regulators, in SCs results in failed radial sorting and
myelination, similar to the phenotype of β1 integrin null SCs (Benninger et al., 2007; Nodari et
al., 2007). These results support the findings that Rac activation occurs in response to β1
integrin stimulation, and that the morphological changes occurring in response to integrin
activation are mediated through Rac (Del Pozo et al., 2004). The Rac null SCs, like the β1
integrin null, failed to produce radial membrane protrusions required for the extension of
multiple processes and the separation of axons. Although advancements are being made in
understanding the extracellular signals required for SC myelination, the mechanisms induced
downstream of these molecules controlling SC morphology still remain unclear. Interestingly, as
mentioned earlier, Schwannomin not only interacts with β1 integrin but it is also phosphorylated
downstream of Rac activation, and this event alters actin dynamics. Additionally, the conditional
disruption of Schwannomin in mice results in dysmyelination, suggesting that Schwannomin
may function downstream of laminin, β1 integrin, and Rac to allow for the restructuring of the
actin cytoskeleton, and process formation.
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1.3.3 Axonal Cues Regulating SC Development: The Roles Of Neuregulin And ErbB2 In
SC Myelination
As mentioned earlier, SC development is intimately coordinated by and dependent on axonal
cues. One of the most significant axonal proteins involved in every stage of SC maturation is the
Neuregulin-1 (NRG1) family of epidermal-like growth factors, or mitogens. Axonal NRG1 can
either be membrane-associated or secreted into the extracellular environment. There are more
than 15 isoforms of NRG1 present throughout the body, but the most abundant forms found in
the nervous system are NRG1 types 1-3 (reviewed in Nave and Salzer, 2006). NRG1 types 1-3
are expressed by motor neurons, dorsal root ganglia neurons, and by glia (reviewed in Falls,
2003). Not only are NRGs implicated in nervous system development and neuropathies like
schizophrenia, but they are also essential for heart development and breast function, as perturbed
neuregulin signaling results in heart disease and breast cancer. The most relevant of all the
NRG1s to SC development and myelination is NRG1 type 3. The expression of NRG1 type 3
was found to be required for the maturation of NCCs to SC precursor and to myelination, as
conditional disruption of NRG1 type 3 in mice lead to hypomyelination, slowed conduction
velocities, as well as aberrant proliferation, migration and maturation of SCs (Michailov et al.,
2004; Lai, 2005; Taveggia et al., 2006). When examined, it was found that SCs in NRG1 type 3
null mice were localized near dorsal root ganglia, resulting from the inability of these SCs to
contact, migrate, and defasiculate axons (reviewed in Garratt et al., 2000b). Re-expression of
NRG1 type 3 in the null mice rescued the aberrant defects in proliferation, migration, and
myelination, while exogenous expression in normal neurons, both large and small diameter,
resulted in hypermyelination and increased myelin thickness (reviewed in Lai, 2005).
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The principal receptor(s) on SCs that bind axonal NRG1 is the heterodimer, ErbB2/ErbB3
(Vartanian et al., 1997). Consistent with NRG1 type 3 null mice, disruption of either ErbB2 or
ErbB3 in SCs results in reduced proliferation, migration and differentiation (Garratt et al., 200a;
Michailov et al., 2004; Lyons et al., 2005). The disruption of ErbB2 and ErbB3 in mice is
conditional from SCs, as a complete knockout of ErbB2 and ErbB3 results in embryonic
lethality, as these mice have impaired cardiac development, as do NRG1 knockout mice
(reviewed in Citri et al., 2003). Recently, it was suggested that Cdc42 functions downstream of
NRG1 during SC myelination, as mice with a conditional deletion of Cdc42 in SCs resulted in
reduced SC proliferation and amyelination similar to the phenotype of NRG1 null SCs
(Benninger et al., 2007). Further analysis showed that stimulation of SCs with NRG1 increased
the activity of Cdc42 significantly. These results provided a partial mechanism for NRG
signaling in SCs, but how this stimulation results in the inability of SCs to migrate and myelinate
is unknown. Like β1 integrin and Rac, Schwannomin was shown to participate in downstream
signaling from both ErbB2 and Cdc42. Cdc42 is known to regulate the activity of
Schwannomin, while the functional consequences of the interaction of Schwannomin with ErbB2
are unclear.

In assessing Schwannomin function during SC development and NF2, we find that its activity as
a tumor suppressor and in actin dynamics is regulated by its phosphorylation, localization and
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conformation. Phosphorylation occurs through Rac-or Cdc42-dependent activation of Pak, or
through PKA, and allows for the stabilization of an open conformation and the inactivation of
Schwannomin’s growth suppression, but the underlying mechanisms promoting its
phosphorylation remain unclear (Kissil et al., 2002; Xiao et al., 2002; Alfthan et al., 2004).
Localization of Schwannomin to the plasma membrane, and its interaction with the membrane
receptors, β1 integrin, and ErbB2, is mediated through paxillin binding, but the physiological
relevance of β1 integrin, and ErbB2 interaction on Schwannomin function is unknown
(Fernandez-Valle et al., 2002). Schwannomin also appears to have a role in SC development and
differentiation, as conditional deletion of Schwannomin exon 2, encoding paxillin binding
domain 1, in mouse SCs results in dysmyelination and the formation of schwannomas
(Giovannini et al., 2000; Fernandez-Valle et al., 2002). Although the conditional mice reveal
that paxillin binding is physiologically relevant to not only the development of NF2 but to
Schwannomin function in myelination, our understanding of Schwannomin’s role during
myelination is unknown. Three molecules recurring as key regulators of Schwannomin activity,
NF2 and peripheral neuropathy development, and SC myelination are paxillin, β1 integrin, and
ErbB2. In order to understand how these molecules regulate Schwannomin activity, and how
Schwannomin functions in both NF2 and SC development, three questions will be addressed in
this dissertation: (1) Is paxillin binding and membrane localization required for Schwannomin
S518 phosphorylation? (2) What are the mechanisms promoting Schwannomin S518
phosphorylation downstream of NRG and laminin? (3) What are the effects of Schwannomin
S518 phosphorylation on SC morphology and myelination?
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CHAPTER 2
PHOSPHORYLATION OF THE NF2 TUMOR SUPRESSOR IN SCHWANN
CELLS IS MEDIATED BY CDC42-PAK AND REQUIRES PAXILLIN
BINDING
2.1 Introduction
Neurofibromatosis type 2 (NF2) is an inherited disorder characterized by formation of bilateral
vestibular schwannomas. NF2 is associated with mutations in the nf2 gene that leads to loss of
expression of Schwannomin (Sch), also called merlin (Rouleau et al., 1993; Trofatter et al.,
1993). Sch is a member of the Band 4.1 superfamily of membrane-cytoskeleton linking proteins
that includes ezrin, radixin and moesin (ERM). These proteins bind F-actin either directly or
indirectly and modify actin polymerization dynamics (Takeuchi et al., 1994; Gary and Bretscher,
1995; Bretscher et al., 1997; Sainio et al., 1997; Scoles et al., 1998; James et al., 2001). Loss of
Sch function in schwannoma cells is associated with F-actin instability, formation of excessive
ruffling membranes, and persistent but slow proliferation (Pelton et al., 1998; Gutmann et al.,
1999a; Sherman and Gutmann, 2001, Bashour et al., 2002). Reintroduction of Sch into
schwannoma cells reverses some of the cytoskeletal defects including the reduction of ruffling
membranes and surface area (Gutmann et al., 1999a; Bashour et al., 2002; Schulze et al., 2002;
Surace et al., 2004).

Sch and ERMs exists in an open and a closed conformation mediated by intramolecular
association of the N- and C-termini (Gary and Bretscher, 1995; Huang et al., 1998; GonzalezAgosti et al., 1999; Gutmann et al., 1999b). Phosphorylation of Sch’s C-terminus appears to
stabilize the open conformation that localizes to the plasma membrane (Shaw et al., 1998;
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Gonzalez-Agosti et al., 1999; Bretscher et al., 2000; Rong et al., 2004). Conformation and
phosphorylation regulate Sch’s tumor suppressor activity (Gutmann et al, 1999b; Surace et al.,
2004). The closed, unphosphorylated conformation of Sch is associated with an antiproliferative function, whereas the open, phosphorylated conformation is associated with a
growth permissive function (Sherman et al., 1997; Gutmann et al., 1999b; Morrison et al., 2001;
Surace et al., 2004).

Sch contains multiple phosphorylated residues, but the only characterized phosphorylation site is
serine 518 in the C-terminus, by p21 activated kinase (Pak) and protein kinase A (Shaw et al.,
1998, 2001; Kissil et al., 2002; Xiao et al., 2002; Alfthan et al., 2004). Of note, Sch and Pak
both associate with paxillin, a 70kDa adaptor protein (Turner et al., 1999; Fernandez-Valle et al.,
2002). Sch binds paxillin directly through two paxillin binding domains (PBD1 and PBD2;
Fernandez-Valle et al., 2002). PBD1, amino acids 50-70, is encoded by exon 2 and PBD2,
amino acids 425-450, overlaps with a putative Pak inhibitory domain (Hirokawa et al., 2004).
Pak binds paxillin indirectly through association with paxillin kinase linker (PKL/GIT1), an ArfGTPase activating protein, and PIX, a Cdc42/RacGTPase Exchange Factor (GEF; Manser et al.,
1998; Turner et al., 1999, 2000; West et al., 2001). The binding of Sch and Pak to paxillin
allows for the stable association of each protein with the plasma membrane (Turner et al., 1999;
Fernandez-Valle et al., 2002). Paxillin mediates formation of integrin dependent focal adhesions
and allows transduction of signals from integrins, receptor tyrosine kinases, and G-protein
coupled receptors (Hildebrand et al., 1995; Schaller et al., 1995; Tachibana et al., 1995; reviewed
in Turner et al., 2000; Chen et al., 2000, Fernandez-Valle et al., 2002). Sch and Pak have not
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been studied together in any cell type and the upstream events leading to Sch phosphorylation
are not well understood.

Here, we report that Sch binding to paxillin through PBD1, but not PBD2, is essential for Sch
phosphorylation. Only a subset of Sch molecules is phosphorylated at specific membrane
domains where they colocalize with paxillin, P-Pak, Cdc42, but not Rac. SchS518A/D-GFP
variants both localize to the plasma membrane where they promote distinct morphologies.
Together our findings suggest that plasma membrane associated Sch locally alters cytoskeletal
organization of SCs in a Cdc42-Pak dependent manner.
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2.2 Materials and Methods
2.2.1 Materials
Sch-EGFP-N1, Sch∆PBD1 (residues 50-70 deleted)-EGFP-C1, Sch∆PBD2 (residues 425-450
deleted)-EGFP-C1, Sch∆∆PBD1&2 (residues 50-70 and 425-450 deleted)-EGFP-C1, SchpcDNA3.1 HisC (N-terminal Xpress tag), Sch∆PBD1-pcDNA3.1 HisC, Sch∆PBD2-pcDNA3.1
HisC, and Sch∆∆PBD1&2-pcDNA3.1 HisC were described previously or were constructed in
the laboratory using standard techniques (Fernandez-Valle et al., 2002). Antibodies were
purchased from the following sources: Rac antibodies from Santa Cruz Biotechnology and BD
Biosciences, paxillin antibody from BD Biosciences, phospho-Pak antibody from Rockland
Immunologicals, Inc, phospho-serine518-Sch antibody from Abcam, Myc antibody from Cell
Signaling Technologies and Xpress antibody from Invitrogen.
2.2.2 Cell Culture
Primary rat SC cultures were prepared from neonatal pups using the Brockes method as
previously described (Brockes et al., 1979, Chen et al., 2000). SCs were expanded on poly-Llysine coated (200µg/ml in borate buffer, pH 8.6, Sigma) tissue culture dishes in Dubelcco’s
Modified Eagle Medium (Gibco/BRL) with 10% heat inactivated FBS (Hyclone), 2µM forskolin
(Sigma) and 20µg/ml bovine pituitary extract (D10M; Biomedical Technologies, Inc.). Cultures
were expanded no more than six times before use.
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2.2.3 Transfections
SCs were transfected using Lipofectamine 2000 (Invitrogen) following manufacturer’s protocol.
Briefly, SCs were incubated in Opti-MEM (Invitrogen) and Lipofectamine with either 2µg of
Xpress-tagged plasmid DNA or 250ng of EGFP-tagged plasmid DNA. After four hours, the
transfection medium was removed and was replaced with standard growth medium. The cells
were analyzed 36 hours later and were either extracted for use in immunoprecipitations or were
immunostained for visualization of cell morphology.
2.2.4 Immunoprecipitation And Western Blotting
SCs were lysed in TAN buffer (10mM Tris-acetate, 1% IGEPAL, 100mM NaCl) with a cocktail
of inhibitors as previously described (Chen et al., 2000). Approximately 100µg of total protein
was used for immunoprecipitation with anti-Xpress antibody after pre-clearing using normal
mouse IgG as previously described (Chen et al., 2000). The samples were loaded onto a 10%
SDS-PAGE gel and proteins were separated at 200V for 50 minutes and were transferred onto
PVDF membranes. The membranes were blocked using 5% bovine serum albumin (BSA) in
TBS-T for 1 hour at room temperature. The primary antibodies were incubated for either 1 hour
at room temperature, or overnight at 4ºC, in 5% BSA/TBS-T. Horseradish peroxidase
conjugated secondary antibody was applied for 30 minutes and was detected using Super Signal
West Pico Chemiluminescent Substrate (Pierce).
2.2.5 Immunostaining
Primary rat SCs were grown on German glass coverslips coated with poly-L-lysine (200µg/ml in
borate buffer, pH 8.6), and laminin (25µg/ml in carbonate buffer, Invitrogen) until 80%
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confluent. SCs were transfected with EGFP-plasmid DNA as described above. SCs were
washed in phosphate buffer (pH 7.6), were fixed in 4% paraformaldehyde for 10 minutes at room
temperature and were permeabilized with 4% paraformaldehyde + 0.2% Triton X-100 for 10
minutes. SCs were incubated with 10% normal goat serum for 30 minutes followed by
incubation with primary antibodies for 1 hour. Alexa Fluor (Molecular Probes) conjugated
secondary antibodies were added for 30 minutes and SCs were post-fixed for 5 minutes in 4%
paraformaldehyde and were mounted in Gel-Mount (Biomeda). For each experiment, 2-4
coverslips were transfected with each construct and 3-4 repetitions were carried out. All
coverslips were imaged and representative cells were selected. Images were obtained on a Zeiss
LSM510 confocal microscope and were processed identically.
2.2.6 Pak-CRIB Pull Down Assay
Assays were performed using an EZ-Detect GTPase Activation kit according to the
manufacturer’s protocol (Pierce). Briefly, SCs were incubated in D10M with or without 100µM
NSC23766 (Calbiochem) overnight, at 37oC. SCs were extracted in 1x Lysis/Binding/Wash
buffer (Pierce). Approximately 500µg of total lysate was incubated with a Swell Gel
Immobilized Glutathione Disc (Pierce), along with 20 µg of GST-Pak CRIB. For controls,
500µg of SC lysate were incubated with either GTPγS, for a positive control and with GDP, for a
negative control. Samples were incubated with GST-Pak CRIB for 1hr at 4oC while rocking.
The samples were centrifuged, washed, and eluted. After elution, the equivalent of 250µg of
sample was run on a 10% SDS-PAGE gels and was transferred as described above. The
membranes were probed first for Rac, then GST, and were then stripped and re-probed for
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Cdc42. Rac- and Cdc42-GTP expression levels were normalized to GST- Pak CRIB levels.
Total SC lysates were analyzed for PS518, Rac, Cdc42, P-Pak and GAPDH. Expression levels
of total Rac, Cdc42, PS518, and P-Pak were normalized to GAPDH.
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2.3 Results
2.3.1 Deletion Of Paxillin Binding Domain 1 Prevents Sch Phosphorylation
To determine if binding to paxillin influences Sch phosphorylation, plasmids encoding Xpresstagged PBD deletion variants of Sch were transiently transfected into primary rat SCs. The
fusion proteins were immunoprecipitated with anti-Xpress antibody and were immunoblotted
with a Sch PS518 antibody (PS518; Figure 2.1). Full-length Sch containing both PBDs and
Sch∆PBD2 lacking the C-terminal binding domain, were phosphorylated on S518. In contrast,
Sch∆PBD1 lacking the N-terminal binding domain, and Sch∆∆PBD1/2, lacking both PBDs were
not phosphorylated (Figure 2.1 and data not shown). The membranes were then re-probed for
paxillin. Paxillin co-immunoprecipitated with both full length Sch and Sch∆PBD2, but not with
Sch∆PBD1. This suggests that Sch-S518 phosphorylation requires paxillin binding at PBD1 and
localization to the plasma membrane.

To confirm these results using a cellular assay, SCs were transiently transfected with plasmids
directing expression of GFP-tagged PBD deletion variants of Sch. After 36 hours, SCs were
immunostained with PS518 antibody (Figure 2.2). SCs expressing full length Sch-GFP become
very elongated and thin, and GFP fluorescence was observed throughout cellular processes,
radial protrusions, and at the plasma membrane surrounding the cell body. However, a high
level of PS518 fluorescence was found only at the tips of atypical radial membrane protrusions
that formed along major processes, and colocalized with Sch-GFP fluorescence. Sch-GFP
present along the plasma membrane, in areas lacking cellular protrusions as well as within the
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cell, was not phosphorylated. This suggests that Sch was phosphorylated by endogenously
expressed kinases active at specific membrane domains. SCs expressing Sch∆PBD1-GFP
displayed spread morphology. There was diffuse intracellular GFP and PS518 fluorescence but
membrane-associated fluorescence was not present. This is consistent with the requirement of
PBD1 for directed translocation of Sch to the plasma membrane (Fernandez-Valle et al., 2002).
SCs expressing Sch∆∆PBD1/2-GFP behaved as those expressing Sch∆PBD1-GFP (data not
shown). SCs expressing Sch∆PBD2-GFP were also atypically elongated and resembled SCs
expressing Sch-GFP. There was a marked increase in total PS518 fluorescence in SCs
expressing Sch∆PBD2-GFP compared to SCs expressing Sch-GFP. The majority of
Sch∆PBD2-GFP molecules appeared to be phosphorylated regardless of their localization.
These results suggest that each PBD in Sch has a unique function that impacts phosphorylation at
serine 518.
2.3.2 Deletion Of PBD2 Is Not Associated With Increased P-Pak Levels
PBD2 (amino acids 425-450) overlaps with a putative domain (amino acids 447-524) reported to
inhibit Pak activity by interfering with binding of Cdc42/Rac-GTP to Pak’s CRIB domain
(Hirokawa et al., 2004). This has been proposed as a regulatory loop between Sch and Pak. To
determine if the increase in PS518 fluorescence observed when Sch∆PBD2-GFP was expressed
in SCs could be due to increased Pak activity, we immunostained SCs expressing Sch PBD
deletion variants with phosphothreonine 423-Pak (P-Pak) antibody (Figure 2.3). SCs expressing
Sch-GFP had a dramatic increase in P-Pak expression, but it was restricted to radial membrane
protrusions that formed along SC processes, similar to those in Figure 2.2, which displayed
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increased PS518 fluorescence. P-Pak and Sch-GFP colocalized in these domains and were also
observed within filopodia extending periodically along the cell length. In SCs expressing
Sch∆PBD1-GFP, P-Pak expression was detectable only at high magnification within radially
extending filopodia that did not contain Sch∆PBD1-GFP. In SCs expressing Sch∆PBD2-GFP,
P-Pak expression was found at the tips of radial filopodia and at the peripheral-most aspects of
membrane protrusions where it colocalized with Sch∆PBD2-GFP. P-Pak was not observed
within membrane protrusions or in SC processes that contained high levels of Sch∆PBD2-GFP
fluorescence. It is unlikely that the increase in PS518 fluorescence observed for Sch∆PBD2GFP in Figure 2.2 is due to the disruption of Sch’s Pak inhibitory domain.
2.3.3 Expression Of Active Forms Of Cdc42 And Rac Indiscriminately Increases
P-Pak Levels In SCs
To determine whether Pak could phosphorylate Sch at the plasma membrane, we first tested the
ability of active forms of Cdc42 and Rac to increase Pak activity, as assessed by Pak
autophosphorylation at threonine 423. SCs were transiently transfected with Myc-Q61LCdc42
and Myc-Q61LRac plasmids and were immunostained with P-Pak and Myc antibodies (Figure
2.4). SCs expressing Myc-Q61LCdc42 had an overall increase in P-Pak expression compared to
surrounding untransfected cells. A focal increase in P-Pak fluorescence was found at the distal
tips of process extensions where it co-localized with a focal increase in Myc-Q61LCdc42
fluorescence (Figure 2.4, arrows). SCs transfected with Myc-Q61LRac also displayed a uniform
increase in P-Pak expression compared to surrounding untransfected cells. The P-Pak and Myc-

30

Q61LRac fluorescence co-localized throughout the cell. This demonstrates that both active
forms of Cdc42 and Rac can increase overall Pak activity in SCs.
2.3.4 Expression Of Active Cdc42 And Rac Does Not Promote Unrestricted
Phosphorylation Of Endogenous Sch But Does Increase Phosphorylation Of Sch-GFP
To assess whether Cdc42 and Rac function equivalently to promote Pak-dependent
phosphorylation of endogenously expressed Sch, SCs were transiently co-transfected with MycQ61LCdc42 and Myc-Q61LRac and GFP and were immunostained with PS518 and Myc
antibodies (Figure 2.5). Dominant negative forms of Cdc42 and Rac (T17N) were also
transfected into SCs but repeatedly resulted in cell death precluding analysis of their effects.
Expression of GFP alone did not alter the level or distribution of PS518 fluorescence with
respect to adjacent untransfected cells. Endogenous PS518 fluorescence was diffusely present in
the perinuclear cytosol and in cellular processes. Surprisingly, expression of Myc-Q61LCdc42
and Myc-Q61LRac did not lead to an increase in PS518 fluorescence throughout the cell as was
observed for P-Pak. SCs expressing both GFP and Myc-tagged Cdc42 and Rac had similar
levels of PS518 as untransfected SCs. A slight increase in PS518 fluorescence that co-localized
with Myc-Q61LCdc42 was observed at the cell periphery and in cellular processes (Figure 2.5,
arrows). This suggests that the majority of endogenous Sch is not readily accessible for Cdc42
and Rac dependent phosphorylation.

To assess whether Cdc42 and Rac function equivalently to promote phosphorylation of
exogenously expressed Sch, Myc-Q61LCdc42 and Myc-Q61LRac plasmids were transiently cotransfected with Sch-GFP into SCs (Figure 2.6). In SCs expressing Sch-GFP alone, there was a
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high level of Sch-GFP fluorescence along cellular processes, membrane protrusions, and at the
plasma membrane surrounding the cell body. PS518 fluorescence did not concomitantly
increase in all GFP-labeled domains. It was expressed in some membrane protrusions and along
major processes, but was absent from the plasma membrane surrounding the cell body that had
multiple filopodia containing Sch-GFP (Figure 2.6, arrowheads). Co-expression of Sch-GFP and
Myc-Q61LCdc42 and Myc-Q61LRac increased PS518 fluorescence throughout the SC. There
was a near complete overlap of Sch-GFP, PS518 and Myc fluorescence. These results suggest
that both active Cdc42 and Rac can equally promote unrestricted Pak-dependent phosphorylation
of Sch-GFP when expressed in SCs.
2.3.5 Inhibition Of Rac-GTP Does Not Reduce Phosphorylation Of Sch S518 Or Pak
To further discriminate between Cdc42 and Rac dependent phosphorylation of endogenous Sch,
SCs were incubated with and without NSC23766, an inhibitor of Rac-GTP (Gao et al., 2004).
Pak-CRIB pull down assays were performed and the amount of Cdc42-GTP and Rac-GTP were
assessed, as were the levels of endogenous Sch S518 and Pak phosphorylation (Figure 2.7).
Normalization of Rac-GTP to the amount of GST-CRIB in each lane revealed a 72% reduction
in Rac-GTP levels in NSC23766 treated, compared to untreated SCs (Figure 2.7A, C).
Normalization to GST-CRIB revealed only a 21% reduction in Cdc42-GTP compared to
untreated SCs (Figure 2.7B, D). Total lysates of treated and untreated SCs were immunoblotted
for Rac, Cdc42, PS518, and P-Pak (Figure 2.7E, G). No reduction in total Rac and Cdc42 levels
were observed in SCs treated with and without NSC23766. Normalization of PS518 to the
GAPDH loading control also revealed no difference in the amount of PS518 in NSC23766treated and untreated SCs (Figure 2.7F). P-Pak levels were also unchanged in response to
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NSC23766 treatment (Figure 2.7G). These results suggest that endogenous Sch is effectively
phosphorylated on S518 by Cdc42-Pak in SCs.
2.3.6 PS518-Sch And Paxillin Co-Localize With Cdc42 And P-Pak In Membrane
Protrusions
We sought to identify proteins localized in membrane protrusions that form at the ends of and
along cellular processes in normal SCs (Figure 2.8). These resemble the atypical radial
membrane protrusions that form along the cellular processes when Sch-GFP is expressed.
Phosphorylated Sch and Cdc42 colocalized in cellular processes, radial membrane protrusions
and often at the distal tips of SCs. Paxillin and PS518 also colocalized along processes and at
the distal ends. Paxillin was found within the perinuclear cytosol and periodically along
processes, in membrane protrusions and in distal tips of processes, but did not colocalize with
Rac. Rac immunofluorescence was much weaker than observed for Cdc42 and was largely
restricted to the perinuclear cytosol, and was only weakly expressed at the distal tips. P-Pak
colocalized with Cdc42 in membrane protrusions and cellular processes. This result suggests
that a paxillin-Cdc42-Pak dependent phosphorylation of Sch can occur at the plasma membrane
and within radial membrane protrusions.
2.3.7 Sch Serine 518 Phosphorylation Modulates Morphology In SCs
We sought to determine the effect of Sch phosphorylation at S518 on SC morphology by
transiently transfecting SCs with GFP-tagged SchS518 variants (Figure 2.9A). All GFP positive
SCs were categorized into six groups based on morphology (Figure 2.9B). In SCs expressing
GFP alone and Sch-GFP, the majority displayed the bipolar shape typical of confluent SCs. At
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least 40% of the total number of GFP and Sch-GFP positive SCs were bipolar. GFP localized to
the nucleus, whereas Sch-GFP localized to the plasma membrane and to microspikes. SCs
expressing SchS518A-GFP, representing an unphosphorylatable form, often extended a sole
elongated process from the SC body. The frequency of occurrence of this unipolar morphology
in SCs expressing SchS518A-GFP was 35% compared to approximately 18% and 20% of SCs
expressing GFP and Sch-GFP, respectively. SchS518A-GFP localized to the plasma membrane
as was observed for Sch-GFP, however it was not found in the plasma membrane of
lamellipodia. SCs expressing SchS518D-GFP, that mimics the phosphorylated form, assumed
both multipolar and bipolar morphologies. The multipolar phenotype was defined as a SC with
more than four processes extending from the SC body. At least 25% of the SchS518D-GFP
positive SCs were multipolar compared to approximately 13% and 19% of SCs expressing GFP
and Sch-GFP, respectively. SchS518D-GFP localized to the plasma membrane along the
multiple processes. The appearance of extensive lamellipodia was low in SchS518D-GFP
expressing SCs compared to those expressing SchS518A-GFP.
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2.4 Discussion
Previously we demonstrated that localization of Sch at the plasma membrane requires interaction
of its N-terminal PBD1 with paxillin (Fernandez-Valle et al., 2002). We now report that PBD1
is required for phosphorylation of Sch at S518. In addition, Sch S518 phosphorylation occurs in
restricted plasma membrane domains, where active Pak, Cdc42 and paxillin are found. The
results presented here suggest that paxillin binding and translocation to the plasma membrane
precede S518 phosphorylation that occurs predominantly by Cdc42-Pak in specific membrane
domains of subconfluent SCs.
2.4.1 Interactions With Paxillin Regulate Sch S518 Phosphorylation
Recent work has raised the question of whether phosphorylation is required for Sch localization
to the plasma membrane (Kissil et al., 2002; Surace et al; 2004). Using both biochemical and
cellular assays, we find that phosphorylation of Sch on serine 518 requires paxillin binding to
PBD1, but is independent of paxillin binding to PBD2. The inability of Sch∆PBD1 to become
phosphorylated results from its inability to associate with the plasma membrane, as both SchGFP and Sch∆PBD2-GFP localize to the plasma membrane and undergo S518 phosphorylation.
This result is independent of the tag, Xpress or GFP, fused onto either the N or C-terminus. In
SCs expressing Sch-GFP, the vast majority of the molecules are at the plasma membrane but
only a small subset become PS518 positive. Phosphorylated Sch-GFP is confined to the most
peripheral aspects of lamellipodia, microspikes, and radial membrane protrusions (Figure 2.2).
P-Pak is enriched at these subdomains consistent with Pak as the effector kinase (Figure 2.3). In
contrast, nearly all Sch∆PBD2-GFP molecules are PS518 positive regardless of their cellular
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localization. The possibility that deletion of PBD2 impairs negative regulation of Pak by Sch is
unlikely, because increased levels of phospho-threonine 423 Pak, that is required for Pak
activity, was not observed in SCs expressing Sch∆PBD2-GFP (Zenke et al., 1999). The focal
increase in P-Pak fluorescence in radial membrane protrusions observed in SCs expressing fulllength Sch-GFP was not observed in SCs expressing the PBD2 deletion variant. A possible
explanation for the deregulation of S518 phosphorylation is that conformation of the C-terminus
in the PBD2 deletion variant is perturbed, impairing intra- and inter-molecular interactions that
usually restrict access to S518. Alternatively, this variant is not effectively dephosphorylated.
Furthermore, neither Sch∆PBD1-S518A nor Sch∆PBD1-S518D localize to the plasma
membrane (unpublished observations). Both GFP-tagged SchS518A/D variants localize
effectively to the plasma membrane (Figure 2.8A). This suggests that Sch phosphorylation
occurs following translocation to the plasma membrane, into areas containing active surface
receptors that promote Pak activity.
2.4.2 Evidence For Cdc42-Pak Dependent S518 Phosphorylation
Both Pak and protein kinase A have been reported to phosphorylate S518 (Kissil et al., 2002;
Xiao et al., 2002; Alfthan et al., 2004). We used constitutively active forms of Cdc42 and Rac to
discriminate between Pak and PKA mediated SchS518 phosphorylation. Introduction of both
constructs into SCs effectively increases P-Pak levels but does not promote indiscriminate
phosphorylation of endogenous SchS518. GST-Pak CRIB pull down assays from SCs treated
with and without NSC23766, reveal that SchS518 and Pak phosphorylation are not reduced
concomitantly with the reduction in Rac-GTP levels. This observation, together with the
localization of Cdc42 but not Rac at the plasma membrane, strongly suggests that in
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subconfluent SCs, the majority of Sch phosphorylation is due to Cdc42-dependent activation of
Pak.

It has also been shown that Cdc42-GTP binds with a higher affinity to Pak than Rac-GTP,

and that only very low amounts of active Rac are present at the plasma membrane in human
Schwann cells (Thompson et al., 1998; Nakai et al., 2006). The limited phosphorylation of
membrane-associated Sch-GFP at domains containing elevated P-Pak is consistent with tight
spatial and temporal regulation of Cdc42-Pak activity at the plasma membrane.
2.4.3 Activation Of Cdc42-Pak Dependent Sch S518 Phosphorylation
The Rho family of GTPases are activated in response to ligand-receptor interactions at the
plasma membrane (reviewed in Kjoller and Hall et al., 1999). Our earlier work demonstrated that
Sch and paxillin localize at the plasma membrane and associate with β1 integrin and ErbB2 in
SCs (Fernandez-Valle et al., 2002). These receptors play fundamental and essential roles in
regulating all aspects of SC function, including survival, proliferation, migration, differentiation
and myelination (Fernandez-Valle et al. 1994; Garrett et al., 2000; Feltri et al., 2002; Michailov
2004, Lyons et al., 2005; Taveggia et al., 2005). Activation of each receptor is coupled to
immediate changes in the actin cytoskeleton through activation of Rho-family GTPases (Otey
and Burridge, 1990; Akiyama, 1996; Adam et al., 1998; Feldner and Brandt; 2002; Juliano et al.,
2004). Work by others has shown that Pak and paxillin are recruited to integrin and ErbB2
receptors (Adams et al., 1998; Turner et al., 1999; del Pozo et al., 2000; reviewed in Turner,
2000; Juliano et al., 2004; Hildebrand et al., 1995, Tachibana et al., 1995, Fernandez-Valle et al.,
2002). Our previous work suggests that β1 integrin and ErbB2 receptors are likely candidates
for Cdc42 and Pak activation at the plasma membrane.
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2.4.4 Sch Regulates The Organization Of The Actin Cytoskeleton
Loss of Sch expression, in human schwannomas alters the characteristic spindle shape of SCs.
Schwannomas display severe cytoskeletal defects including excessive membrane ruffling, loss of
stress fiber formation, and increased surface area (Pelton et al. 1998; Rosenbaum et al., 1998;
Bahsour et al., 2002). We find that introduction of Sch-GFP into SCs reinforces their innate
spindle shape. Sch-GFP localizes to the plasma membrane and promotes extensive cell
elongation. Overall, SCs remain bipolar but become longer and thinner than those expressing
GFP alone. This is consistent with the introduction of a negative regulator of Rac, which further
limits cell spreading. The expression of SchS518-GFP variants in SCs similarly promotes cell
elongation. The S518 variants additionally influence the finer organization of the actin
cytoskeleton and SC polarity. SchS518D-GFP promotes branching of bipolar cellular processes,
often promoting extension of multiple processes from the cell body. Both are atypical
phenotypes for SCs and are reminiscent of oligodendrocyte morphology. SchS518A-GFP
promotes extension of a single process from the cell body and elaboration of a large lamellipodia
from the opposite pole. This morphology resembles that reported for SCs migrating along axons
in vitro (Gatto et al., 2003). Deletion of PBD1 from these constructs abrogates their
morphological effects, as neither localize to the plasma membrane (unpublished observation,
CFV). Therefore, a function of membrane-associated Sch appears to be promotion of cellular
elongation. Its S518 phosphorylation state influences cell polarity and the final branching
pattern of processes. The SchS518D variant has also been reported to promote extension of
multiple processes in RT4 schwannoma cell lines (Surace et al., 2004). Establishment and
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maintenance of a bipolar phenotype and dynamic regulation of actin polymerization are critical
for SC function (Billings-Gagliardi et al., 1974; Fernandez-Valle et al., 1997).
2.4.5 Two Pools Of Sch With Distinct Functions
Recently it was shown in endothelial cells, that expression of Sch S518A sequesters Rac in the
cytosol, preventing its localization to the plasma membrane (Okada et al., 2005). The
morphological and proliferative abnormalities in schwannomas have been attributed to increased
levels of Rac activity at the plasma membrane (Shaw et al., 2001; Hirokawa et al., 2003;
Kaempchen et al., 2003; Kissil et al., 2003; Nakai et al., 2005). Here, we show in primary SCs
that very little endogenous Rac is found at the plasma membrane or in cellular processes. The
majority is present within the perinuclear cytosol. In contrast, we show here and in previous
work that, Cdc42 and RhoA and B are abundantly expressed at the plasma membrane, along
processes, and within their distal endings (Taylor et al., 2003). Sch likely exists in two distinct
pools within subconfluent SCs. A membrane-associated pool consisting of open, S518
phosphorylated and unphosphorylated molecules, that participate in cytoskeletal reorganization;
and a cytosolic pool, consisting of closed, S518 unphosphorylated molecules that negatively
regulate Rac and/or Pak activity by preventing localization of Rac to the plasma membrane.
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In summary, we demonstrate that phosphorylation of Sch requires paxillin binding and plasma
membrane localization, where a subset can be phosphorylated on S518 by Cdc42-Pak.
Membrane-associated Sch is poised to coordinate cytoskeletal reorganization in response to
receptor activity. This dynamic regulation of the actin cytoskeleton is fundamental for effective
interactions of SC processes with axons during development and regeneration of peripheral
nerves.
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Figure 2.1 PBD1 Is Required For Serine 518 Phosphorylation Of Sch.
Primary rat SCs were transiently transfected with plasmids encoding Xpress-tagged Sch PBD
deletion variants and β-galactosidase (LacZ) as a control. SCs were extracted 36 hours after
transfection and Xpress-tagged proteins were immunoprecipitated using Xpress antibody and
were immunoblotted with Sch PS518 and paxillin antibodies. Full-length Sch (Sch) and the
PBD2 deletion variant (Sch∆2) were positive for PS518 and co-immunoprecipitated with
paxillin. Sch variants lacking PBD1 (Sch∆1and Sch∆∆1/2; data not shown) and Xpress-βgalactosidase (LacZ) were not positive for PS518 and did not co-immunoprecipitate with
paxillin. This experiment was performed four times with identical results. This suggests that
Sch-PBD1 binding to paxillin and association with the membrane is required for Sch
phosphorylation.
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Figure 2.1 Figure 2.1 PBD1 Is Required For Serine
518 Phosphorylation Of Sch.
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Figure 2.2 Sch-GFP Is Phosphorylated At Restricted Plasma Membrane Domains.
SCs expressing of Sch-GFP often formed radial membrane protrusions along the SC process.
These radial protrusions were not observed in SCs expressing Sch variants lacking PBD1. The
protrusions contained enhanced Sch-GFP and PS518 fluorescence; colocalization was observed
in the distal most aspects of the specialization (insets). Sch-GFP found within processes and
along the plasma membrane lacking specializations was associated with only weak PS518
fluorescence. SCs expressing Sch∆PBD1-GFP did not have increased PS518 fluorescence as
observed in SCs expressing Sch-GFP or in untransfected SCs. Sch∆PBD1-GFP was present in
the perinuclear cytosol and within processes but did not colocalize with PS518 fluorescence. In
SCs expressing Sch∆PBD2-GFP, a significant increase in PS518 fluorescence as was observed
compared to SCs expressing Sch-GFP. Sch∆PBD2-GFP and PS518 fluorescence colocalized
irrespective of cellular localization and membrane morphology. This indicates that the presence
of each PBD influences the phosphorylation dynamics at serine 518 in Sch. This result was
observed consistently in four individual experiments.
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Figure 2.2 Sch-GFP Is Phosphorylated At Restricted Plasma Membrane Domains.
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Figure 2.3 Deletion Of PBD2 Is Not Associated With Increased Pak Activity In SCs.
SCs were transiently transfected with plasmids encoding GFP-tagged Sch PBD deletion variants.
SCs were immunostained with Pak phosphothreonine 423 (P-Pak) antibody. Expression of SchGFP was associated with increased P-Pak fluorescence in radial membrane protrusions (inset)
and in filopodia. Intracellular Sch-GFP found within processes did not colocalize with P-Pak
fluorescence. Expression of Sch∆PBD1-GFP was not associated with changes in P-Pak
fluorescence intensity or distribution as compared to untransfected and Sch-GFP expressing SCs.
Expression of Sch∆PBD2-GFP did not promote an overall increase in P-Pak fluorescence as was
observed for PS518 fluorescence. P-Pak fluorescence was largely restricted to distal tips of
radial filopodia (inset) and to the peripheral-most aspects of a large membrane protrusion where
it colocalized with Sch∆PBD2-GFP.
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Figure 2.3 Deletion Of PBD2 Is Not Associated With Increased Pak Activity In SCs.
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Figure 2.4 Expression Of Active Cdc42 And Rac Increases Endogenous P-Pak Levels.
SCs were transiently transfected with plasmids encoding active Myc-tagged Q61LCdc42 and
Q61LRac. SCs were immunostained with phospho-threonine 423-Pak and Myc antibodies. SCs
expressing Myc-Q61LCdc42 and Myc-Q61LRac had increased P-Pak fluorescence throughout
the cell compared to adjacent untransfected SCs. There was a focal increase in P-Pak and Myc
staining in distal tips of processes when active Cdc42 was expressed (arrows).
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Figure 2.4 Expression Of Active Cdc42 And Rac Increases Endogenous P-Pak Levels.
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Figure 2.5 Expression Of Active Cdc42 and Rac Does Not Increase Phosphorylation of
Endogenous Sch.
SCs were transiently co-transfected with GFP and Myc-tagged Q61LCdc42 and Q61LRac. SCs
were immunostained with PS518 and Myc antibodies. Co-expression of GFP with Myc-Q61LCdc42 and Rac did not lead to an overall increase in endogenous PS518 fluorescence as was
observed for endogenous Pak. In Myc-Q61LCdc42 transfected SCs, there were areas of
increased PS518 fluorescence that colocalized with Myc staining. These were along short
cytoplasmic processes (arrows). Similar areas in Myc-Q61LRac transfected SCs did not show
elevated PS518 expression (arrowheads). Each experiment was repeated three times with
identical results.
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Figure 2.5 Expression Of Active Cdc42 and Rac Does Not Increase Phosphorylation of Endogenous Sch.

50

Figure 2.6 Expression Of Active Cdc42 And Rac Increases S518 Phosphorylation Of
Exogenous Sch-GFP.
SCs were transiently transfected with expression plasmids for Sch-GFP, alone and with
Myc-tagged Q61LCdc42 and Q61LRac. SCs were immunostained with PS518 and Myc
antibodies. In SCs expressing only Sch-GFP, fluorescence was observed at the plasma
membrane and within cellular processes. Co-localization of Sch-GFP with PS518 fluorescence
revealed that only a subset of Sch-GFP molecules was phosphorylated. The PS518-positive
molecules were found at distal aspects of membrane protrusions, but not along the plasma
membrane surrounding the cell body from which many filopodia protruded (arrowhead).
Co-expression of Sch-GFP with either Myc-Q61LCdc42 or Myc-Q61LRac led to similar
increases in Sch PS518 fluorescence throughout the cell as compared to untransfected and SchGFP transfected SCs. All membrane domains containing Sch-GFP were positive for PS518
when activated Cdc42 and Rac were co-expressed. Identical results were obtained in three
experiments with 2-4 coverslips per transfection group.

51

Figure 2.6 Expression Of Active Cdc42 And Rac Increases S518 Phosphorylation Of Exogenous Sch-GFP.
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Figure 2.7 Inhibition of Rac GTPase Does Not Reduce Sch S518 and Pak Phosphorylation.
A, B) GST- Pak CRIB pull down assays were conducted using lysates from SCs incubated
overnight with (+) and without (-) NSC23766, an inhibitor of Rac GTPase activity. The
membrane was blotted for Rac, then for GST and was stripped and was re-blotted for Cdc42.
Positive (+GTP) and negative (+GDP) controls were also performed. C, D) Normalization of
the amount of Rac-GTP and Cdc42-GTP to GST demonstrated that NSC23766 reduced
Rac-GTP by 72% of the untreated control level, whereas it reduced Cdc42-GTP by only 21% of
untreated controls. E) Lysates of SCs incubated with and without NSC23766 were
immunoblotted for total Rac, Cdc42, and PS518. NSC23766 did not reduce the levels of total
Rac and Cdc42 or PS518. F) Sch phosphorylation levels were normalized to GAPDH and no
reduction in Sch-PS518 was observed in response to NSC23766 treatment. G) Lysates of SCs
incubated with and without NSC23766 were immunoblotted for P-Pak. No reduction of P-Pak
levels was observed in treated compared to untreated SCs. This experiment was performed twice
with identical results and is consistent with Cdc42-Pak dependent phosphorylation of Sch-S518.
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Figure 2.7 Inhibition of Rac GTPase Does Not Reduce Sch S518 and Pak Phosphorylation.
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Figure 2.7 Inhibition of Rac GTPase Does Not Reduce Sch S518 and Pak Phosphorylation.
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Figure 2.8 Sch-PS518, Paxillin, Cdc42, P-Pak, But not Rac Colocalize In Membrane
Protrusions.
Subconfluent SCs grown under standard conditions were immunostained with antibodies for
PS518, paxillin, Cdc42, Rac and P-Pak to ascertain if the proteins colocalized at the cell
periphery. Cdc42 and PS518, as well as paxillin and PS518 colocalize along cellular processes,
membrane protrusions and at their distal tips. In contrast, paxillin and Rac were not colocalized.
Only weak fluorescence was observed for Rac within the cytosol and at the plasma membrane.
P-Pak colocalized with Cdc42 in cellular processes and radial membrane protrusions. All
images were obtained using identical settings and were processed identically.
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Figure 2.8 Sch-PS518, Paxillin, Cdc42, P-Pak, But Not Rac Colocalize In Membrane Protrusions.
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Figure 2.9 Sch Phosphorylation Status Alters SC Morphology.
A) Confluent SCs were transfected with Sch S518 variants and were stained with phalloidin to
visualize F-actin 36 hours after transfection. SCs expressing GFP alone and Sch-GFP were
typically bipolar. SCs expressing Sch-S518A-GFP were most frequently unipolar with a single
elongated process, whereas SCs expressing Sch-S518D-GFP were typically multipolar or bipolar
with heavily branched processes. B) Morphological changes were assessed by counting all
GFP-positive SCs in each group and categorizing their shape. The counts were obtained from
three independent experiments in which a total of 1500-3000 SCs per group were assessed.
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Figure 2.9 Sch Phosphorylation Status Alters SC Morphology.
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CHAPTER 3
NEUREGULIN AND LAMININ STIMULATE PHOSPHORYLATION OF
THE NF2 TUMOR SUPPRESSOR IN SCHWANN CELLS BY DISTINCT
PROTEIN KINASE A AND P21-ACTIVATED KINASE DEPENDENT
PATHWAYS
3.1 Introduction
The Neurofibromatosis type 2 (NF2) tumor suppressor Schwannomin (Sch), also known as
merlin, is a membrane-cytoskeleton linking protein (Rouleau et al., 1993; Trofatter et al., 1993).
Mutations in the NF2 gene predispose individuals to benign, slow-growing schwannomas. Sch’s
conformation, localization, and phosphorylation are important determinants of its ability to
regulate proliferation and actin organization (reviewed in McClatchey and Giovannini, 2005).
The tumor suppressor function of Sch is associated with its closed, intracellular form lacking
phosphorylation on serine 518 (S518; Rong et al., 2004; Shaw et al., 2001). In this
conformation, Sch inhibits Rac-mediated signaling cascades and progression through the G1
phase of the cell cycle (reviewed in Okada et al., 2007). Phosphorylation of Sch-S518 is
believed to stabilize Sch in the open conformation, inhibiting its tumor suppressor function while
unmasking binding sites for trans-membrane receptors and actin-associated proteins (James et
al., 2001; Rong et al., 2004). P21-activated kinase (Pak) and protein kinase A (PKA)
phosphorylate Sch on S518, but the receptor mechanisms leading to Sch phosphorylation are
unknown (Kissil et al., 2002; Xiao et al., 2002; Alfthan et al., 2004).

Previously, we demonstrated that Sch localization to the plasma membrane, and its
phosphorylation on S518 requires direct binding of residues 50-70 within Sch’s N-terminus to
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the scaffold protein, paxillin (Fernandez-Valle et al., 2002, Thaxton et al., 2007). We also
demonstrated that Sch is present at the plasma membrane of subconfluent Schwann cells (SCs),
where Sch and paxillin interact with β1 integrin and ErbB2; receptors critical for SC adhesion,
motility, proliferation and myelination (Fernandez-Valle et al., 2002; reviewed in Garratt et al.,
2000; reviewed in Chernousov and Carey, 2000). Paxillin also recruits Pak to the plasma
membrane, and serves as a scaffold for Sch-Pak interactions by binding multiple regulators of
Rac and Cdc42, members of the Rho family of GTPases, as well as actin binding proteins and
components of focal complexes and adhesions (reviewed in Turner, 2000).

Here, we demonstrate that NRG1β and laminin-1, ligands for ErbB and β1 integrin receptors,
respectively, induce Sch phosphorylation in SCs through two independent pathways, NRG1β by
PKA, and laminin-1 by Pak. NRG1β and laminin-1 do not synergize to increase Sch
phosphorylation, but rather NRG1β partially antagonizes laminin-induced Sch phosphorylation.
These findings show that Sch is a convergence point for transduction of signals from ErbB and
β1 integrin receptors that regulate proliferation, differentiation and cytoskeletal dynamics in SCs
during peripheral nerve development.
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3.2 Materials and Methods
3.2.1 Materials
The following materials were used: Natural mouse laminin-1 and Lipofectamine 2000
(Invitrogen; Carlsbad, CA, USA), AG825 and PKI14-22 amide (EMD Biosciences; San Diego,
CA, USA). Sch-GFP constructs were described previously (Thaxton et al., 2007). Recombinant
human NRG-1 beta/type II (NRG1β was a generous gift from Mark Marchionni. Myc-Pak
K299A and Myc-Pak L107F, T423E (Myc-Pak T423E) constructs were generous gifts from
Gary Bokoch (The Scripps Research Inst., La Jolla, CA, USA). Antibodies were purchased from
the following sources: ErbB2 and Sch (C18) from Santa Cruz Biotechnology (Santa Cruz, CA,
USA); β1 integrin from BD Transduction Labs (San Jose, CA, USA); Pak, Myc, and P-CREB
from Cell Signaling (Boston, MA, USA); PS518-Sch and P-ErbB2 (Y1248) from Abcam
(Cambridge, MA, USA); P-Pak (T423) from Rockland Immunologicals, Inc. (Gilbertsville, PA,
USA); Xpress from Invitrogen; ErbB2 from EMD Biosciences; and Alexa Fluor conjugated
secondary antibodies from Invitrogen.
3.2.2 Cell Culture
Primary rat SC cultures were prepared from neo-natal day 1 rat pups as described previously
(Chen et al., 2000). Subconfluent SC cultures were grown on glass coverslips coated with polyL-lysine (PLL; 200µg/ml) alone or sequentially with laminin-1 (25µg/ml). Cultures were
starved overnight in Dulbecco’s Modified Eagle Medium with 0.5 % fetal bovine serum (D0.5)
before use. The SCs were either left unstimulated, or were stimulated with NRG1β (10ng/ml)
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for 30 minutes. For laminin-1 stimulation, primary rat SCs were grown on PLL coated glass
coverslips and were starved overnight in D0.5. The SCs were then stimulated with soluble
laminin-1 (10µg/ml) or were left unstimulated.
3.2.3 Immunostaining
The SCs were immunostained as described previously (Fernandez-Valle et al., 2002). Cells were
analyzed with a Zeiss laser scanning microscope and LSM 510 software. Images shown in each
figure are single planes that were collected with identical settings and were processed identically.
3.2.4 Western Blotting
Primary rat SCs were grown to approximately 60% confluency on PLL coated dishes. The
cultures were serum starved overnight in D0.5 and were either left in D0.5 or were pre-incubated
with AG825 (1µM) or PKI14-22 (50nM) for 1 hour. Next, the SCs were either left unstimulated or
were stimulated with NRG1β (10ng/ml) and/or laminin-1 (10µg/ml) in the presence and absence
of AG825 (1µM) or PKI14-22 (50nM) for 30 minutes. The SCs were extracted as described
previously (Fernandez-Valle et al., 2002) in either TAN buffer (10mM Tris-acetate pH8.0,
100mM NaCl, and 1% IGEPAL) or HEPES buffer (50mM HEPES, 1mM DTT, 150mM NaCl,
1% IGEPAL) containing protease inhibitors. Following extraction, the SC lysate was measured
for protein concentration, and 10µg of total SC lysate was separated by SDS-PAGE and was
transferred to PVDF membranes. The indicated primary antibodies were used, followed by
corresponding HRP-conjugated secondary antibody and chemiluminescence detection.
Densitometric analysis was conducted on all Western blots. Bands intensities were quantified
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and normalized to GAPDH, and to their respective total proteins for phosphorylated forms.
Statistical analysis was acquired using the Student t-test by paired analysis.
3.2.5 Immunoprecipitation
Subconfluent SC cultures grown in medium containing 10% FBS, forskolin (2µM) and pituitary
extract (20µg/ml) were extracted in TAN buffer and 500µg of lysate were immunoprecipitated
withβ1 integrin antibody, as described previously (Chen et al., 2000). Immunoprecipitation with
β1 integrin antibody covalently linked to magnetic beads was performed as described previously
(Taylor et al., 2003).
3.2.6 Transfections
Primary rat SC cultures were transfected using Lipofectamine 2000 as described previously
(Thaxton et al., 2007). Thirty-six hours after transfection, the SCs were immunostained.
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3.3 Results
3.3.1 NRG1β and Laminin-1 Induce Phosphorylation of Sch at SC Distal Tips and Radial
Membrane Protrusions
NRG and laminin activate Cdc42/Rac GTPases and Pak in other cell types (Adam et al., 1998;
Del Pozo et al., 2000). Work from this laboratory has demonstrated that Sch can interact with
both ErbB2 and β1 integrin, and that paxillin-dependent localization to the plasma membrane is
required for phosphorylation of Sch by Cdc42-Pak (Fernandez-Valle et al., 2002; Thaxton et al.
2007). Here, we sought to identify receptor(s) that trigger Pak activity and Sch phosphorylation.
We stimulated subconfluent and serum-starved primary rat SCs grown on laminin-1 with
NRG1β for 30 minutes and assessed the phosphorylation states and localization of ErbB2, Sch
and Pak. ErbB2, ErbB3, and Sch were found along SC processes and were concentrated at the
distal tips. NRG1β stimulation induced a focal enrichment of P-ErbB2 and PS518-Sch at the
distal tips of SC processes and within membrane protrusions (Figure 3.1). These molecules colocalized with Cdc42 and paxillin. Phosphorylated Pak was also enriched in membrane
protrusions and at the distal tips where it co-localized with ErbB2.

We quantified the changes in phosphorylation of ErbB2, Sch, and Pak in serum starved and
NRG1β stimulated SC processes (Figure 3.2 A, B). We found marked increases in fluorescence
intensity along SC processes for P-ErbB2, PS518-Sch, and P-Pak, particularly at process tips of
stimulated versus starved SCs (Figure 3.2 A). P-ErbB2 levels increased by 1.6-fold, PS518-Sch
by 1.5-fold, and P-Pak by 1.9-fold in the processes of NRG1β stimulated versus starved SCs
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(Figure 3.2 B). These results demonstrate that acute stimulation of SCs with NRG1β induces
phosphorylation of Sch downstream of ErbB2/ErbB3, possibly by Pak.

As the SCs were grown on laminin-1, a ligand for β1 integrin that mediates SC adhesion
(Fernandez-Valle et al., 1994), we tested whether a 30-minute exposure to soluble laminin-1
stimulated Sch phosphorylation in subconfluent and serum-starved SCs grown on PLL.
Laminin-1 promoted a strong increase in the fluorescence intensity of phosphorylated Sch and
Pak compared to starved SCs (Figure 3.2 C). Quantification of fluorescence intensitity along the
processes revealed a 1.4-fold increase in PS518-Sch and a 1.7-fold increase in P-Pak levels
compared to untreated SCs (Figure 3.2 D). These results demonstrate that adhesion to laminin-1
induces Sch phosphorylation at the plasma membrane, possibly by Pak.

3.3.2 NRG1β Promotes Sch Phosphorylation Through PKA
To determine the relative contributions of ErbB2/ErbB3 and β1 integrin activation on Sch
phosphorylation, we repeated the experiments using SCs plated on PLL rather than laminin-1
and employed the use of AG825 to specifically inhibit ErbB2 kinase activity (Osherov et al.,
1993). Subconfluent SCs were starved and then were stimulated with NRG1β in the presence
and absence of AG825 (Figure 3.3). Western Blot analysis revealed that NRG1β promoted a
4.9-fold increase in P-ErbB2 and a 2.7-fold increase in PS518-Sch levels compared to starved
SCs. AG825 significantly reduced NRG1β stimulated phosphorylation of ErbB2, as well as,
Sch-S518 phosphorylation (Figure 3.3 A, B). Surprisingly, Pak phosphorylation was not
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observed in NRG1β stimulated SCs. When total protein levels were assessed, we found that
NRG1β stimulation reduced the amount of ErbB2 by 54% (Figure 3.3 C, D). This is consistent
with rapid, ligand-induced degradation of ErbB2 receptors (Lotti et al., 1992; Iacovelli et al.,
2007). AG825 partially attenuated the reduction in ErbB2 levels. These results suggest that
NRG1β triggers Sch phosphorylation independently of Pak in SCs.

PKA has been reported to phosphorylate Sch at S518 in vitro (Alfthan et al., 2004).
Additionally, NRG1β stimulation has been suggested to induce PKA activity in SCs (Kim et al.,
1997). Therefore, we tested whether PKA phosphorylated Sch in response to NRG1β activation
of ErbB2/ErbB3 receptors on SCs. Subconfluent SCs were serum starved and were stimulated
with NRG1β in the presence and absence of PKI14-22 amide, a specific inhibitor of PKA activity
(Figure 3.3 E, F). NRG1β alone stimulated a 2.1-fold increase in phosphorylated Sch compared
to starved SCs, and induced phosphorylation of the cyclic-AMP response element binding
protein (P-CREB), a known substrate for PKA. PKI14-22 reduced the levels of Sch and CREB
phosphorylation in response to NRG1β stimulation by 70%. Additionally, stimulation of starved
SCs for 30 minutes with forskolin, an activator of adenylyl cyclase that increases intracellular
cyclic-AMP and activates PKA, also induced phosphorylation of Sch and CREB. These results
indicate that PKA phosphorylates Sch following NRG1β binding to ErbB2/ErbB3 in SCs.
3.3.3 Laminin-1 Promotes Phosphorylation Of Sch-S518 By Pak
To determine if laminin-1 induced phosphorylation of Sch by Pak, we stimulated SCs grown on
PLL with soluble laminin-1 for 30 minutes and conducted western blot analyses (Figure 3.4).
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Laminin-1 promoted a substantial 3.5-fold increase in Sch-S518 phosphorylation and a 1.5-fold
increase in Pak phoshorylation compared to starved SCs (Figure 3.4 A, B). The levels of total
Sch and β1 integrin did not significantly change in response to laminin-1, while the levels of
total Pak fell by 27% (Figure 3.4 C, D). We additionally tested whether laminin-1 activated
ErbB2 and PKA. Stimulation of SCs with laminin-1 did not induce the phosphorylation of
ErbB2 or CREB. These findings are consistent with Pak mediated phosphorylation of Sch-S518
following laminin-1 binding to β1 integrins expressed on the surface of subconfluent SCs.

To obtain additional evidence that Pak phosphorylates Sch in response to stimulation with
laminin-1, we transiently co-transfected SCs plated on PLL and laminin-1 with GFP-tagged Sch
and Myc-tagged Pak kinase mutant constructs (Figure 3.5). As previously shown, expression of
wild-type Sch (Sch-GFP) resulted in increased S518 phosphorylation at the plasma membrane
within discrete membrane protrusions that contain P-Pak (Thaxton et al., 2007). Co-expression
of Sch-GFP with catalytically inactive Pak (Myc-Pak K299A) resulted in a loss of PS518-Sch
fluorescence in these domains and throughout the SC, whereas co-expression with constitutively
active Pak (Myc Pak T423E) resulted in unrestricted Sch-S518 phosphorylation. These results
support Pak-mediated phosphorylation of Sch induced by β1 integrin adhesion to laminin-1.
3.3.4 β1 Integrin And ErbB2 Exist As A Functional Co-Receptor Complex On The SC
Surface
To investigate the possibility that ErbB2 and β1 integrin act as co-receptors to regulate Sch
phosphorylation, we tested their ability to co-localize and co-immunoprecipitate. We found that
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β1 integrin and ErbB2 co-localized with PS518-Sch and P-ErbB2 at the distal tips of SC
processes acutely stimulated with NRG1β (Figure 3.6 A). β1 integrin immunoprecipitations
prepared from lysates of subconfluent SC cultures contained β1 integrin and ErbB2, as well as,
PS518-Sch and paxillin (Figure 3.6 B). To ascertain whether the receptors associated on the cell
surface, β1 integrins were clustered on suspended intact SCs using a β1 integrin antibody
immobilized on magnetic beads, and were subsequently lysed and the clustered receptor
complexes were isolated (Figure 3.6 C). A subset of ErbB2 receptors and PS518-Sch were
present in the β1 integrin immunoprecipitate. RhoA, used as a control, was not present in the
immunoprecipitate.

Trans-activation between integrins and receptor tyrosine kinases occurs and can lead to changes
in receptor protein expression (reviewed in Lee and Juliano, 2004). To determine if transactivation takes place in SCs, β1 integrin and ErbB2 protein levels were measured following
stimulation with NRG1β or laminin-1 for 30 minutes. Stimulation with NRG1β significantly
increased β1 integrin levels 2.0-fold, but decreased ErbB2 levels by half as compared to starved
SCs (Figure 3.6 D, E). Stimulation of SCs with NRG1β and AG825 suppressed NRG1β’s effect
on both β1 integrin and ErbB2 protein levels. Stimulation of SCs with laminin-1 did not alter β1
integrin protein levels, but did increase ErbB2 protein levels by a statistically significant 1.5-fold
compared to untreated SCs (Figure 3.6 F, G). Surprisingly, stimulation with laminin-1 and
AG825 decreased β1 integrin levels by 58%, while ErbB2 levels slightly increased with respect
to laminin-stimulated SCs. This is consistent with a basal level of autocrine activation of
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ErbB2/ErbB3 in SCs. SCs have been shown to synthesize and secrete NRGs in response to
serum deprivation, thereby transducing survival signals (Rosenbaum et al., 1997).
3.3.5 Dual Stimulation With NRG1β And Laminin-1 Does Not Synergistically Increase Sch
Phosphorylation
To determine if simultaneous activation of ErbB2/ErbB3 and β1 integrin in SCs synergize to
increase phosphorylation of Sch, we stimulated serum-starved SCs grown on PLL for 30 minutes
with NRG1β and soluble laminin-1, in the presence and absence of AG825 (Figure 3.7). Dual
stimulation resulted in a significant 1.7-fold increase in PS518-Sch and a 2.1-fold increase in PPak compared to unstimulated SCs. This level of Sch phosphorylation was not higher than levels
observed in SCs stimulated with either NRG1β or laminin-1 alone, which were 2.7-fold and 3.5fold higher than starved SCs, respectively (Figure 3.7 A, B compared to Figure 3.3 B and Figure
3.4B). Surprisingly, stimulation with NRG1β and laminin-1 in the presence of AG825 promoted
greater phosphorylation of Sch-S518 (a 4.6-fold increase) and Pak (a 3.1-fold increase)
compared to starved SCs, suggesting that ErbB2 kinase activity partially inhibits Pak and its
phosphorylation of Sch. PKA has been shown to directly phosphorylate and inhibit Pak (Howe
and Juliano, 2000). We found that AG825 inhibited phosphorylation of CREB in response to
NRG1β in dually stimulated SCs, suggesting that ErbB activation of PKA might function to
inhibit Pak in SCs following NRG1β and laminin-1 stimulation (Figure 3.7 G). Sch, Pak and β1
integrin protein levels were not significantly changed in SCs stimulated with NRG1β and
laminin-1 in the presence and absence of AG825 (Figure 3.7 C, D). Stimulation with NRG1β
and laminin-1 resulted in a 20% decrease in ErbB2 compared to starved SCs. These results
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suggest that ErbB2 kinase activity inhibits or competes with Pak-dependent phosphorylation of
Sch in response to laminin-1, possibly through PKA. A model consistent with our results is
shown (Figure 3.8).
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3.4 Discussion
Phosphorylation of S518 is a critical switch that controls Sch’s tumor suppressor activity. Pak
and PKA have been shown to phosphorylate Sch on S518 when overexpressed with Sch in cell
lines and in in vitro kinase assays, but neither kinase has been linked to receptor activation and
phosphorylation of endogenously expressed Sch in any cell type (Kissil et al., 2002; Xiao et al.,
2002; Alfthan et al., 2004). Here, we identify two receptors that lead to rapid phosphorylation of
Sch-S518 in SCs. Laminin-1 binding to β1 integrin activates Pak, whereas NRG1β binding to
ErbB receptors activates PKA. Each kinase phosphorylates Sch-S518 within 30 minutes of
stimulation. Both receptors regulate all stages of Schwann cell development including
proliferation, and both play central roles in the tumorigenic and metastatic capacities of many
additional cell types.
3.4.1 Two Distinct Receptor Mediated Pathways Promote Sch Phosphorylation
Our data provide strong evidence that NRG1β binding to ErbB2/ErbB3 induces PKA-dependent
phosphorylation of endogenous Sch. This conclusion is supported by the following results.
First, serum-starved SCs have basal levels of phosphorylated Pak and Sch. NRG1β inhibits
basal Pak activity while increasing the amount of phosphorylated Sch, 2.7-fold. Second,
inhibition of ErbB2 kinase activity by AG825 reduces Sch-S518 phosphorylation in response to
NRG1β by 120%. Third, the PKA inhibitor, PKI14-22 similarly reduces Sch-S518
phosphorylation in response to NRG1β by 70%. Lastly, although not as effective as NRG1β,
forskolin increases Sch phosphorylation. We also show that NRG1β promotes phosphorylation
of CREB, and that both AG825 and PKI14-22 inhibit this phosphorylation, consistent with NRG1β
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stimulation of PKA activity. In support, others have also found evidence of PKA activation by
NRG in SCs (Kim et al., 1997). Overall, our results indicate that NRG1β binds to ErbB2/ErbB3
receptors and stimulates rapid phosphorylation of Sch on S518 by PKA.

Cell adhesion to extracellular matrix through integrins activates Pak (Del Pozo et al., 2000).
Laminin-1 is present in the endoneurium of nerves in perinatal mice, and promotes strong in
vitro adhesion, migration and proliferation of SCs (Milner et al., 1997; Dubovy et al., 2000).
Previously we demonstrated that α6β1 integrin is the predominant laminin-1 binding integrin
present in SCs at this stage of development (Fernandez-Valle et al., 1994). Our new findings
indicate that laminin-1 binding to α6β1 integrin promotes Sch-S518 phosphorylation by Pak.
Our evidence is as follows: First, stimulation of SCs with soluble laminin-1 increases both PPak (1.5-fold) and PS518-Sch (3.5-fold) over basal levels. Similarly, P-Pak and PS518-Sch are
increased within SC processes as assessed by quantification of immunofluorescence. Second,
Sch-GFP expressed in SCs adhering to laminin-1 is phosphorylated by an endogenous kinase,
predominantly when localized at the plasma membrane of cellular processes and particularly in
radial membrane protrusions. Previously, we reported that Cdc42-Pak rather than Rac-Pak was
associated with phosphorylation of Sch in these domains (Thaxton et al., 2007). Consistently,
we find that expression of catalytically inactive Pak inhibits phosphorylation of Sch-GFP in SCs
adhering to laminin-1. Lastly, laminin-1 does not activate PKA or trans-activate ErbB2, as PErbB2 and P-CREB were not found, ruling out PKA dependent phosphorylation of Sch in
response to laminin-1. It has been established that Pak is recruited to focal complexes through
an indirect interaction with paxillin, stimulated by Cdc42 and Rac activity (Brown et al., 2002).
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Together, our results indicate that aggregation of α6β1 integrins by laminin-1 triggers
translocation of a Pak-paxillin-Sch complex to nascent membrane protrusions where Sch-S518 is
phosphorylated by Cdc42-Pak.
3.4.2 ErbB2 Modulates β1 Integrin Signaling
Our data demonstrate that ErbB2/ErbB3 and β1 integrin physically interact and function as coreceptors that regulate both the turnover rate of each receptor and their downstream signals.
ErbB2/ErbB3 and β1 integrin co-immunoprecipitate and co-localize on the SC surface, and are
enriched at the distal tips of SC processes stimulated with NRG1β. Simultaneous activation of
ErbB2/ErbB3 and β1 integrin receptors does not synergistically increase Sch phosphorylation,
but rather ErbB2 activity appears to antagonize Pak-dependent phosphorylation of Sch. In SCs
stimulated with NRG1β, laminin-1 and AG825, PS518-Sch and P-Pak levels are increased with
respect to the levels in dually stimulated SCs, while CREB phosphorylation is eliminated.
AG825, in the absence of NRG1β also increases basal levels of phosphorylated Pak and Sch
(data not shown), consistent with autocrine stimulation of ErbB2 and PKA activity (Rosenbaum
et al., 1997). PKA has been shown to directly phosphorylate and inhibit Pak in NIH3T3 cells
(Howe and Juliano, 2000). Together, these findings indicate that ErbB2, possibly through PKA,
antagonizes Pak dependent phosphorylation of Sch downstream of β1 integrin.
3.4.3 Implications For Schwannoma Development
β1 integrin and ErbB receptors regulate SC proliferation during development. Conditional
inactivation of genes encoding their respective ligands, the laminin γ1 gene and the neuregulin
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gene, in mice are associated with low proliferative capacity of SCs during development,
demonstrating that both receptors are essential for SC proliferation (reviewed in Garratt et al.,
2000; Chen and Strickland, 2003; Yang et al., 2005). Cooperation between receptor tyrosine
kinase and integrin signaling is required for activation of the Ras-Raf-Mek-Erk pathway, which
is active in both human and rodent SCs (reviewed in Lee and Juliano, 2004; Monje et al., 2006;
Iacovelli et al., 2007). Activation of mitogenic receptor tyrosine kinases, in the absence of
integrin-dependent adhesion, is coupled only to Ras and Raf and does not lead to Mek and Erk
activity. Adhesion of integrins to extracellular matrix activates the Rho family of GTPases and
Pak, allowing Pak phosphorylation of c-Raf and Mek. Mek then associates with, and
phosphorylates Erk (Del Pozo et al., 2000; Coles and Shaw 2002). One mechanism by which
Sch restricts proliferation is by inhibiting Rac-Pak activity in confluent cells (reviewed in Okada
et al., 2007). Phosphorylation of Sch downstream of both ErbB and β1 integrin receptors would
inactivate this ability, and would allow Rac-Pak signaling to couple to Ras-Erk pathways and
stimulate proliferation of subconfluent cells.

Consistent with the rapid turnover of focal contacts in subconfluent, motile cells, we find that β1
integrin and ErbB2 protein levels are rapidly modulated by receptor activity. Whereas laminin-1
stimulates a 50% increase in ErbB2 protein expression over starved SCs, NRG1β promotes a
55% decrease in ErbB2 receptors while increasing β1 integrin levels 2.0 fold over the levels
observed in starved SCs. AG825 attenuates the loss of ErbB2 protein in response to NRG1β,
and inhibits the increase in β1 integrin, confirming that ErbB2 kinase activity modulates the fate
of each receptor. In laminin-1 stimulated SCs, AG825 decreases β1 integrin levels and increases
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ErbB2 levels, consistent with autocrine stimulation of ErbB2 in SCs. These effects are likely
mediated through changes in protein stability and/or degradation, as they occur within 30
minutes of stimulation. Moreover, our results show that each receptor has a different fate after
activation, β1 integrins are stabilized following NRG1β stimulation, whereas ErbB2 is degraded.
This also implies that ErbB2 dependent inhibition of Pak is transient, and that β1 integrin and
Pak dependent phosphorylation of Sch occurs during the time ErbB2 receptor expression on the
plasma membrane is low.

Sch is at a critical convergence point for transduction of signals from these receptors, and reveals
why loss of this protein in SCs predisposes them to tumor formation. There is evidence that Sch
controls endocytosis of ErbB family members, possibly through its interaction with HRS (Scoles
et al., 2005; Maitra et al., 2006). Additionally, other paxillin binding proteins regulate vesicle
trafficking and receptor degradation (reviewed in Turner, 2000). Of note, human schwannoma
cells have increased expression of β1 integrin and activated ErbB2, Rac and Pak (Hansen and
Linthicum, 2004; Kaempchen et al. 2003; Utermark et al., 2003). Loss of Sch expression in SCs
could allow unrestricted autocrine stimulation of ErbB2/ErbB3, resulting in increased β1 integrin
levels and prolonged activation of PKA, Rac-Pak, Ras-Erk and PI3K/AKT pathways. Activation
of these signaling cascades would stimulate a slow, but continuous proliferation of SCs,
characteristic of schwannoma growth in individuals with NF2.

In summary, we show that activation of ErbB2/ErbB3 and β1 integrin receptors promotes
phosphorylation of Sch through distinct PKA- and Pak-dependent pathways. In vivo, these
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signaling cascades would cooperate to promote SC proliferation in response to axonal NRG and
basal lamina adhesion. In its phosphorylated state, Sch would also permit Rac-Pak dependent
changes in the actin cytoskeleton associated with extension of processes along axons, a critical
function for myelination. Our findings shed light on Sch’s function during development and
pathogenesis in the peripheral nervous system.
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Figure 3.1 Phosphorylated Forms Of ErbB2, Sch, And Pak Co-localize With Paxillin And
Cdc42 In Processes, Their Distal Tips And Radial Protrusions Following Acute Stimulation
With NRG1β.
Subconfluent SCs plated on PLL/laminin-1 coated coverslips were serum-starved overnight and
were then stimulated with NRG1β for 30 minutes. Immunostaining was conducted for the
indicated proteins to assess their phosphorylation states and localizations. SCs are shown at low
magnification (left), and the boxed area is shown at higher magnifications to the right and within
insets. All proteins were present in the cytosol, along SC processes and were focally enriched at
radial membrane protrusions and distal tips. Scale bars represent 20µm.
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Figure 3.1 Phosphorylated Forms Of ErBb2, Sch, And Pak Co-Localize With Paxillin And Cdc42 In Processes,
Their Distal Tips And Radial Protrusions Following Acute Stimulation With NRG1β.
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Figure 3.2 NRG1β And Laminin-1 Induce Sch Phosphorylation In SC Processes.
Subconfluent SCs grown on PLL/laminin-1 were starved overnight (D0.5) and were left
untreated, or were stimulated for 30 minutes with A) NRG1β (N;10ng/ml) or C) laminin-1
(L;10µg/ml). Phosphorylation of ErbB2 (P-ErbB2), Sch (PS518-Sch), and Pak (P-Pak) was
assessed by immunostaining with phospho-specific antibodies. B, D) Quantification of mean
fluorescence intensity in 15-20 isolated SC processes per condition is shown. The graphs
represent the average fold increase in three or more experiments. Error bars represent the SEM.
p-values are < 0.05(*). Scale bars represent 20µm.
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Figure 3.2 A,B) NRG1β And Laminin-1 Induce Sch
Phosphorylation In SC Processes
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Figure 3.2 C,D) NRG1β And Laminin-1 Induce Sch
Phosphorylation In SC Processes
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Figure 3.3 NRG1β Stimulates Phosphorylation Of Sch By PKA
A, C) Subconfluent SC cultures grown on PLL were serum-starved overnight and were
stimulated for 30 minutes with NRG1β (10ng/ml) in the absence and presence of AG825 (1µM).
Western blot analysis was used to determine the levels of phosphorylated and total ErbB2, Sch,
and Pak. B, D) Quantification of the blots are shown for starved (D0.5), NRG1β stimulated (N)
and NRG1β plus AG825 (N+A) stimulated cultures. E) Subconfluent SCs grown as above were
stimulated for 30 minutes with NRG1β in the presence and absence of PKI 14-22 (50nM), and
with forskolin (FSK; 2µM) alone. Western blot analysis was used to determine the level of
phosphorylated Sch (PS518-Sch) and CREB (P-CREB). F) Quantification of PS518-Sch in
starved (D0.5) and NRG1β (N), NRG1β plus PKI 14-22 (N+P), and forskolin (FSK) stimulated
cultures. GAPDH was used as a loading control. The graphs represent the average fold increase
in three or more experiments. Error bars represent the SEM for each condition. p-values are <
0.05(*) and <0.01(**) with respect to starved SCs or as indicated.
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Figure 3.3 NRG1 Stimulates Phosphorylation Of Sch By PKA.
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Figure 3.4 Laminin-1 Stimulates Phosphorylation Of Sch.
A, C) Subconfluent SC cultures grown on PLL were stimulated with laminin-1 (Lam; 10µg/ml)
for 30 minutes after overnight serum starvation. Western blot analysis using phospho-specific
for Sch (PS518-Sch), Pak (P-Pak), ErbB2 (P-ErbB2), and CREB (P-CREB), and antibodies
against total Sch (Sch-C18), Pak, and β1 integrin are shown. B, D) Quantification of Western
blots for starved (D0.5) and laminin-1 stimulated (L) cultures is shown. The graphs represent the
average fold increase observed in three or more experiments. GAPDH was used as a loading
control for all blots. Error bars represent the SEM. p-values are < 0.05(*) and <0.01(**).
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Figure 3.4 Laminin-1 Stimulates Phosphorylation Of Sch.
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Figure 3.5 Catalytically Inactive Pak Inhibits Sch Phosphorylation In SCs Adhering To
Laminin-1.
SCs plated on PLL and laminin-1 were transiently transfected with GFP-tagged full length Sch
(Sch-GFP) alone or with Myc-tagged catalytically inactive Pak (Myc-Pak K299A) or Myctagged constitutively active Pak (Myc-Pak T423E), and were immunostained to assess Sch-S518
phosphorylation (PS518-Sch) and Myc-Pak expression (Myc). Scale bars represent 20µm.

87

Figure 3.5 Catalytically Inactive Pak Inhibits Sch Phosphorylation In SCs Adhering To Laminin-1.
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Figure 3.6 β1 integrin And ErbB2 Exist As A Complex On The Plasma Membrane.
A) Subconfluent SC cultures grown on PLL and laminin-1 were starved overnight and were
stimulated with NRG1β (10ng/ml) for 30 minutes. SCs were triple-labeled with the indicated
antibodies to assess protein co-localization. B) Subconfluent SC cultures were extracted and
lysates (TE) were pre-cleared (PC) with normal IgG and were immunoprecipitated with β1
integrin antibody (β1 IP). Western blots analysis was conducted on the immunoprecipitate, precleared, and total extracts (TE) with the indicated antibodies. C) Intact SCs in suspension were
incubated with β1 integrin antibody immobilized on magnetic beads to induce clustering. SCs
were lysed, and the immunoprecipitate (β1IP) and total cell extract (TE) were immunoblotted
with the indicated antibodies. D) Subconfluent and serum-starved SCs grown on PLL were
stimulated for 30 minutes with NRG1β (10ng/ml) in the presence and absence of AG825 (1µM).
Western blot analysis was conducted with the indicated antibodies. E) Quantification of total β1
integrin and ErbB2 expression was assessed by densitometry in starved (D0.5),
NRG1β stimulated (N) and NRG with AG825 (N+A) stimulated cultures. F) Subconfluent SCs
were starved overnight in D0.5 and then were stimulated for 30 minutes with laminin-1 (Lam;
10µg/ml) in the presence and absence of AG825 (1µM). Western blot analyses were conducted
to examine changes in receptor expression levels. G) Quantification of total β1 integrin and
ErbB2 expression in starved (D0.5), laminin-1 (L) stimulated and laminin-1 + AG825 (L+A)
stimulated cultures is shown. GAPDH was used as a loading control for all blots. The graphs
represent the average fold increase in three or more experiments. Error bars represent the SEM.
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p-values are < 0.05(*), <0.01(**), and < 0.005 (***) with respect to starved SCs or as indicated.
Scale bars represent 20µm.
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Figure 3.6 β1 Integrin And ErbB2 Exist As A Complex On The Plasma Membrane.
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Figure 3.6 β1 Integrin And ErbB2 Exist As A Complex On The Plasma Membrane.
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Figure 3.7 AG825 Increases Sch Phosphorylation In Response To Laminin-1 And NRG1β.
Subconfluent SC cultures grown on PLL were serum-starved overnight and were stimulated for
30 minutes with NRG1β (10ng/ml) and laminin-1 (Lam; 10µg/ml) together, in the absence and
presence of AG825 (1µM). A, C, E, G) Western blot analysis was conducted using phosphospecific antibodies for Sch (PS518-Sch), Pak (P-Pak), and CREB (P-CREB). Total protein
expression was analyzed using antibodies against Sch (Sch-C18), Pak, β1 integrin, and ErbB2.
B, D, F) Quantification of the expression levels of phosphorylated forms of Sch (PS518-Sch)
and Pak (P-Pak) were assessed in starved (D0.5), NRG1β and laminin-1 stimulated (N+L), and
NRG1 plus laminin-1 and AG825 (N+L+A) stimulated cultures. The amount of total Sch (SchC18), Pak, β1 integrin, and ErbB2 proteins were measured by densitometry. GAPDH was used
as a loading control. The graphs represent the average fold increase in three or more
experiments. Error bars represent the SEM. p-values are < 0.05(*) with respect to starved SCs,
or as indicated.
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Figure 3.7 AG825 Increases Sch Phosphorylation In Response To Laminin-1 And NRG1β.
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Figure 3.8 Model Of ErbB And β1 Integrin Induced Phosphorylation Of Sch And
Inactivation Of Its Tumor Suppressor Function In Subconfluent SCs.
Unphosphorylated Sch restricts proliferation by inhibiting activation of the Rac-Pak pathway in
confluent cells. In a regulatory loop, Pak phosphorylates Sch, inactivating its tumor suppressor
ability. In subconfluent SCs, Sch is phosphorylated in response to activation of ErbB2/ErbB3
and α6β1 integrin receptors by NRG1β and laminin-1, respectively, through two distinct
pathways involving PKA and Pak. Simultaneous co-activation of both receptors does not
synergistically increase Sch phosphorylation, but rather ErbB2 antagonizes Pak phosphorylation
of Sch, possibly through its activation of PKA (dashed line). Phosphorylated Sch is unable to
inhibit Rac-Pak and allows transduction of ErbB and α6β1 integrin signals that promote G1
progression. Additionally, the presence of this complex at the motile distal tip of SC processes
coordinates motility along axons and other cytoskeletal changes in response to NRG and laminin,
present in basal lamina, which is necessary for myelination of peripheral nerves during
development.
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Figure 3.8 Model Of ErbB And β1 Integrin Induced Phosphorylation Of Sch And
Inactivation Of Its Tumor Suppressor Function In Subconfluent SCs.
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CHAPTER 4
EXPRESSION OF THE NF2 TUMOR SUPRESSOR IN SCHWANN CELLS
PROMOTES PROCESS EXTENSION AND MYELINATION
4.1 Introduction
Schwann cells (SC) are the sole glial cell in the peripheral nervous system responsible for the
segregation, ensheathment and myelination of axons in nerves. SC development consists of
three main stages: proliferation and migration, defasiculation and radial sorting, and terminal
differentiation and myelination. Every stage of SC development progressing towards
myelination is accompanied by morphological changes involving the extension of processes
along and around axons. Migration requires the simultaneous extension and retraction of bipolar
SC processes in contact with axons, and is accompanied by proliferation. Radial sorting requires
SCs to extend multiple processes between axon bundles, until each axon is surrounded by SC
membrane. Myelination requires SCs to extend bipolar processes in contact with an axon, to
define the internode (the length of a SC between consecutive Nodes of Ranvier). This is
followed by radial spreading of an expansive membrane sheath inwards around an axon with
repeated spiraling to build the multi-lamellar myelin sheath that is compacted through the action
of myelin-specific proteins. Although considerable advances have been made in identifying
myelin-specific genes and proteins, very little is known about the proteins required, or the
mechanisms regulating the changes in morphology necessary for myelination, including the
fundamental ability to extend bipolar processes.

97

Several non-myelin proteins essential for SC ensheathment and myelination have been identified,
such as β1 integrin, NRG1 type III, actin, and Rac1 (Fernandez-Valle et al., 1994; FernandezValle et al., 1997; Lyons et al., 2005; Tavaggia et al., 2005; Benninger et al., 2007, Nodari et al.,
2007). Loss of β1 integrin, actin and Rac1 genes in mice results in aberrant radial sorting arising
from the inability to extend processes. Disruption of NRG1 type III in mice results in
amyelination due to decreased proliferation of SCs. Accordingly, mice with a conditional
knockout of ErbB2, the receptor for NRG1 type III, also have peripheral amyelination
(Michailov et al., 2004). Together, integrins, Rac1, and ErbB receptors participate in
cooperative signaling pathways controlling both cell cycle progression and regulation of actin
dynamics in multiple cell types (reviewed in Lee et al., 2004).

Previously, we demonstrated in SCs that Sch exists in a complex with β1 integrin and ErbB2
(Fernandez-Valle et al., 2002). More recently, we have shown that stimulation of β1 integrin
and ErbB2 receptors by laminin-1 and NRG1β respectively, promotes phosphorylation of the
NF2 tumor suppressor Sch at S518. Moreover, we demonstrated that Sch promotes process
extension and that the phosphorylation state of S518 specifies cellular morphology (Thaxton et
al., 2007a; Thaxton et al., in press). Conditional inactivation of exon 2 in the nf2 gene in mouse
SCs results in dysmyelination, revealing a possible role for Sch during myelination (Giovannini
et al., 2000). We reported that exon 2 encodes a direct binding site for paxillin (PBD1) that is
necessary for Sch localization to the plasma membrane (Fernandez-Valle et al., 2002). Others
have suggested that Sch lacking PBD1 has a decreased half-life and may undergo ubiquitinmediated degradation (Gautreau et al., 2002). Schwannoma cells lacking functional Sch
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expression also lose the ability to extend processes and assume the typical bipolar morphology.
Instead, these tumor cells become large and spread with ruffling membrane, indicative of the
increased Rac activity (Pelton et al., 1998; Kaempchen et al., 2003). Interestingly, these cells
also fail to contact or align on axons in vitro (Nakai et al., 2006). The lack of process formation
in schwannoma cells suggests that Sch may control process formation and extension in SCs, a
basic requirement for its physiological function in the nervous system.

Here, we show that a major effect of Sch expression in SCs is to increase process extension.
Exogenous expression of Sch in primary SCs induced an 82% increase in process length,
whereas expression of a dominant negative form of Sch, Sch BBA-GFP, reduced process length
by 16%. Additionally, overexpression of Sch in myelinating SCs resulted in increased internodal
length. These results are consistent with a role for Sch in process extension. However, process
extension in myelinating SCs is not regulated by Sch S518 phosphorylation, as both an
unphosphorylatable and a phospho-mimicking form of Sch equally increase myelin internodal
length. Instead, Sch phosphorylation influenced the frequency of myelination, as myelinating
SCs expressing either wild-type Sch or the unphosphorylatable form had increased numbers of
myelinating SCs. These results demonstrate that Sch is a key regulator of cytoskeletal dynamics
that induces myelination in SCs, and shed’s light on its role during SC development and
peripheral neuropathies.
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4.2 Materials and Methods
4.2.1 Materials
GFP, Sch-GFP, Sch S518A-GFP, Sch S518D-GFP were all previously described (Thaxton et al.,
2007). Sch BBA-GFP and CASPR antibodies were a generous gift from Stephen Lambert
(University of Central Florida, Orlando, FL, USA). The following materials were used: Natural
Mouse Laminin-1 and Lipofectamine 2000 (Invitrogen; Carlsbad, CA, USA). The following
antibodies were used: Neurofilament H (Daco), P-ERM (Cell Signaling), PS518-Sch (Abcam),
ErbB2 (EMD Biosciences), and Alexa Flour conjugated secondary antibodies (Invitrogen).
4.2.2 Cell Culture
Primary rat SC cultures were prepared from neo-natal pups as described previously (Chen et al.,
2000). Primary rat SC cultures were grown on poly-L-lysine (PLL; 200µg/ml) and laminin-1
(25µg/ml) coated german glass coverslips.

The SCs were then transiently transfected with

GFP-tagged constructs as described previously (Thaxton et al, 2007). For dissociate rat
Schwann cell and dorsal ganglion neuron co-cultures (SC/DRGN), DRGN were harvested from
embryonic day 15 rats as described previously (Chen et al., 2000). The equivalent of 1 DRGN is
seeded onto each PLL and laminin coated german glass coverslip. One day after harvesting, the
media for the DRGN is changed to an anti-mitotic media for purification of the neurons. Once
purified, the DRGN are washed over a week with at least three changes of media to remove the
anti-mitotic media. Next, the DRGN are seeded with primary rat SC cultures at 2x105 SCs per
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coverslip. These co-cultures are maintained until the SCs have proliferated and reached a high
density, at which point they are either transfected or used in a time course of myelination.
4.2.3 Transfection Of Schwann Cell And Dorsal Root Ganglion Neuron Co-Cultures
SC/DRGN co-cultures described above are transiently transfected with GFP-tagged constructs
using Lipofectamine 2000. Briefly, 250ng of GFP-tagged construct is transfected per coverslip
according to the manufacturer’s protocol. After 4 hours in Lipofectamine 2000, the culture
medium was replaced with the standard medium, CB10, containing 10% serum. Twenty hours
after transfection, the medium on the SC/DRGN co-cultures was replaced with media containing
ascorbic acid to induce myelination. The SC/DRGN co-cultures were then fed every other day
with medium containing ascorbic acid for at least 10-12 days, then they were fixed and
immunostained to assess myelination.
4.2.4 Immunostaining
Primary rat SC cultures were fixed with 4% paraformaldehyde, washed with phosphate buffer
(0.1M phosphate), stained with phalloidin, and mounted. Immunostaining of the SC/DRGN cocultures was as described previously (Thaxton et al., 2007), with modifications. Briefly,
SC/DRGN co-cultures were washed 3 times in Lebovitz 15 (L-15) media, followed by fixation
with 4% paraformaldehyde (in 0.1M phosphate) and permeablization with 4% paraformaldehyde
and 0.2% TritonX-100 (in 0.1M phosphate). The co-cultures were blocked in 10% normal goat
serum (NGS) in L-15 for 30minutes, incubated for 1 hour with primary antibodies, rinsed 4x in
blocking buffer, and incubated with Alexa Flour conjugated secondary antibodies. Finally, the
SC/DRGN co-cultures were rinsed 2x in blocking buffer followed by 2 rinses with phosphate
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buffer (0.1M) and mounted using BioMedia gel (Biomedia, CA, USA). All cultures were
analyzed with a Zeiss scanning laser microscope and LSM510 software. Images shown
represent single planes, and all images were processed identically.

4.3 Results
4.3.1 Sch Expression Promotes Process Extension In SCs
Dynamic control of process extension is required at every stage of SC development. This allows
SCs to migrate down axons, to proliferate in response to axonal mitogens during radial sorting,
and to delineate and establish the location of the internodes and nodes during myelination.
Previously, we showed that Sch regulates cell morphology and process formation in SCs
(Thaxton et al., 2007). Additionally, it was shown by others that schwannomas deficient in Sch
assumed a rounded shape and failed to contact and align on axons when co-cultured with
neurons (Nakai et al, 2006). To examine Sch’s role in process elongation, we transiently
transfected primary rat SCs with GFP, Sch-GFP, and the dominant negative isoform, Sch BBAGFP and measured process lengths. SCs expressing GFP extended processes that were most
frequently between 51-100µm (Figure 4.1 A, B). These SC processes typically remained within
a single frame of view, and the mean length was 140µm (Figure 4.1 C). SCs expressing SchGFP extended processes that were significantly longer than GFP controls. Often the processes
extended for 2-4 fields of view (Figure 4.1A). The most frequently occurring lengths of SchGFP positive processes ranged between 151-251µm, and again at greater than 401µm. The
average process length of SCs expressing Sch-GFP was 256µm, an 82% increase in length
compared to SC expressing GFP alone (Figure 4.1 B, C). Processes from SCs expressing Sch
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BBA-GFP averaged 118µm and the most frequent length was 51-100µm (Figure 4.1 A, B, C).
These results demonstrate that Sch modulates process elongation in SCs.

4.3.2 Sch Expression Increases Myelin Internodal Length
To determine if expression of Sch also increased myelin internodal length, we transiently
transfected SC/DRGN co-cultures with GFP, Sch-GFP, and Sch BBA-GFP twenty-four hours
prior to the addition of ascorbate, that triggers initiation of myelination. After 10 - 12 days in
ascorbate containing medium, the SC/DRGN co-cultures were fixed and were immunostained
with antibodies against myelin specific proteins. Assessment of internodal length was performed
on every GFP positive myelin segment in each culture per condition (Figure 4.2). The most
frequent length of a GFP-positive myelin internode fell between 101-125µm, with an average
internodal length of 125µm (Figure 4.2A-C). There was a modest, but consistently observed and
significant increase in internodal length in SCs expressing Sch-GFP compared to GFP. The
average internodal length was 146µm, and the most frequent length fell between 126-150µm
(Figure 4.2A-C).

Quantification of the internodal length could not be assessed for SCs

expressing Sch BBA-GFP, as these SC did not myelinate (data not shown). The absence of
myelination in SCs expressing Sch BBA-GFP is consistent with the inability of schwannoma
cells, lacking Sch expression, to extend processes toward axons and to align on them (Nakai et
al., 2006). Moreover, it demonstrates that Sch has a critical role in myelination.
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4.3.3 Myelin Formation But Not Internodal Length Is Dependent On Sch-S518
Phosphorylation
We previously demonstrated in isolated SCs that the phosphorylation state of Sch-S518 regulates
SC morphology by influencing process formation and cell polarity (Thaxton et al, 2007). SCs
expressing Sch-S518A that cannot be phosphorylated at amino acid 518, assume a unipolar
morphology, whereas those expressing a phospho-mimicking form, Sch S518D, developed
multiple processes. To examine whether Sch-S518 phosphorylation affected the myelin
internodal length, we introduced plasmids encoding the S518 Sch-GFP variants in DRGN/SC cocultures and measured the lengths of GFP-positive myelin segments. Myelinating SCs
expressing Sch S518A-GFP were most frequently between 151-175µm in length, with an
average internodal length of 156µm (Figure 4.2 A, B). These SCs were 25% and 7% longer than
myelinating SCs expressing GFP and Sch-GFP, respectively. Interestingly, the range of
internodal lengths for myelinating SCs expressing Sch S518D-GFP was the same as those
expressing Sch S518A-GFP, and the average internodal length was similar at 158µm (Figure 4.2
C). These results indicate that Sch’s ability to increase process elongation is not regulated by the
phosphorylation state of S518, but rather by its increased expression level in the cell that leads to
increased concentration of Sch at the plasma membrane.

Although the length of myelin internodes is independent of Sch-S518 phosphorylation, it is
known that phosphorylation regulates Sch’s ability to suppress growth, with the
unphosphorylated form promoting cell cycle arrest (Surace et al., 2004). In order for SCs to
begin myelination, they must exit the cell cycle and induce transcription of myelin-specific
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genes, such as myelin associated glycoprotein (MAG), myelin basic protein (MBP) and protein
zero (P0; reviewed in Jessen and Mirsky, 2005). To further analyze the effects of expression of
Sch-S518 phosphorylation variants on myelination, we quantified the ratio of GFP positive
myelinating SCs in co-cultures expressing GFP, Sch-GFP, Sch S518A-GFP, and Sch S518DGFP. These co-cultures were assessed for their overall myelination efficiency and transfection
efficiency, and only those experiments (coverslips) exhibiting equivalent transfection and
myelination efficiencies were quantified (Figure 4.2 D). Myelinating SCs expressing GFP
represented the baseline, and averaged 21 cells per culture. The average number of Sch-GFP
positive myelinating SCs per culture increased 1.57-fold, to 35, compared to myelinating SCs
expressing GFP alone. Interestingly, Sch S518A-GFP positive myelinating SCs averaged 41
cells per culture, a 1.96-fold increase over those expressing GFP. There was a 20% decrease in
myelinating SCs expressing Sch S518D-GFP as compared to those expressing GFP alone, with
only 17 cells per culture. These results were observed in three independent experiments, and
suggest that dephosphorylation of Sch-S518 regulates either the exit of SCs from the cell cycle,
and/or the initiation of differentiation of SC into a myelinating phenotype.

4.3.4 Sch-S518 Phosphorylation Decreases With The Onset Of Myelination
To further investigate the role of Sch phosphorylation during differentiation, we performed a
myelination time course in dissociated SC/DRGN co-cultures by examining the levels of
phosphorylated Sch and ERM (ezrin/radixin/moesin) at 0 hrs, 24 hrs, 6 days, and 12 days after
the addition of ascorbate (Figure 4.3). Twenty-four hours after ascorbate addition, PS518-Sch
levels were modestly increased compared to cultures maintained in medium lacking ascorbate
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(CB10, 0 hrs), whereas P-ERM levels were reduced compared to CB10. The highest level was
observed within the cytosol of SCs aligning on axons (Figure 4.3). PS518-Sch also localized
along the processes of these SCs. Six days after the addition of ascorbate, myelin is observed
and the levels of PS518-Sch were drastically reduced in myelinating SCs compared to
surrounding non-myelinating SCs, and to SCs grown in ascorbate-containing medium for 24
hours. In contrast, P-ERM staining was increased 6 days post ascorbate compared to 24 hrs post
ascorbate, and was localized along processes. At 12 days after ascorbate addition, the cocultures contained large amounts of myelin and Sch-S518 phosphorylation levels were
essentially undetectable in myelinating SCs. Focal increases in P-ERM was observed at the
distal tips of myelinating SCs representing the nodal microvilli, consistent with the known
localization of these proteins in myelinating SCs (Scherer et al., 2001).

4.3.5 GFP-Positive Myelin Segments Express CASPR and P-ERM at the Paranode and
Node of Ranvier
We sought to assess the ability of myelinating SCs over-expressing Sch-GFP to properly
synthesize and localize paranodal and nodal components. Transiently transfected dissociated
SC/DRGN co-cultures expressing GFP, Sch-GFP, Sch S518A-GFP, and Sch S518D-GFP were
induced to myelinate by addition of ascorbate, and were immunostained with antibodies against
CASPR and P-ERM (Figure 4.4). CASPR, an axonally derived paranodal protein, localized
normally in SCs expressing GFP, Sch-GFP, Sch S518A-GFP, and Sch S518D-GFP.
Occasionally, a CASPR spiral was observed (Figure 4.4, GFP), indicating that myelination was
not complete, as compaction of the myelin layers causes CASPR to compact as well (Einheber et
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al., 1997). A few myelinating SCs expressing Sch S518D-GFP had slightly altered CASPR
localization, where distinct and separated CASPR staining was observed along one process
indicating the formation of two paranodes, or possible dysmyelination (Figure 4.4, Sch S518DGFP, red). P-ERM, a glial marker for the nodal microvilli, was found localized to the distal most
aspects of myelinating SCs expressing GFP, Sch-GFP, Sch S518A-GFP, and Sch S518D-GFP.
No abnormalities in the localization and expression of P-ERM were observed in myelinating SCs
expressing any of the Sch variants (Figure 4.4, second column). These results indicate that Schmediated extension of SC internodal length is not a result of perturbation of paranodal and nodal
protein components, in either axons or glia observed at the light level.
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4.4 Discussion
Process formation and elongation is a fundamental behavior of SCs required for both
proliferation and differentiation in response to axonal contact. Several proteins, including
integrins and ErbB receptors, have been linked to SC myelination as they enable process
formation and radial sorting of axons in developing nerves. However, the downstream signaling
pathways activated by these receptors that dynamically control the cytoskeleton remain
unknown. Previous work from this laboratory has shown that Sch, through its interaction with
the scaffold protein paxillin, associates with both ErbB2 and β1 integrin at the plasma membrane
of undifferentiated and sub-confluent SCs (Fernandez-Valle et al., 2002). Moreover, activation
of each receptor triggers phosphorylation of Sch at S518 and changes in SC morphology and
polarity (Thaxton et al., 2007; Thaxton et al., in press). Thus Sch integrates signals from ErbB2
and integrins to coordinate cell cycle and cytoskeletal responses. Here we demonstrate that Sch
regulates process elongation and myelin internode length in isolated and myelinating SCs, and it
also appears to induce differentiation in a phosphorylation dependent manner. Regulation of
Sch-S518 phosphorylation dynamics downstream of ErbB2 and β1 integrin activation by NRG
and laminin may couple cell cycle arrest and initiation of terminal differentiation and
myelination in SCs.
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4.4.1 Control of Process Formation and Extension By Sch
A key event during SC development is the ability of SCs to regulate the formation of processes
in a stage dependent manner. The inability to extend and retract processes leads to aberrant
migration, radial sorting, proliferation, and myelination. Our data indicate that Sch, a tumor
suppressor that regulates actin dynamics, controls process formation and elongation. We find
that Sch expression in both primary and myelinating SCs increased cytoplasmic process and
internodal length, respectively. When Sch BBA, a dominant negative form of Sch that interferes
with the function of endogenous Sch, is expressed in primary SCs the average process length is
reduced by 16%. Interestingly, when Sch BBA is expressed in myelinating SCs, the internodal
length cannot be assessed as these SCs fail to myelinate. These results are consistent with the
inability of schwannoma cells to extend processes, contact and align on axons, and thus to
myelinate in our assays (Pelton et al., 1998; Nakai et al., 2006). Overall, our results indicate that
Sch functions to promote process formation and extension during SC development.

4.4.2 SC Myelination is Regulated by Sch-S518 Phosphorylation
The onset of myelination requires three events: (1) the establishment of a 1:1 relationship of a SC
with an axon, (2) exit from the cell cycle and (3) induction and expression of myelin specific
genes. Previously, we have demonstrated that Sch-S518 phosphorylation regulates SC
morphology (Thaxton et al., 2007). Similarly, S518 phosphorylation also controls Sch’s tumor
suppressor function, with the unphosphorylated form acting as a growth inhibitor (Surace et al.,
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2004). Here, we demonstrate that Sch-S518 phosphorylation regulates the frequency of SC
myelination. SCs expressing the unphosphorylatable form of Sch, S518A, are two times more
likely to myelinate, as indicated by the 96% increase in the number of myelinating SCs
compared to control SCs. Conversely, the phospho-mimicking form of Sch, S518D, reduces the
number of myelinating SCs by 20%. These results are consistent with accelerated differentiation
in SCs expressing the active tumor suppressor form of Sch, S518A. Additionally, when SCs
were induced to form basal lamina and myelinate by the addition of ascorbate, Sch-S518
phosphorylation was reduced as the numbers of myelinating SCs increased. These findings
indicate that Sch phosphorylation dynamics influences the induction of myelination in SCs.

4.4.3 Implications for the Development of Myelin Abnormalities and Neuropathies
NRG and ErbB2/ErbB3, and laminins (types 2 and 8) and β1 integrin signaling are critical for
every stage of SC development, including maturation, proliferation, migration and myelination
(reviewed in Garratt et al., 2000; Court et al., 2006). Conditional mutations in these genes result
in aberrant myelination due to reduced proliferation, and failed defasiculation and radial sorting
of axon bundles (Feltri et al., 2002; Michailov et al., 2004; Yang et al., 2005; Yu et al., 2005).
Recently, it was shown that Rac functions downstream of β1 integrin to facilitate process
extension and radial sorting, but the mechanisms controlling the cytoskeletal changes are unclear
(Benninger et al., 2007; Nodari et al., 2007). Interestingly, Sch participates in a negative
feedback loop with Rac, and its effector Pak, dependent on its phosphorylation at S518.
Unphosphorylated Sch can inhibit Rac activity, whereas activated Rac can phosphorylate and
inactivate Sch’s ability to restrict proliferation. Accordingly, we previously demonstrated that
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Sch is phosphorylated at S518 within radial membrane protrusions similar to those needed for
radial sorting, and that Sch regulates SC membrane dynamics and cell morphology in a
phosphorylation dependent manner (Thaxton et al., 2007). Additionally, we have shown that
Sch is phosphorylated downstream of NRGβ1 and laminin-1, and serves as a convergence point
for ErbB2/ErbB3 and β1 integrin signaling (Thaxton et al., in press). Here we extend our data to
show that Sch regulates the ability of SCs to myelinate in a phosphorylation dependent manner.
Expression of the unphosphorylated Sch variant was associated with increased numbers of
myelin-forming SCs whereas expression of the phosphorylated variant decreased the ability of
SCs to differentiate into myelinating cells. Increased Sch expression facilitates process
extension and contact with axons. At the time of radial sorting, the SCs would be in close
apposition with NRG-expressing axons and basal lamina, allowing the phosphorylation of Sch
downstream of ErbB2/B3 and β1 integrin. The phosphorylation of Sch would initiate process
formation and extension in SCs, as the phospho-mimicking form results in multipolarity
(Thaxton et al., 2007). This would allow for the defasiculation of axon bundles. As a select
group of SC prepare to myelinate, Sch would become dephosphorylated, promoting cell cycle
exit and myelination. We predict that SCs that are not associated with large diameter axons
requiring myelination would continue to express phosphorylated Sch. In support of this model, it
was found that conditional mutation of exon 2 in the nf2 gene results in dysmyelination
(Giovannini et al., 2000). When these cells are co-cultured in vitro with neurons, they fail to
extend processes and remain large, rounded cells with prominent membrane ruffles (Nakai et al.,
2006). Impaired Sch signaling would lead to the deregulation and loss of coordination of
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ErB2/ErbB3and β1 integrin signaling, resulting in dysmyelination and the formation of
schwannomas.

In summary, these results demonstrate that Sch is an integral protein controlling SC process
elongation and myelination through its ability to regulate actin dynamics. In vivo, as SCs
progress through development, the reciprocal phosphorylation and dephosphorylation of Sch
would allow for the morphological and physiological changes necessary for migration, radial
sorting, proliferation and myelination. By elucidating Sch’s cooperative role as an actin
regulator and growth inhibitor, we allow for the future development of therapeutic strategies for
the treatment of NF2 and other peripheral neuropathies.
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Figure 4.1 Expression Of Sch Increases SC Process Length
(A) Primary rat SCs were transiently transfected with either GFP alone, Sch-GFP, or Sch BBAGFP and were stained with phalloidin to assess process length. The arrows denote the measured
lengths. Scale bars indicate 20µm. (B) The frequency of process lengths from SCs expressing
GFP, Sch-GFP, and Sch BBA-GFP is shown. (C) Quantification of the mean process length for
SCs expressing GFP, Sch-GFP, and Sch BBA-GFP is shown. The graphs represent the average
distribution and mean length for each condition in three independent experiments. An average of
50-60 processes were assessed for each condition in three independent experiments. Error bars
represent the SEM. P-values are indicated as follows: (*) <0.05, (**) <0.01, (***) < 0.005.
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Figure 4.1 Expression Of Sch Increases SC Process Length.
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Figure 4.2 Sch Increases The Myelin Internodal Length And The Frequency Of
Myelination Is Dependent On S518 Phosphorylation.
(A) Dissociated SC/DRG neuron co-cultures were transiently transfected with either GFP alone,
Sch-GFP, or GFP-tagged Sch S518 phospho-variants and were induced to myelinate. The cocultures were immunostained with antibodies to MAG, P-ERM, and CASPR to assess
myelination, and with Neurofilament antibody (blue) to visualize axons. Scale bars indicate
20µm. (B) The frequency of internodal lengths from myelinating SCs expressing GFP, SchGFP, Sch S518A-GFP, and Sch S518D-GFP is shown. (C) Quantification of the mean
internodal length for myelinating SCs expressing GFP, Sch-GFP, Sch S518A-GFP, and Sch
S518D-GFP is shown. The graph represents the average myelin internodal length for each
condition in 3-4 independent experiments. All GFP+, myelinating SCs were assessed in each
culture for all conditions. (D) Quantification of the frequency of appearance of GFP+,
myelinating SCs for GFP, Sch-GFP, Sch S518A-GFP, and Sch S518D-GFP is shown. The
graph represents the fold change in the number of GFP+, myelinating SCs found in each
condition in 3 independent experiments. All GFP+, myelinating SCs were assessed per coculture for all conditions. Error bars represent the SEM. P-values are indicated as follows: (*) <
0.05, (**) < 0.01, (***) < 0.005.
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Figure 4.2 Sch Increases The Myelin Internodal Length And The Frequency Of
Myelination Is Dependent On S518 Phosphorylation.
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Figure 4.3 Sch-S518 Phosphorylation Decreases In SC At The Onset Of Myelination.
Dissociated SC/DRG neuron co-cultures were grown in standard media (CB10) until SC density
was very high. The medium was then changed to medium containing ascorbic acid (M-feed) to
induce myelination. Co-cultures were immunostained 0 hrs (CB10), 24hrs, 6 days, and 12 days
later to assess the localization and expression of ErbB2 (green), PS518-Sch and P-ERM (red)
and phalloidin (blue). Low magnification (first column) and high magnification (second
column) are shown. Arrows indicate SC of interest. Scale bars indicate 20µm.
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Figure 4.3 Sch-S518 Phosphorylation Decreases In SC At The Onset Of
Myelination.
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Figure 4.4 Expression Of Sch Phospho-variants Does Not Alter CASPR Or P-ERM
Localization In Myelinating SC/DRGN Co-Cultures. Dissociated SC/DRG neuron cocultures were transiently transfected with either GFP alone, Sch-GFP, or GFP-tagged Sch S518
phospho-variants and were induced to myelinate. The co-cultures were immunostained with
antibodies against CASPR and P-ERM to assess paranodal and nodal structures, respectively,
and with Neurofilament antibody (NF) to visualize the axon(s). Scale bars indicate 20µm and
the insets represent a 2x digital zoom of the paranodal-nodal region.
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Figure 4.4 Expression Of Sch Phospho-variants Does Not Alter CASPR Or PERM Localization In Myelination SC/DRGN Co-Cultures.
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CHAPTER 5
GENRAL DISCUSSION
The focus of this dissertation was to study the normal function of the cytoskeleton-associated
tumor suppressor, Schwannomin, during Schwann cell (SC) development; specifically on its role
in specifying SC morphology and regulating myelination. We have identified paxillin, β1
integrin, and ErbB2/ErbB3 as important upstream regulators of Schwannomin function. Control
of Schwannomin-S518 phosphorylation by these proteins is likely involved in the cytoskeletal
reorganization necessary for proper radial sorting and myelination of SCs. Conversely,
Schwannomin serves as to integrate and modify the downstream effector pathways from both β1
integrin and ErbB2/ErbB3. Deregulation of Schwannomin signaling would result in
morphological defects, abnormal myelination, and tumor predisposition as occurs in NF2. A
summation of the results found and their relevance to SC development are discussed below.

5.1 Schwannomin-S518 Phosphorylation Is Dependent On Paxillin Binding and Plasma
Membrane Localization
Paxillin binding is essential to Schwannomin’s function as a tumor suppressor as mice with a
conditional deletion of exon 2, encoding paxillin binding domain 1 (PBD1), in the nf2 gene
develop schwannomas (Giovaninni et al., 2000; Fernandez-Valle et al., 2002). Some of the most
severe forms of NF2 arise in patients carrying a mutation in, or deletion of exon 2. Previously it
was shown that paxillin binding, through PBD1, was required for Schwannomin’s plasma
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membrane localization (Fernandez-Valle et al., 2002). Expanding on these initial results, it was
shown here that Schwannomin-S518 phosphorylation also requires paxillin binding through
PBD1. Accordingly, phosphorylation of Schwannomin-S518 is regulated by it’s localization to
the plasma membrane, as those molecules that fail to target due to deletion of PBD1 remain in
the cytosol and are not phosphorylated. Moreover, Cdc42 and Pak mediate Schwannomin-S518
phosphorylation at the plasma membrane. Paxillin promotes this event by binding PKL and Pix,
a guanine nucleotide exchange factor for Cdc42, and localizing Cdc42 and Pak to the plasma
membrane (reviewed in Turner et al., 2001). Additionally, we demonstrated here that deletion of
PBD2, within the C-terminus of Schwannomin, results in unrestricted Schwannomin
phosphorylation independent of Pak activity and plasma membrane localization. A possible
explanation for this result is that deleting PBD2 perturbed Schwannomin’s ability to bind a
phosphatase and be dephosphorylated. Together these findings further demonstrate the
physiological importance of paxillin binding in regulating to Schwannomin phosphorylation at
S518 that determines its tumor suppressor function.

5.2 Schwannomin-S518 Phosphorylation Is Stimulated By NRG And Laminin-1 Through
Distinct PKA And Pak Mediated Pathways
Mitogenic and extracellular matrix (ECM) signals are fundamental for the proliferation and
migration of many types of cells (reviewed in Lee and Juliano, 2004). Specifically in SCs, the
axonal mitogen NRG, and the ECM molecule laminin are important for every aspect of SC
development (reviewed in Jessen and Mirsky, 2005). Without these ligands or their respective
receptors, ErbB2/ErbB3 and β1 integrin, SCs fail to myelinate due to reduced proliferation
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and/or the failure to associate and defasiculate axon bundles. Schwannomin, and paxillin,
associate with ErbB2/ErbB3 and β1 integrin either directly or indirectly (Fernandez-Valle et al.,
2002). Because Pak can be activated downstream of ErbB2/ErbB3 and β1 integrin in other cells,
we examined whether Schwannomin-S518 phosphorylation occurred in response to NRG and
laminin stimulation of ErbB2/ErbB3 and β1 integrin in SCs. Stimulation of SCs with NRG and
laminin revealed that Schwannomin-S518 was phosphorylated by distinct kinases. NRG
stimulation of ErbB2/ErbB3 in SCs triggered PKA dependent phosphorylation of Schwannomin,
whereas laminin-1 stimulation of β1 integrin triggered Pak-mediated phosphorylation of
Schwannomin-S518. This is the first study to identify extracellular signals that promote
Schwannomin phosphorylation in any cell type. Notably, dual stimulation of SCs with NRG and
laminin-1 did not result in a concomitant increase in Schwannomin-S518 phosphorylation, but
rather an intermediate level. Co-regulation of receptor dynamics was also observed, as NRG
stimulation of SCs led to an increase in β1 integrin protein levels, while laminin-1 stimulation
lead to an increase in ErbB2 protein levels. Overall, these results demonstrate that Schwannomin
is a key convergence point for NRG and laminin signaling that integrates and regulates the
activation of downstream signaling cascades from ErbB2/ErbB3 and β1 integrin, allowing for
controlled SC proliferation, migration, and possibly myelination.

123

5.3 Schwannomin Promotes Process Elongation In Primary And Myelinating SCs And
Controls Myelination In A Phosphorylation Dependent Manner
Until this point, the focus of this dissertation was to elucidate the mechanisms promoting
Schwannomin phosphorylation in SCs. In order to characterize the function of phosphorylated
Schwannomin in SCs, the effects of Schwannomin expression and phosphorylation on SC
morphology and myelination was examined. Schwannomin expression was found to regulate
process formation and elongation in primary SCs. Additionally, Schwannomin-S518
phosphorylation regulated actin dynamics and SC morphology, as unphosphorylated
Schwannomin promoted a unipolar phenotype, whereas the phosphorylated form promoted a
multipolar phenotype. In myelinating SCs, Schwannomin regulated the length of the internode,
consistent with its ability to increase process length in primary SCs, but this effect was
independent of S518 phosphorylation. However, S518 phosphorylation was found to be
important for the promotion of myelination. SCs expressing an unphosphorylatable form of
Schwannomin were more likely to myelinate than SCs expressing a phospho-mimicking or wildtype form of Schwannomin. In accordance, it was shown that Schwannomin phosphorylation
levels decreased during the progression of myelination. The increase in internodal length
mediated by Schwannomin expression was not attributed to disruption of the paranode or node,
as CASPR and P-ERM expression and localization were normal. In summary, these results
indicate that Schwannomin phosphorylation is an important event controlling SC morphology,
and identifies Schwannomin as a regulator of SC development, specifically during myelination.
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5.4 Implications for Schwannomin Phosphorylation During SC Development: Control Of
SC Process Formation and Extension, Migration, Proliferation, And Myelination
Migration, for most cells, requires the reciprocal extension and retraction of processes in
response to extracellular stimuli. For SCs, the crucial stimulus promoting migration is the
axonally derived mitogen, NRG. Because Schwannomin is phosphorylated in response to NRG,
and its subsequent phosphorylation results in morphological changes involving process
formation and extension, it is likely that Schwannomin phosphorylation mediates SC migration.
Initially, NRG would acutely stimulate Schwannomin-S518 phosphorylation downstream of
ErbB2, allowing processes to form and extend along an axon. With prolonged exposure to NRG,
ErbB2 internalizes and its activity and signaling are reduced (Iacovelli et al., 2007). Therefore
with time, Schwannomin-S518 phosphorylation levels will decrease concomitantly with ErbB2
levels, resulting in retraction of processes. It is important to note that at this stage in SC
development the basal lamina has not formed, therefore Schwannomin phosphorylation is not
induced, nor affected by signaling downstream of laminin and β1 integrin. The reciprocal effect
of activation and deactivation of Schwannomin and ErbB2 would allow for alternating extension
and retraction of SC processes, and movement of SCs down the developing nerve.

Radial sorting of axons immediately follows migration, and is accompanied by proliferation.
Sorting allows the SCs to adequately populate and define the axons that will be myelinated, as
opposed to those that will be ensheathed. At this stage of development the basal lamina, a
specialized form of extracellular cellular matrix (ECM), has begun to form and couples with
axonal cues to stimulate SCs to reorganize the actin cytoskeleton. In response to these cues, SCs
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will form multiple processes that will intercalate into, and segregate axon bundles until every
axon is surrounded by SC membrane. Considering that Schwannomin regulates both the actin
cytoskeleton and proliferation, and that this regulation is dependent on it’s phosphorylation at
S518, it is likely that Schwannomin phosphorylation dynamics plays a role during radial sorting
of SCs. As proposed during migration, Schwannomin-S518 phosphorylation will initially be
stimulated downstream of NRG, through ErbB2/ErbB3 and PKA. In contrast to migration,
where Schwannomin-S518 phosphorylation is transient, Schwannomin phosphorylation during
radial sorting would be sustained due to the increasing deposition of basal lamina. The presence
of laminin would stimulate Schwannomin-S518 phosphorylation through β1 integrin and Pak
and prolong Schwannomin phosphorylation. Sustained Schwannomin-S518 phosphorylation
would promote process formation and elongation required for radial sorting of axons. In support
of this model, data presented here demonstrates that Schwannomin is phosphorylated in response
to laminin-1 stimulation of SCs, through β1 integrin and Pak. Moreover, work by others
revealed that Rac functions downstream of β1 integrin to promote the formation of radial
membrane protrusions required for defasiculation (Benninger et al., 2007; Nodari et al., 2007).
In addition, Pak is activated in response to GTP loading of Rac, which leads to SchwannominS518 phosphorylation (Shaw et al., 2001; Kissil et al., 2002; Xiao et al., 2002; reviewed in
Bokoch, 2003). Although NRG signaling would be transient during radial sorting, it may
facilitate laminin signaling, as it was demonstrated here that NRG stimulation of SCs increases
β1 integrin protein levels. By increasing the levels of β1 integrin, or allowing for its stabilization
at the plasma membrane, NRG acts to prolong β1 integrin dependent phosphorylation of
Schwannomin-S518 during radial sorting in response to laminin, and enhance process formation
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and extension. Similarly, it was also shown that laminin stimulation increased ErbB2 protein
levels, indicating that NRG signaling may be modestly increased in the presence of laminin. The
co-regulation of ErbB2/ErbB23 and β1 integrin receptor signaling is a key event that finely tunes
Schwannomin-S518 phosphorylation to regulate process formation and extension, segregation of
axons, as well as proliferation.

Proliferation of SCs, and many epithelial and endothelial cell types, requires coordinated
signaling between ECM and mitogens, through integrins and receptor tyrosine kinases, like
ErbBs (reviewed in Lee and Juliano, 2004). At the time of radial sorting, SCs are exposed to
both the basal lamina and to the axon, allowing for full activation of the cell cycle. Of note,
Schwannomin’s function as a tumor suppressor is regulated by its phosphorylation at S518, as is
its ability to regulate actin dynamics (Surace et al., 2004; Rong et al., 2004; Xiao et al., 2005;
Thaxton et al., 2007). Therefore as NRG and laminin stimulate Schwannomin phosphorylation,
they concomitantly inactivate its growth inhibition to permit proliferation. Repression of
Schwannomin’s growth regulation would allow for progression through the G1-phase. Work by
others has revealed that schwannoma cells lacking Schwannomin expression have increased
levels of cyclin D1 resulting in progression through G1 into the S-phase of the cell cycle (Xiao et
al., 2005). Re-expression of Schwannomin in these cells resulted in growth inhibition and
reduced cyclin D1 levels. Additionally, sustained S518 phosphorylation in response to NRG and
laminin might prevent Schwannomin’s ability to repress Pak activation, as only the
unphosphorylated form of Schwannomin is able to suppress growth. Sustained Pak activity
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would couple with ErbB2 induced Raf activation to promote MAPK, MEK, and ERK and
progression through the G1-phase of the cell cycle.

Myelination of SCs requires exit from the cell cycle, association of a 1:1 relationship with an
axon, and the induction of myelin specific genes. Integration of signals from the axon and basal
lamina are necessary for SC differentiation. Axonal NRG determines the ensheathment fate of
axons, as well as stimulates the expression of Krox-20, a transcription factor controlling the
expression of the myelin specific genes, periaxin and P0 (Murphy et al, 1996; Michailov et al.,
2004; Taveggia et al., 2005; Iacovelli et al., 2007). Similarly, basal lamina is required for SCs to
myelinate by maintaining the proper expression of transcription factors needed for myelination,
like Krox-20, inducing the myelin specific gene P0, and by providing support and stability for
SCs during myelination (Eldridge et al., 1989; Fernandez-Valle et al., 1993; Yu et al., 2005).
Due to Schwannomin’s ability to regulate myelination, and integrate and coordinate proliferative
and morphological signaling downstream of NRG and laminin in a phosphorylation dependent
manner, it may be possible that Schwannomin contributes to signals inducing SC differentiation
into myelinating cells. The work here demonstrates that dephosphorylation of SchwannominS518 is critical in promoting myelination. Unphosphorylated Schwannomin would allow for the
retraction of multiple processes from radial sorting, and the establishment of a 1:1 ratio with an
axon. Moreover, in the unphosphorylated form, Schwannomin would be capable of inhibiting
growth, allowing for cell cycle exit and differentiation. At this stage in development, SCs are
constantly exposed to NRG and laminin, therefore other factors must contribute to the
dephosphorylation of Schwannomin, and one such factor might be cell density. As SCs
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progressively sort and proliferate, an increasing number of SCs will be present in the developing
nerve. SC: SC contact, possibly mediated through cadherins, would limit Schwannomin’s
phosphorylation. Accordingly, other labs have shown that cell density and formation of cadherin
mediated adherens junctions induce Schwannomin dephosphorylation, resulting in contact
dependent inhibition of the cell cycle (Shaw et al., 1998; Lallemand et al., 2003). Another factor
that may influence Schwannomin phosphorylation dynamics is the switch in integrins during
myelination, in which β4 integrin is more highly expressed than β1 integrin. This change in
expression might contribute to an altered response in Schwannomin phosphorylation, as β1
integrin-dependent phosphorylation may no longer occur or may be significantly reduced.
Therefore, only a transient and modest level of Schwannomin phosphorylation may present and
localized to discrete areas such as the inner mesaxon (the inner membrane responsible for
initiating wrapping of the SC membrane around the axon). Additional support is provided by our
observation that continued deposition of the basal lamina leads to a reduction of Schwannomin
phosphorylation and its re-localization to the cytosol. Eventually, Schwannomin expression
would be reduced or restricted, as is evident by the finding that in myelinated SCs,
Schwannomin is found only in the paranodal region (Scherer and Gutmann, 1996). In contrast to
myelination, those select SCs destined to an ensheathing fate would have increased levels of
Schwannomin-S518 phosphorylation. By maintaining Schwannomin phosphorylation in discrete
membrane domains, these SCs will maintain multiple processes that contact and wrap the axon
just once.
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5.5 Implications for the Development of Schwannomas and Neurofibromatosis Type 2
Altered expression and signaling of the tumor suppressor Schwannomin is the cause of
Neurofibromatosis type 2 (NF2), and leads to the development of schwannomas and other
peripheral nervous system tumors (Rouleau et al., 1993; Trofatter et al., 1993). The ability of
Schwannomin to control the signaling and response of SCs to potent stimuli, like NRG and
laminin, as shown here, conveys the importance of its expression in maintaining homeostasis of
SCs during development. This work reveals that if Schwannomin function is perturbed,
deregulation of signaling would ensue downstream of NRG and laminin, through ErbB2/ErbB3
and β1 integrin respectively. These cascades are major avenues for controlling proliferation and
actin reorganization. As a result, SCs would no longer be able to integrate signaling from the
axon or basal lamina to allow process formation and extension necessary for migration,
proliferation, radial sorting and myelination. This would lead to increased proliferation in SCs,
altered migration and radial sorting, and the inability of SCs to maintain a myelinating
phenotype. Coincidentally, schwannoma cells expressing mutant Schwannomin or those lacking
Schwannomin expression are known to have increased activation of ErbB2/ErbB3 and β1
integrin (Utermark et al., 2003; Hansen and Linthicum, 2004). These schwannomas also fail to
contact and align on axons (Nakai et al., 2006). Additionally, contact inhibition of growth is
disrupted, resulting in tumor formation (Rosenbaum et al., 1998). Moreover, SCs containing a
conditional deletion of Schwannomin that is induced at the beginning stages of myelination, have
disrupted and unorganized myelin, and are prone to hyperplasia (Giovannini et al., 2000).
Although it is not currently known whether schwannomas formed in NF2 originate from
unmyelinated, ensheathed or myelinated SCs, this work, as well as work by others suggests that
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schwannomas may in fact arise from myelinating SCs that have dedifferentiated (Hung et al.,
2002). Because NF2 is a disease that presents during puberty, it is possible that the tumors may
arise from SCs that were once myelinating but have subsequently reentered the cell cycle, due to
disrupted regulation of integrin and ErbB signaling.

Overall, the findings presented here reveal Schwannomin as a critical regulator of SC
morphology and myelination. The perturbation of Schwannomin function may not only lead to
the development of NF2, but also to the development of demyelinating diseases such as
Schwannomatosis, congenital hypomyelinating neuropathy, and congenital muscular dystrophy.
By examining the regulation of Schwannomin function by paxillin, ErbB2/ErbB3, β1 integrin,
PKA, and Pak, we have exemplified these proteins as potential therapeutic targets for the
treatment of NF2 and other peripheral neuropathies.
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APPENDIX:
EXPERIMENTAL PROCEDURES
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A.1 Molecular Cloning Procedures
A.1.1 Bacterial Transformation of Plasmid DNA
1. Pre-chill sterile electroporation cuvette(s) (0.1 cm gap), one for each sample, and a sterile
1.5 ml eppendorf tube(s) for each sample on ice.
2. Prepare a 200µl aliquot of SOC media in a 2ml tube and place on ice.
3.

Place a 40µl aliquot of electro-competent bacterial cells on ice.

4. Set the electroporator to 1.7 kV, 25 µF, 200 Ω.
5. At the electroporator, add 1µl of ligated DNA (or the equivalent of 50ng DNA) to the
electro-competent cells with gentle mixing.
6. Transfer the cell-DNA mixture to a chilled electroporation cuvette, tapping the cuvette
until the mixture settles evenly to the bottom.
7. Pulse the sample once and remove from the electroporator.
8. Add 42 µl of SOC media to the cuvette.
9. Remove the 84µl of sample and transfer to the tube containing the SOC media.
10. Incubate at 37oC for 1 hr at 225 rpm.
a. Prepare LB Agar plates with the appropriate antibiotics for the plasmids that were
electroporated into the bacterial cells.
11. Plate 50 µl of bacterial cells on 1 LB Agar plate, and 100µl of bacterial cells on another
LB Agar plate.
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a. Make sure to flame the bacterial spreader before and after each sample. Let the
spreader cool or it will kill the bacterial cells.
12. Incubate plates at 37oC overnight (less than 24 hrs).
13. Remove the plates from the incubator, you should have nice individual colonies
14. At this point you can pick individual colonies to grow up and purify, or you can wrap the
plates with parafilm and save at 4oC until ready to use (for at least a week).
For culturing Individual Colonies:
15. Prepare 5ml of LB broth plus the appropriate antibiotic for each colony to be isolated.
a. Label tubes carefully to distinguish each individual colony.
16. Using a sterile toothpick or a sterile pipet tip, scrape the individual colony of the plate,
making sure not to scrape any surrounding colonies.
17. Place the toothpick/ pipet tip into the appropriately labeled culture tube containing the
5ml of LB broth.
18. Incubate the colonies at 37oC while shaking at 225 rpm overnight (less than 24 hours).
19. The next day the broth should be cloudy, indicating growth.
20. Prepare a glycerol stock of the cultures by mixing 1ml of culture to 500µl of sterile
filtered 50% glycerol and label tube appropriately and place at -80 oC.
21. Aliquot the remaining culture(s) into 1.5ml microcentrifuge tubes and spin down at
14,000 rpm.
22. Remove the supernatant (and discard), leaving the bacterial pellet.
23. Perform a mini prep.
135

A.1.2 Mini Prep of Plasmid DNA (Qiagen QIAprep Miniprep Protocol/Method)
1. Resuspend pelleted bacterial cells in 250µl of Buffer P1.
a. If you have more then one tube of the same culture then resuspend sequentially.
2. Add 250µl of Buffer P2 and mix by inverting the tubes 4-6 times.
3. Add 350µl of Buffer N3 and mix thoroughly by inverting the tube 4-6 times.
a. A white precipitate should have formed.
4. Centrifuge sample(s) at 10,000 rpm for 10 mins.
5. Apply the supernatants from step 4 to the QIAprep spin column, making sure to avoid the
precipitate.
6. Centrifuge sample(s) for 30-60s. Discard flow through.
7. Wash the column by adding 750µl of Buffer PE and centrifuge for 30-60s at 10,000 rpm.
8. Discard the flow through and centrifuge for an additional 30-60s at 10,000 rpm.
a. This removes the excess wash buffer from the column.
9. Place the QIAprep column in a clean 1.5ml centrifuge tube and elute the DNA by adding
30ul of DNase-, RNase-, Protease-free water to the center of the column.
10. Let the water stand for 2 mins and centrifuge for 1 min at 10,000 rpm to elute the DNA.
11. Calculate the DNA concentration by using the spectrophotometer.
a. Compare OD260 between a 1:50 and a 1:100 dilution of the DNA, and average
the concentration. Make sure the OD260/280 ratio is between 1.6-1.8 for good
DNA preps.
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A.2 Biochemical Procedures
A.2.1 Transfection of Primary Rat Schwann Cells (Lipofectamine 2000)
Solution A: 20ul (OptiMEM+ DNA)/ coverslip
Solution B: 0.5ul Lipofectamine 2000/ 20ul OptiMEM for coverslips or 5ul Lipofectamine
2000/250ul Opti-MEM
Note: Schwann cells are grown on German glass round coverslips. The coverslips are coated
with 200ug/ml poly-L-lysine or 200ug/ml poly-L-lysine and 25ug/ml Laminin. Once the
Schwann cells have been seeded on coverslips, they are fed with D10M media until ready for
transfection.
1. Calculate the amount of DNA you want to transfect into cells.
a. Ex. I use 250ng of GFP tagged construct / coverslip or 1ug of Xpress-tagged
construct/well.
2. Prepare Sol’n B: Add the Lipofectamine 2000 to OptiMEM (in the ratio stated above).
Let it incubate for 5 mins. At RT.
a. While Sol’n B is incubating prepare Sol’n A
3. Prepare Sol’n A: by adding DNA to the appropriate amount of OptiMEM (in the ratio
above).
a. Ex. If you are transfecting 2 coverslips with the same DNA, you should add the
DNA (500ng) to OptiMEM so the final volume is 40ul.
4. Mix solutions A and B at a 1:1 ratio.
a. Ex. 20ul of Solution B/ 20ul Solution A for the coverslips.
5. Let the mixture incubate at room temperature for 20 mins, but no longer than an hour.
6. Prepare final solution: Once solution mixture (Solution B+A) is finished incubating add
OptiMEM to the mixture to a final ratio of 100ul of solution per coverslip, or 2ml of
solution per well.
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a. Ex. If you are transfecting 2 coverslips with the same DNA, you should add 120ul
of OptiMEM to the Solution B +Solution A mixture (from step 4).
7. Remove medium from coverslips
8. Add 100ul of final solution (OptiMEM + Solution mixture (from step 6)) per coverslip,
or 2ml for wells.
9. Let cells incubate for 4 hours in 5% CO2 at 37oC.
10. Remove transfection media from cells and add fresh media (D10M).
11. Mount or extract cells ~36 hours post transfection.
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A.2.2 Transfection of Dissociated Schwann Cell/ Dorsal Root Ganglion Neuron Co-cultures
(Lipofectamine 2000)

Solution A: 20ul (OptiMEM+ DNA)/ coverslip
* the amount of DNA and OptiMEM should total 20ul/coverslip
Solution B: 0.5ul Lipofectamine 2000/ 20ul OptiMEM
* prepare this in advance for the total number of coverslips you will be
transfecting; it needs to incubate for at least 5 mins but no longer than 30 min. It
will then be aliquoted out at step 3.
1. Calculate the amount of DNA you want to transfect into cells.
a. I transfect 250ng of DNA/cs.
2. Prepare Solution B as stated above. Let incubate at room temp. for 5 mins.
3. Solution A: Add DNA to the appropriate amount of OptiMEM
a. Ex. I am transfecting 8 coverslips with the same DNA, so I added the DNA (2ug)
to OptiMEM so the final volume is 160ul.
4. Mix Solution A and Solution B in a 1:1 ratio for each coverslip to be transfected.
a. Ex. If transfecting 8 coverslips with the same DNA, add 160ul of Solution B to
160ul of Solution A.
5. Let the mixture incubate at room temperature for 20 min.
6. Once solution mixture (Solution A+B) is finished incubating add, CB10 media to equal
100ul of final solution/coverslip. Mix well.
a. Ex. If am transfecting 8 coverslips with the same DNA, add 480ul of CB10 to the
Solution B +Solution A mixture (from step 3), this should equal 800ul of final
solution, for a ration of 100ul/ coverslip.
7. Remove media from coverslips.
8. Add 100ul of final solution from step 6/ coverslip.
9. Let cells incubate for 4 hours in 5%-5.5% CO2 at 37oC.
10. Remove transfection mixture from cells and add CB10 media.
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11. Change media from CB10 to M-feed (myelinating feed) 20hrs post transfection.
12. Continue to feed the co-cultures M-feed every other day for 10-12 days until myelination
is visible.
13. Immunostain co-cultures according to protocol and assess coverslips for GFP expressing,
myelinating Schwann cells
Condition/ Methods for Myelination of Dissociated Co-cultures

Conditions
Media before transfection

CB10

Media during transfection

CB10

Media immediately after transfection CB10
Media 20 hrs after transfection
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M Feed

A.2.3 Extraction of Primary Rat Schwann Cells (transfected and non-transfected)
Materials:
Ice
Cell Scraper(s) – one per condition
Cold PBS
Extraction Buffer (see recipe below)
Blue Microcentrifuge Pestle Tubes - 1 per condition
Pestle(s) – 1 per condition
Cells (type of cell, size of dish, and number of dishes to be determined by the experiment)
Procedure:
1. Prepare extraction buffer, chill before use.
TAN Extraction Buffer:
Stock Concentration

Final Concentration

Tris-Acetate (pH 8.0)

200mM

10mM

IGEPAL

100%

2%

NaCl

5M

100mM

ddH2O

Depends on final vol.

Depends on final vol.

Aprotinin

1mg/mL

20µg/mL

Leupeptin

1mg/mL

10µg/mL

SPP

100mM

1mM

NaF

1M

50mM
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PMSF

100mM

2mM

SOV

100mM

1mM

Note: PMSF has a half life of only 30 minutes, so do not add it until immediately
before use***
Cell Extraction
1. Rinse the dish to be extracted 2x with 4 mL chilled PBS.
2. Remove the PBS.
3. Add 80-500 µl of TAN (depending on the size of the well to be extracted).
4. Scrape dish/well with cell scraper(s).
5. Pipette extract into blue pestle microcentrifuge tubes.
6. Pellet cells by centrifugation at 14000 rpm for 10 min(s) at 4°C
7. Crush cell pellet by grinding with pestle for 20 strokes.
a. Make sure that the extract does not overflow out of tube during pestle grinding.
8.

Rotate pestle tubes at 4°C for 15 minutes.

9. Pellet cells by centrifugation at 14000 rpm for 10 minutes at 4°C.
10. Remove supernatant and place in a new, pre-chilled 1.5 ml microcentrifuge tube.
11. Perform Bio-Rad DC Protein Assay (Lowry).
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A.2.4 Lowry Method For The Determination Of Cell Lysate Protein Concentration
Note: Based on the Bio-Rad DC Protein Assay Protocol.
1. Calculate Reagent A, use 25µl of Reagent A per well.
2. Calculate Reagent S, use 20µl of Reagent S per 1000µl of Reagent A.
3. Combine Reagent A and Reagent S, this is the Working Reagent (WR).
4. Prepare the protein Standards using BSA (2mg/ml)
Standard

BSA Conc. I

BSA vol.

Extract. Buffer Vol.

Final Vol.

BSA Conc. F

#5

2.0 mg/ml

70µl

30 µl

100 µl

1.4 mg/ml

#4

1.4 mg/ml

60 µl

24 µl

84 µl

1.0 mg/ml

#3

1.4 mg/ml

20 µl

20 µl

40 µl

0.7 mg/ml

#2

1.0 mg/ml

30 µl

30 µl

60 µl

0.5 mg/ml

#1

0.5 mg/ml

30 µl

30 µl

60 µl

0.25 mg/ml

5. Add 5 µl of Blank (extraction buffer used), in duplicate, in a 96-well plate.
6. Add 5 µl of Standards (1-5) to the subsequent wells following the blank, in duplicate.
7. Add 5 µl of each Sample to the wells subsequent to the standards, in duplicate.
8. Add 25 µl of WR to each well.
9. Add 200ul of Reagent B to each well and incubate for 15 min(s) at room temp.
10. Read plate using the Lowry assay protocol in the KC Junior program.
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A.2.5 Immunoprecipitation using Total Schwann Cell Extract
A) Calculate the volume of total cell lysate required = usually 300-500ug of total lysate for
ErbB2 and integrin immunoprecipitation and 100ug for Schwann cells transfected with Xpresstagged constructs
B) Calculate volume of normal IgG required = 1ug IgG / 200ug cell lysate
C) Calculate volume of Primary Antibody required = 1ug Ab / 100ug cell lysate
1. Aliquot the appropriate amount of Total cell lysate needed (amount calculated in A)
a. Label tube Pre-clear Control (PC)
2. Add appropriate amount of IgG ( from B) into Pre-clear tube
3. Rotate at 4oC for 2 hours
4. Add 50ul of appropriate beads (Protein G or Protein A)
a. Beads are located in the 4oC fridge
5. Rotate at 4oC for 4 hours or overnight
6. Centrifuge samples at 510g at 4oC for 5 min
7. Transfer supernatant into a new tube labeled Immunoprecipitation (IP)
a. The supernatant should know be clear of all non specific binding proteins
8. Save the Pre-cleared beads, until ready to wash, at 4oC
9. Add required amount of Primary antibody (part C) to the supernatant in the IP labeled
tube ( from step 7)
10. Rotate at 4oC for 2-4 hours
11. Add 50ul of appropriate beads (Protein G or Protein A), the same used for the preclearing.
12. Rotate at 4oC for 4 hours to overnight
13. Centrifuge IP sample at 510g at 4oC for 5 min
14. Transfer supernatant to a new tube labeled post IP store at 4oC until ready to run on gel
15. Re-suspend the remaining IP beads in 1ml of TAN extraction buffer
16. Centrifuge sample(s) at 510g at 4oC for 5 min
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17. Remove supernatant from the sample carefully, DO NOT REMOVE BEADS, and
discard
18. Wash IP sample and Pre-clear sample (separately)
19. Add 1 ml of Wash B to each and rock for 1 min (RT)
20. Centrifuge samples at 510g at 4oC for 5 min.
21. Remove and discard supernatant, STAYING AWAY FROM BEADS
22. Add 1ml of Wash C to each and rock for 1 min
23. Centrifuge samples at 510g at 4oC for 5 min
24. Remove and discard supernatant, STAYING AWAY FROM BEADS
25. Add 1ml of Wash A to each and rock for 1 min
26. Centrifuge samples at 510g at 4oC for 5 min
27. Remove and discard supernatant, STAYING AWAY FROM BEADS
28. Resuspend samples (beads) in 25-50ul of 2x SDS sample buffer.
29. Boil for 5-10 mins at 95oC.
30. Save samples at -20oC, or run of an SDS-PAGE gel.
Wash A: 10mM Tris pH 7.0, 1mM EDTA, 0.5% TritonX-100
Wash B: 10mM Tris pH 7.0, 1mM EDTA, 1M NaCl, 0.5% TritonX-100
Wash C: 10mM Tris pH 7.0, 1mM EDTA, 0.2M NaCl, 0.5% TritonX-100, 0.1% SDS
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A.2.6 Magnetic Bead Immunoprecipitation of β1 integrin
Note: protocol based on the Dynal protocol for IP of M280 Tosylactivated Dynabeads.
Lifting Schwann Cells
1.

Rinse dish of cells 2x with 3-4ml of HBSS (Hank’s balanced salt solution, Ca2+ and Mg2+

free)
2.

Using 3-4ml of HBSS with 2mM EDTA, lift cells.
a. Note: if the cells do not lift within 10 min(s), add 0.05% Trypsin.

3.

Once lifted, transfer lifted cells into a centrifuge tube containing 5ml of L-15.
a. If using trypsin, inactivate by adding serum.

4.

Centrifuge cell suspension at 1500 rpm at 4oC for 5 min.

5.

Remove the supernatant, and discard, being careful not to disturb the cell pellet.

6.

Resuspend cells in 1-2 ml of L-15 + 0.1% BSA.

7.

Triturate cells to create a single cell suspension.

Determination of the amount of Ab coated beads required for IP.
1.

Determine the number of cells using the hemacytometer.

2.

Determine the number of Ab coated beads required.
a. You want a ratio of 6 Ab-coated beads per cell.

3.
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A.2.7 Preparation Of SDS-PAGE Gel And Electrophoretic Separation Of Proteins
For a 10% resolving gel:
Components

For 10ml final Vol.

H2O

4 ml

30% Acrylamide Mix

3.3 ml

1.5 M Tris (pH 8.8)

2.5 ml

10% SDS

100 µl

10% Ammonium Persulfate (APS)

100 µl

TEMED

4 µl

For a 5% Stacking Gel:
Components

For 4ml final Vol.

H2O

2.7 ml

30% Acrylamide Mix

670 µl

1.5 M Tris (pH 8.8)

500 µl

10% SDS

40 µl

10% Ammonium Persulfate (APS)

40 µl

TEMED

4 µl

1.

Assemble glass plates and gel apparatus according to the Bio-Rad manufacturer protocol.

2.

Add approximately 5ml of 10% resolving solution in between the glass plates per gel.
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3.

Pipette ddH2O gently over top of the resolving solution.

4.

Let the gel(s) polymerize for at least 25 min(s).
a. Note: IF the gel doesn’t polymerize after an hour, then something went wrong.

5.

After the resolving gel is polymerized, remove the ddH2O from the gel ad using filter

paper, remove any excess ddH2O.
6.

Pipette approximately 2ml of 5% stacking gel over the resolving.

7.

Place the well comb into the unpolymerized stacking gel.

8.

Incubate for at least 15-20 min(s) to allow the gel to polymerize.

9.

Remove comb, and assemble plates into running apparatus.

10.

Add SDS-Running buffer to the inside well and the out.

11.

Load samples into the gel wells

12.

Run gel at 200V for 45-60min(s).
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A2.8 Electrophoretic Transfer Of SDS-PAGE To A PVDF Membrane.
Note: Before assembling the apparatus, label a PVDF membrane with your initials and gel
number in the top right hand corner, then pre-soak the membrane in 100% methanol for at least
2-5 min(s).
13.

Prepare a gel ser-up sheet

14.

Assemble the transfer apparatus.

15.

Place holder into a dish filled with pre-chilled SDS Transfer Buffer.

16.

Lay the Black side of apparatus down, with the white side open and facing out.

17.

Place a filter pad down on the black side followed by a filter paper.

18.

Remove the gel(s) from the glass plates and place on top of the filter paper.
a. When separating the glass plates, try and have the gel lay on the short glass plate.
b. When placing the gel on the filter paper, turn the short plate with the gel, gel side
down onto the filter paper.

19.

Place the pre-soaked PVDF membrane on top of the gel
a. Place the membrane label side down on top of the gel, this way when it transfers,
your membrane will read as the gel set-up sheet does.

20.

Place a filter paper followed by another filter pad on top of the membrane.

21.

Carefully close the white side of the apparatus down on top of the gel sandwich and

close.
a. Try not to move the pads, papers, membrane, or gel.
22.

Place the gel sandwich into the running chamber with the black sides facing, and the

white and red side facing the same way.
23.

Fill the chamber with the pre-chilled SDS Transfer Buffer

24.

Transfer the gel overnight at 10V.
a. If the transfer buffer is not pre-chilled you can se an ice block to cool the
apparatus.
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A.2.9 Immunoblotting
* TBST=Tris-buffered Saline with Tween-20
1. Remove membrane(s) from transfer cassette(s).
2. Ink membranes with India ink (70ul/15ml TBST).
3. Rinse membrane(s) 2x for 10 mins in TBST.
4. Block membrane(s) for 30 mins at room temp while rocking.
a. Blocking solutions are as follows: 5% Bovine Serum Albumin (BAS) for
phosphorylated proteins, or 5% non-fat milk for non-phosphorylated proteins.
5. Incubate membrane(s) with primary antibody(s) for either 1 hr (non-phosphorylated
proteins) @ room temp with rocking, or overnight (phosphorylated proteins) @ 4oC
while rocking.
a. Prepare primary antibody at a final volume of 100ul in TBST
6. Remove membrane(s) from surf blotter and rinse 3x for 10 mins each at room temp.
7. Incubate membrane(s) with secondary antibodies for 30 mins at room temp.
a. Prepare secondary antibody at a final volume of 15ml in TBST.
8. Rinse membrane(s) 3x for 1o mins each in TBST.
9. Prepare the chemiluminescence detection reagents at a 1:1 ratio
a. Total volume of 6 ml needed for each membrane.
10. Lift membrane(s) and blot of excess TBST
11. Place membrane(s) on saran wrap, with the protein side facing up.
12. Incubate membrane(s) with detection reagents for 5 mins at room temp.
13. Lift membrane(s) and blot off excess detection reagent
14. Transfer membrane(s) to a new piece of saran wrap, and wrap the membrane making sure
to remove all bubbles from the protein side.
15. Expose membrane(s) to film in the dark room, and process the film.
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A.2.10 Immunostaining of Primary Rat Schwann Cells
* Use 100ul for all amounts when using coverslips
1. Remove culture medium
2. Rinse coverslips 2x with 0.1M PO4.
3. Fix: Incubate cells on coverslips with 4% paraformaldehyde for 10mins at room temp.
4. Rinse cells 3x with 0.1M PO4.
5. Permeablize: Incubate cells on coverslips with 4% paraformaldehyde + 0.2% TX-100 for
10mins at room temp.
6. Rinse coverslips 2x with 0.1M PO4 + 0.2% TX-100.
7. Block: Incubate cells on coverslips with appropriate serum at 10% (v/v) (usually 10%
Normal Goat Serum) for 30mins at room temp.
a. Type of serum used depends on the secondary antibody and what animal the
secondary Ab was made in.
b. While blocking prepare primary Ab in 10% serum.
8. Remove serum and incubate with primary Ab for 1hr at room temp.
a. While incubating prepare the secondary Ab, remembering to spin down to collect
particulates and to only take from the top.
9. Rinse cells 4x with 10% serum.
10. Incubate with secondary Ab for 30mins at room temp…in the dark (put in a drawer or
cover with foil).
11. Rinse 4x with 0.1M PO4.
12. Post-Fix: Incubate cells on coverslips with 4% paraformaldehyde for 5 mins at room
temp.
13. Rinse 2-3x with 0.1M PO4.
14. Mount coverslips on slides using Gel mount.
*Make all solutions up in 0.1M PO4, by diluting from a 0.2M PO4.
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A.2.11 Immunostaining of Dissociated Schwann Cell/ Dorsal Root Ganglion Neuron Cocultures

* Use 100ul for all amounts when using coverslips
* Using L-15 to wash with Co-cultures so that the matrix doesn’t pull up.
1. Remove culture medium
2. Rinse coverslips 2x with 0.1M PO4.
3. Fix cells with 4% paraformaldehyde (in 0.1M PO4) for 10mins at room temp.
a. Cannot use L-15 as it changes the pH of the paraformaldehyde.
4. Rinse cells 3x with L-15
5. Permeablize cells with 4% paraformaldehyde + 0.2% TX-100 (in 0.1M PO4) for 10mins
at room temp.
6. Rinse coverslips 2x with L-15 + 0.2% TX-100.
7. Block cells with appropriate serum at 10% (v/v) in L-15 for 30mins at room temp.
a. Type of serum used depends on the secondary antibody and what animal the
secondary Ab was made in, usually Normal Goat Serum.
b. While blocking prepare primary Ab in 10% serum (in L-15).
8. Remove serum and incubate with primary Ab for 1hr at room temp.
a. While incubating prepare the secondary Ab (in 10% serum in L-15), remembering
to spin down to collect particulates and to only take from the top.
9. Rinse cells 4x with 10% serum (in L-15).
10. Incubate with secondary Ab for 30mins at room temp. in the dark (put in a drawer or
cover with foil).
11. Rinse 2x with 10% Serum (in L-15).
12. Rinse 2x with 0.1M PO4.
13. Post-Fix cells with 4% paraformaldehyde (in 0.1M PO4) for 5 mins at room temp.
14. Rinse 2-3x with 0.1M PO4.
15. Mount coverslips on slides.
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16. *Make all solutions up in 0.1M PO4, by diluting from a 0.2M PO4.
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A.3 Cell Culture Procedures
A.3.1 Rat Sciatic Nerve Dissection
Materials:
•

Dissection kit: 1 pair large curved scissors, 1 pair small curved scissors, 1 pair

•

spring scissors, 1 pair curved forceps

•

Dissecting Platform (Blue Goo – Carolina Biologicals vinyl dissection pad)

•

2 Pairs of Large Forceps (autoclaved)

•

4 Large Glass Petri Dishes (autoclaved)

•

2 Large Glass Petri Dishes with Filter Paper in the bottom (autoclaved)

•

4 each of Fine Forceps, and Extra Fine Forceps

•

2 250mL Beakers with blue goo pad

•

1 60mm Dish (sterile)

•

1 35mm Dish (sterile)

•

2mL 1mg/mL Collagenase (Worthington Biochemical L50041714)

•

2mL 0.25% Trypsin/EDTA (Gibco 15015-065)

•

1 Aliquot D10

•

L15 (Gibco 11415-064)

•

70% Isopropanol

•

4 Long Needles (22G1½)

•

8 Short Needles (25G5/8)

•

PBS (sterile) (Gibco 20012-027)

•

3 Sterile Crystallizing Dishes

•

Ice

•

Glass Pasteur Pipets, regular and small bore (autoclaved)

•

1 15mL Centrifuge Tube

•

2 Small Red Biohazard Bags
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Preparation:
1. Wipe down hood and microscope with 70% isopropanol.
2. Make sure the light source is in place and the cord is taped to the walls of the hood
and out of the way.
3. Place unautoclaved instruments (fine and ultra fine forceps), and dissecting platforms
into large petri dishes and cover with 70% isopropanol. Add 70% isopropanol to
250mL beakers with blue goo pads in them. Allow to soak for 30 minutes. (After 30
minutes remove alcohol from dishes and beakers containing blue goo and allow to air
dry under the hood)
4. Add 2-3mL L-15 media to the 35mm dish, and to a 60mm dishes.
5. Fill 2 of the sterile crystallizing dishes with L-15, and put one on ice.
6. Fill the third crystallizing dish with 70% isopropanol.
7. When the blue goo pads in the 250mL beakers are dry, add some PBS to each. Keep
one on each side of the microscope. These will be for keeping instruments clean
during dissection.
Dissection:
1. Place 4-6 pups (an even number) into a large, filter –paper lined petri dish. Place
pups evenly in dish, not touching one another. Place the dish into the –20°C freezer
for about 20 minutes, or until the pups are sedated.
2. Once sedated, use the large curved scissors from the dissection kit to decapitate the
pups in the dish.
3. Place the bodies of the pups on ice in L15. Discard the heads and filter paper into a
small, red biohazard bag, labeled with the date and number of pups.
4. Remove one pup at a time and rinse with clean L15, followed by a rinse in 70%
isopropanol.
5. Pin the pup dorsal side up onto the blue goo, a secure in place with needles. Place
one needle through the spinal cord where decapitated, and one through each hind
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limb. When placing needles through the hind limbs, pull the limbs out
perpendicularly and secure on the dissection pad. Re-secure the top needle if needed
making sure that the limbs are taut, as shown below::

6. Use the spring scissors and the curved forceps to remove the skin from the legs of
each animal.
7. Using one pair of fine forceps, insert closed forceps into the right fossa behind the
femur, and open the forceps. Locate the sciatic nerve through the opening. With a
second pair of fine forceps, hold the incision open and use the first pair to clear away
connective tissue. Use both sets of fine forceps to hold the nerve at 2 ends, one close
to the knee, and the other close to the spine. Pinch the forceps to sever the nerve at
both ends while pulling up to remove the nerve segment. Place nerve segment into
the 60mm dish of L15.
8. Once all of the nerve segments have been collected, clean the segments with extra
fine forceps to remove epinurium, muscle, fat, and blood vessels that are attached.
9. Place cleaned nerves into the 35mm dish of L15.
Dissociation:
**Remember, always rinse Pasteur pipets with media containing serum before picking up nerve
segments, this will keep the nerve segments from sticking to the glass.
1. Remove L15 from 35mm dish without removing the nerve segments.
2. Add 2 mL of collagenase (1mg/mL) and incubate for 30 min at 37°C.
3. Remove collagenase without removing the nerve segments.
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4. Add 2mL Trypsin (0.25%) and incubate for 30 min at 37°C.
5. Pre-rinse glass Pasteur pipet (regular bore) with D10, then transfer the nerve segments, in
the trypsin, to a 15mL centrifuge tube containing 5mL of D10. Triturate several times to
remove nerve segments remaining in the pipet.
6. Rinse the 35mm dish with fresh D10, and then transfer it to the 15ml centrifuge tube.
7. Bring the volume in the centrifuge tube up to 10mL with D10.
8. Centrifuge for 10 min at 1500 rpm.
9. Remove supernatant, staying away from the pellet, and discard.
10. Add 2mL of D10 to the tube and triturate to break up the nerve segments at least 20 times
with a regular bore Pasteur pipet, followed by trituration with a small bore Pasteur pipet.
11. Bring the volume in the tube up to 10mL.
12. Centrifuge for 10 min at 1500rpm.
13. Resuspend into 3mL of D10, and plate on to a non-coated 60mm dish. This will be day
0, P0 of the culture.
Culture:
Day 1: Feed with 3mL D10 + AraC (add 15µL AraC for every 3mL D10).
Day 3: Feed with 3mL D10 + AraC.
Day 7: Perform Thy 1.1 Treatment. Schwann cells will be considered P1 when finished.
Day 8: Wash 2X with HBSS, then add D10M.
Day 11: Feed with D10M.
Day 14: Passage to 6 dishes. Feed with D10M. (=P2).
Day 15: Wash 2X with HBSS and feed with D10M.
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Day 19: Feed with D10M
Day 21: Freeze cells.

A.3.2 THY 1.1 Treatment
Materials:
•

2 PLL coated 100mm dishes

•

1 Aliquot of D10

•

1 Aliquot of D10M

•

Hank’s Free (Gibco 14170-112)

•

2mL 0.05% Trypsin/EDTA (Gibco 25300-062)

•

2mL Thy 1.1 (must be filter sterilized)

•

1mL Guinea Pig Complement (Rockland Inc. C300-0010)

•

1 15mL Centrifuge tube

•

Ice

Method:
1. Rinse the 60mm dish containing the culture 2X with Hank’s Free.
2. Add 2mL 0.05% Trypsin, and observe until cells come up from the plate.
3. Transfer cells to Centrifuge tube, and bring to 10mL with D10.
4. Centrifuge for 10 min at 4°C, 1500rpm.
5. Remove supernatant and discard.
6. Resuspend the cells in 2mL of Thy1.1 and incubate on ice for 30 min.
7. Bring to 10mL with D10.
8. Centrifuge for 10 min at 4°C, 1500rpm.
9. Remove supernatant and discard.
10. Resuspend in 1mL Guinea Pig Complement and incubate at 37°C for 20-30 min.
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11. Bring to 10mL with D10.
12. Centrifuge for 10 min at 4°C, 1500rpm.
13. Resuspend cells in 2mL D10 and triturate 10 times. Bring the volume in the tube up to
10mL with D10.
14. Centrifuge for 10 min at 4°C, 1500rpm.
15. Resuspend into 2mL D10M, and plate onto 2 PLL coated dishes with 6mL of D10M.
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A.3.3 Rat Dorsal Root Ganglion Dissection
Note: Laminin coating must be performed on coverslips at least 48 hours in advance
Materials:
•

1 pregnant Sprague Dawly Rat at E16 at time of dissection (Charles River)

•

Rat C-Section Kit (1 pair large sharp scissors, 1 pair large blunt scissors, 1 pair

•

large curved scissors, 3 pairs rat tooth forceps, 2 hemostats), autoclaved

•

Embryo Dissection Kit (3 pairs small curved scissors, 3 pairs curved forceps), autoclaved

•

4 Pairs Fine Forceps, sterilized in 70% isopropanol

•

4 Pairs Extra Fine Forceps, sterilized in 70% isopropanol

•

1 250mL Beaker with Blue Goo Insert

•

70% isopropanol

•

PBS (Gibco 20012-027)

•

L15 Media (Gibco 11415-064)

•

1 Crystallizing Dish

•

Tub with Tergazyme Detergent

•

1-100mm Sterile Petri Dishes

•

1-60mm Sterile Petri Dish

•

1-35mm Sterile Petri Dish

•

Plastic Box With Lid

•

Halothane or Isofluorane

•

50mL Conical Tube

•

Gauze

•

Small Red Biohazard Bags

•

Dissection Board, with 4 nails for tying back limbs

•

Electric Shaver
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•

2 Large Glass Petri Dishes

•

Ice

•

Large Petri Dish with Filter Paper Insert, autoclaved

•

Pasteur Pipets (Sterile)

•

2mL 0.25% Trypsin/EDTA (Gibco25200-056)

•

CB10 Media

•

15mL Centrifuge Tube

•

CH5 Media

•

150mm Sterile Petri Dishes (1 for every 10 coverslips)

•

Sterile Water

Preparation:
1. Wipe down hood and microscope with 70% isopropanol.
2. Wipe down light source with 70% isopropanol and put into place under the hood, taping
the loose cord to the walls of the hood so it is out of the way.
3. Place forceps into large glass petri dishes and cover with 70% isopropanol. Place under
hood, and allow them to rinse in isopropanol for 30 minutes before using.
4. Place blue goo insert into sterile 250mL glass beaker and cover with 70% isopropanol.
Allow to rinse in isopropanol for 30 minutes. After 30 minutes remove isopropanol and
allow pad to air dry under the hood. Once dry, add 200-250mL of sterile PBS. This will
be for keeping instruments clean during dissection.
5. Add about 10mL of L15 media to the 100mm dish.
6. Add about 3mL of L15 to the 60mm dish.
7. Add 1-2mL L15 to 35mm dish.
8. Fill a sterile crystallizing dish with L15 media and place on ice.
Dissection:
1. Work under the fume hood: Stuff some gauze into the 50mL conical tube and saturate
gauze with 2mL of Isofluorane, and place into the glass dessicator and secure the lid.
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2. Transfer the pregnant rat into the glass dessicator with isofluorane and sedate (do not kill)
the rat.
3. Once sedated, transfer the rat to the dissection board, dorsal side down. Secure the limbs
with twine, so that the rat is taut.
4. Shave the rat’s stomach, and sterilize with 70% isopropanol.
5. Use the rat tooth forceps and lift the skin near the genital area of the rat.
6. Use the large, sharp scissors, cut an opening in the skin. Remove the connective tissue
holding the skin to the muscle of the abdomen, and place skin to the outer sides.
7. Using the blunt scissors and a new pair of rat tooth forceps, cut a small incision into the
abdominal muscles, then using the hemostats, clamp each side of the cut, and lay the
hemostats to the outside of the rat (the hemostats will hold back the muscle). Proceed
cutting an incision with the blunt scissors from the lower abdomen up to the chest.
8. Locate the uterus and lift it out with a new rat tooth forceps. Use the sharp, curved
scissors and cut the uterus at the cervix, while lifting the intact uterine horn out of the
abdomen.
9. Place the uterine horn into a filter lined, sterile, petri dish, and carry into the tissue culture
room.
a. Using the sharp curved scissors, reach into the cavity of the adult rat, and cut the
aorta. Place the rat into a biohazard bag.
10. At this point change gloves.
11. Use a sterile set of small curved scissors, and forceps to remove cut away the outer layer
of the uterine horn; this should expose each individual placenta.
12. Using a new, sterile set of small curved scissors and curved forceps, cut the embryo (still
within its amniotic sac) away from the placenta, and place into a pre-chilled crystallizing
dish of L-15.
13. Transfer about 5 pups at a time into a 100mm dish of L15.
14. Use a new sterile set of curved scissors and forceps to remove the amniotic sac from
around each embryo. Check for the developmental stage under the microscope (The
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digits on its front paws can be webbed or separated, while the digits on its hind paws
should still be webbed)
15. Align the scissor blades from under the chin of the pup across its ear, and to the air sac
dent in the back of its head (see figure). Hold the pup firmly in place with forceps and
decapitate with scissors.

16. Using fine forceps turn the embryo onto its back, grip the umbilical cord and use a
second pair of forceps to stabilize its shoulders.
17. Once the shoulders are stabilized firmly, release the umbilical cord, and use forceps to
dislocate hip joints, allowing the embryo to lay flat. Eviscerate the embryo using the
same forceps.
18. Remove all internal organs, i.e. esophagus, from neck and abdomen of pup, being careful
not to pierce the spinal cord.
19. Reposition the pup, if necessary, and re-stabilize the shoulders using fine forceps.
20. Insert one side of another pair of extra fine forceps into the vertebral column, being
careful not to gouge or cut the spinal cord.
21. Squeeze the forceps to break the vertebrae, and continue down the vertebral column until
all vertebrae are broken. If the vertebrae will not break by squeezing with the forceps
place one set of forceps as indicated above and then use a second set of forceps to break
the bones by dragging the pointed end across the vertebrae.
22. Separate vertebrae so that the spinal cord is exposed.
23. Use forceps to tease some of the connective tissue away from the spinal cord around the
neck/shoulder area.
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24. Using one pair of fine forceps, grasp the top of the spinal cord and hold firmly in place.
Avoid squeezing forceps too tightly, as to not cut the spinal cord. If the spinal cord is too
fragile, and breaks apart during this step, it may be an indication that the embryonic stage
of this animal is too early.
25. Use a second pair of fine forceps and grasp the neck/shoulder of the embryo.
26. Hold the spinal cord in place, and pull the body of the embryo out from under the spinal
cord.
27. Transfer the spinal cord, with its attached DRGs to the 60mm dish of L-15. If the DRGs
do not come out attached to the spinal cord, it may be an indication that the
developmental stage of the embryo is too late or early.
28. Using extra fine forceps remove only the cervical DRGs from spinal cord and transfer to
the 35mm dish of L-15. Cervical DRGs can be distinguished because of their large,
rounded size (while thoracic DRGs tend to be smaller and more elongated).
29. Repeat until the desired amount of cervical DRGs are collected.
Enzyme Treatment:
**Remember to always wash Pasteur pipets with media containing serum before transferring
DRGs to keep the DRGs from sticking to the glass.
1. Once all ganglia are collected, remove L-15, without removing the ganglia, from the
35mm dish.
2. Add 2mL of Trypsin (0.25%)/EDTA to the 35mm dish and incubate at 37°C for 30
minutes.
3. Using a Pre-rinsed Pasteur Pipet, add CB10 directly to the dish, and then transfer ganglia
to a 15mL centrifuge tube.
4. Bring the volume of the centrifuge tube up to 10mL with CB10, and spin at 1500rpm for
10 minutes.
5. Remove supernatant, staying away from the bottom pellet, and discard. Add 10 mL fresh
CB10 and triturate well, then spin at 1500 rpm for 10 minutes.
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6. Remove supernatant, staying away from the bottom pellet, and discard.
7. Resuspend neurons into 5mL of the seeding media (CH5 or neurobasal media) and
triturate well. Spin at 1500rpm for 10 minutes.
a. While spinning, rinse laminin coated coverslips 2x with sterilized dH20, then
once with L-15. Add 100µL of CH5 to each coverslips and place in incubator
until ready to seed neurons.
8. Remove and discard supernatant.
9. Resuspend neurons into enough CH5 to allow for 50µL/coverslip at 1 ganglion/coverslip.
10. Seed neurons onto coverslips containing CH5.
11. Place each 100mm dish of coverslips into the incubator at 37°C, on the bottom shelf.
Care and Feeding:
1. The day after the dissection, change the media to E2F (this is an anti-mitotic). They
should remain in E2F for three days.
2. After anti-mitotic treatment, feed the cultures with CB5 (100 - 120µL) every other day.
Check the cultures every day to make sure they are not drying, and maintain the water in
the outer 150mm dish.
3. After 3 changes of CB5, the neurons are ready to be seeded with Schwann cells (2x105
Schwann cells/coverslip) in CB10 media.
4. Feed the co-cultures with CB10 every other day until the Schwann cells have proliferated
enough for the induction of myelination.
5. When the Schwann cells are plentiful enough for myelination, change the media to Mfeed (this contains 15% serum and ascorbic acid).
6. Continue to change M-feed media every other day until myelin is evident.
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A.3.4 Laminin Coating

Materials:
•

Teflon Discs

•

2 Pairs of Fine Forceps

•

Alconox Soap (1% solution)

•

3% Acetic Acid

•

70% Isopropanol

•

12mm German Glass Coverslips (Carolina Biologicals)

•

Sterile Water (Gibco 15230-162)

•

Poly-L-Lysine (PLL; Sigma P2636)

•

Borate Buffer

•

Laminin (Gibco 23017-015) – thawed on ice

•

Carbonate Buffer

•

100mm Sterile Petri Dishes (1 for every 10 coverslips to be coated)

•

Crystallizing dishes (autoclaved)

•

Side Arm Bottle

•

Mesh Sheet

•

Rubber Band

•

Tubing

•

Large Glass Petri Dish

•

Large Glass Petri Dish With Filter Paper Insert (Sterile)

•

Ice

•

15mL conical tube, prechilled

•

Dessicator(s) Assembly(ies)

•

Silicon Vacuum Grease

Preparing coverslips:
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1. Wash each coverslip with a kimwipe and alconox soap, and place into a crystallizing dish
with water.
2. Rinse with water several times until all soap is removed. Pour excess water out of
crystallizing dish being careful to avoid dropping coverslips into the sink.
3. Cover the coverslips with 3% Acetic Acid and agitate for several minutes.
4. Attach the tubing to the de-ionized water faucet and to the side arm bottle and fill the
bottle with water.
5. Pour as much of the acetic acid off of the coverslips as possible, being careful not to drop
any coverslips into the sink.
6. Use the forceps to transfer the coverslips into the side arm bottle. Tilt the bottle onto its
side to allow the coverslips to slide down to the bottom rather than dropping.
7. Use the mesh sheet and the rubber band to cover the top of the bottle and rest the bottle
on its side in the sink (prop the neck of the bottle with another crystallizing dish).
8. Turn on the water and allow the coverslips to rinse for 20 minutes. The water should be
on just enough to agitate the coverslips – do not let the water pressure get too high or it
will break the coverslips.
9. Turn off the water and tilt the bottle down so that the coverslips start to flow to the neck
of the bottle and onto the mesh. (Turn the water on and off gently until all coverslips
wash toward the mesh)
10. While the bottle is upside down, remove the mesh with all the coverslips on it and
transfer the coverslips to a sterile crystallizing dish and cover them with 70%
isopropanol.
11. Allow them to sit in 70% isopropanol for at least 30 minutes before using.
12. Place the forceps into the large glass petri dish and cover them with 70% isopropanol.
Allow to sit in 70% isopropanol for 30 minutes before using.
13. Use template to cut Teflon discs that will fit into 100mm petri dish (one disc for every 10
coverslips to be coated).
14. Wash each Teflon disc with kimwipes and alconox soap.
15. Rinse thoroughly with tap water, de-ionized water, and distilled de-ionized water.
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16. Place discs into 100mm petri dish and cover with 70% isopropanol. Allow them to sit in
70% isopropanol for 30 minutes before using.
Coating:
1. Use forceps to remove Teflon discs from 70% isopropanol and blot dry on filter paper
insert of large glass petri dish that has been autoclaved to sterilize.
2. Once dry, transfer Teflon disc to 100mm petri dish (dishes for agar plates can be used
rather than dishes treated for tissue culture, but they must be sterile), and repeat until all
dishes have Teflon discs.
3. Use forceps to transfer some coverslips to the filter paper.
4. Carefully separate each coverslip and set aside to dry. Allow only one side of the
coverslip to touch the filter paper. This will become the bottom, so it will not matter if it
has picked up lint from the filter paper.
5. Place 10 coverslips into each 100mm petri dish with a Teflon disc in the bottom.

6. Use Borate buffer to dilute PLL down to 200ug/mL and put 100uL onto each coverslip.
Go around the edges, including the outer edges, of each coverslip with the pipet tip to
make sure that PLL completely coats the coverslip.
7. Allow to sit under the hood for 1 hour.
8. Wash coverslips 2 times with sterile water.
9. Dilute Laminin to 50ug/mL with cold carbonate buffer, cool pipet tip in chilled carbonate
buffer before transferring laminin. Keep laminin solution on ice.
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10. Put 100uL of the 50ug/mL laminin onto each coverslip. Use pipet tip to go around edges,
including outer edges, and ensure that laminin completely coats coverslip. A complete
laminin coating will help to prevent the cultures from detaching.
11. Place dishes of laminin coated coverslips inside the incubator at 37°C for at least 48
hours prior to dissection.
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